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Research suggests that the concurrent use of alcohol and medications can lead to a
number of health problems. This is of importance for older adults, who take more medication
than any other age group. Despite older adults’ increased risk of alcohol-medication interaction
there has been limited research focused on the patterns and correlates of simultaneous alcohol
and medication use in older adults. The purpose of this study was to examine the prevalence and
patterns of concurrent use among community-dwelling older adults by gender, race and age. The
impact of group membership on health status was also examined.
Data from the Cardiovascular Health Study (CHS), a population-based longitudinal study
of older adults, were analyzed for this study. The CHS cohort consists of 5,888 individuals ages
65 and older. Participants completed a series of face-to-face and telephone interviews along with
clinical examinations. This analysis utilizes CHS data from waves 1 through 6.

Univariate

analyses were conducted at baseline to determine the prevalence rates and correlates of
concomitant use among older adults. Group-based logit modeling was used to chart longitudinal
patterns of use over the course of the study. Finally, multinomial logistic regression analyses
were employed to assess the relationship between various patterns of concurrent use and health
outcomes.

iv

Results demonstrated that concurrent use is fairly common among community-dwelling
older adults. Men, Whites, younger individuals and problem drinkers were significantly more
likely to concurrently use than women, African Americans, older respondents and low to
moderate alcohol users. Furthermore, group-based logic analysis revealed four distinct patterns
of concurrent use: a no to low use group, a decreasing use group, an increasing use group, and a
high use group. Males and Whites had the highest probability of being in the high use group.
Group membership was found to be related to physical and mental health. Furthermore,
concurrent use was found to increase the risk of mortality among study participants.
These findings indicate a significant need for social work and health care professionals to
educate older adults about the dangers of concurrent alcohol-medication use. Additionally, it
appears that there is a need for health campaigns that focus on the promotion of safer use of
alcohol and medications by older adults.

v
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1.0

INTRODUCTION

Medication may well be the single most important health care technology to prevent illness,
disability, and death in older adults (American Society of Consultant Pharmacists (ASCP), 2004;
American Society on Aging (ASA), 2001). Older persons with chronic conditions and diseases
benefit the most from taking medications yet risk the most from failing to take them properly
and/or combining them with alcohol (Sullivan et al., 2007; Vik et al., 2006). The misuse of
alcohol and medications among older adults is one of the most rapidly developing public health
issues in the United States (Sullivan et al., 2007; Christensen et al., 2006; Patterson & Jeste,
1999). Over half of individuals aged 65 and older consume alcohol, with approximately 34% of
older adults reporting regular weekly consumption of alcoholic beverages (Onder et al., 2002). In
addition, seniors take an average of 5.3 prescription drugs and 5.7 over-the-counter medications
a day (Substance Abuse and Mental Health Service Administration (SAMHSA), 2004; ASA,
2001). Although the interaction of alcohol and prescription drugs is an important health concern
for individuals of all ages, it is a particularly salient issue for older adults who take more
medication than any other age cohort and are more susceptible to the effects of alcohol and/or
medications.
Older adults are at an increased risk for medication misuse for a number of reasons
including but not limited to polypharmacy, socioeconomic changes, and physiological as well as
psychological changes associated with aging (Sullivan et al., 2007; Swift et al., 2007; SAMHSA,
1

2004). Social workers, who come in frequent contact with older Americans, are employed in a
variety of settings and have a wide range of duties, making them uniquely situated to deal with
issues associated with concurrent alcohol and medication use among older adults. Social
workers can play an instrumental role in identifying and reducing rates of concomitant use as
well as the subsequent negative social and economic costs associated with the behavior by
assisting in the development of screening and diagnostic measures of concurrent use;
implementing education programs for older adults, caregivers and health care professionals;
helping to form linkages among professionals in the aging care network; and assisting in the
implementation of harm reduction models.
Despite an emerging body of empirical evidence that suggests that concurrent use is
rather common among older adults, little research has focused on examining patterns of
concomitant alcohol and medication use among older adults. The primary goal of this study was
to examine the prevalence, correlates, and consequences associated with the concurrent use of
alcohol and medication in a sample of community-dwelling older adults. Although past
empirical research has examined concurrent use among community-dwelling older adults, this
study is unique in that it explores the issue of concurrent use outside of the primary and acute
care settings using longitudinal data from a large sample of individuals aged 65 and older. This
allowed for the exploration of the prevalence and patterns of concurrent use in a general
population of older adults without a precipitating adverse drug event.

2

1.1

STUDY PURPOSE

The overall aim of this research study was to examine patterns of concurrent alcohol and
prescription and/or over-the-counter medications use among community-dwelling older adults.
This study explored how usage patterns evolve over time and the factors, including age, gender,
and race, affecting various trajectories of concurrent use. Group-based modeling was used to
identify distinct clusters of individuals with homogenous longitudinal patterns of concurrent use
within the sample. Moreover, individual-level differences in concomitant usage patterns at the
group level were also explored. Being able to identify distinctive trajectories of concurrent use is
particularly helpful for both research and practice. In addition, understanding individual
developmental trajectories and what factors impact patterns of concurrent use can be
instrumental in the formulation of both policy and intervention strategies that target subgroups of
older adults at increased risk for concurrent use.
In addition to examining longitudinal patterns of concurrent use, this study sought to
explore the impact of individual trajectories of concomitant use on health status. Despite the fact
that older adults are at an increased risk of alcohol-medication interaction, limited research has
focused on the effects of concomitant alcohol and medication use on their health status. In an
effort to expand upon the existing knowledge base regarding concurrent use and health, this
study also sought to examine how specific trajectories of concomitant use affected the health
status of older adults. While existing research indicates that moderate levels of alcohol use may
be beneficial to the overall health of older adults (Hendriks & van Tol, 2005), there is reason to
believe that the concomitant use of alcohol and medication can lead to a number of significant
health problems for older adults (Blow & Barry, 2002; Kennedy et al., 1999; Weathermon &
Crabb, 1999). Physiological changes associated with aging, coupled with the high rates of
3

medication use, make older adults extremely vulnerable to the adverse effects of concurrent
alcohol and medication use. Past research indicates that a broad range of measures are necessary
to accurately assess physical and mental health functioning (Newsom & Schulz, 1996).
Therefore, a combination of measures was used to obtain a comprehensive measure of health
status including, self-reported health status and physical functioning (IADLs and ADLs) to
measure physical health status and depression to assess mental health.
Concurrent use has been defined in a variety of ways; however, a common definition and
the one employed in the present study refers to the use of one or more substances in the same
time period but not necessarily at the same time (Schensul, Convey & Burkholder, 2005;
McCabe, Cranford, Morales & Young 2006). 1 The focus of this study is the concurrent use of
alcohol and alcohol-interactive drugs. Medications are considered alcohol-interactive if the use
of alcohol with the medication influences the metabolism of the drug, impacts the enzymes
involved in drug pharmacokinetics, or magnifies the effects of the medication (Jalbert et al.,
2007; Alberta Alcohol and Drug Abuse Commission (AADAC), 2003).
The current study used longitudinal data from the Cardiovascular Health Study (CHS), a
population-based longitudinal study of nearly 6,000 adults 65 years or older, to explore patterns
of concurrent use and examine the effects of concurrent alcohol and medication on the health of
older adults. This study had three specific goals:
(1) To describe the prevalence rates of concurrent alcohol and medication use among
community-dwelling older adults. In addition, analyses were conducted to examine
whether rates of concomitant alcohol and medication use vary by demographic
factors including age, gender, and race.
1

Note: An in-depth explanation of key study terms, including definitions of concurrent use and alcohol-interactive
medications, is presented in the literature review and methodology sections.
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(2) To examine how the concomitant use of alcohol and medications in older adults
evolves over time. Analyses explored various trajectories of concurrent use and
whether individual patterns of use differ by age, gender, and race.
(3) To assess how various trajectories of concomitant alcohol and medication use affect
the physical and mental health status of older adults.

1.2

RESEARCH QUESTIONS AND HYPOTHESES

This study focused on three primary areas of interest: 1) prevalence of concurrent alcohol and
medication use among community-dwelling older adults; 2) differences in longitudinal patterns
of concurrent use among older adults and; 3) the relationship between patterns of concurrent use
and physical as well as mental health status among community-dwelling older adults. Given
these three areas of focus the current investigation addresses the following questions and
hypotheses.
Given the fact that approximately half of individuals aged 65 and older consume alcohol,
and seniors take an average of 5.3 prescription drugs and 5.7 over-the-counter medications a day
it was predicted that concurrent use would be fairly common among older adults (Substance
Abuse and Mental Health Service Administration (SAMHSA), 2004; ASA, 2001). The
literature also shows that Women and African Americans report higher rates of abstinence than
Men and Whites. Therefore, it was hypothesized that rates of concurrent use would be greatest
among males and Whites (Breslow et al., 2003)

5

1. Prevalence of concurrent use among community-dwelling older adults
Q-1: What is the prevalence rate of concurrent alcohol and medication use among
community-dwelling older adults?

H.1: Concurrent use is common among community-dwelling older adults.

Q-2: Do rates of concurrent alcohol and medication use differ by gender, race, and age?

H.2.a: Males are more likely than female community-dwelling older adults to concurrently
use alcohol and medications.
H.2.b: White community-dwelling older adults have higher rates of concurrent use than
their African American counterparts.
H.2.c: Younger community-dwelling older adults are more likely to concurrently use when
compared to older individuals.

Approximately half of all seniors consume alcohol on a regular basis and epidemiological
research on alcohol use among older adults estimates that anywhere from 2% to 15% of older
adults are at-risk or problem drinkers (Grant et al., 2004; NIAAA, 2004; Olsin & Holden, 2002;
ASA, 2001). Furthermore, 2% to 5% of these seniors meet the criteria for alcohol abuse or
dependence (NIAAA, 2004; ASA, 2001). Prevalence and amount of consumption also varies by
gender and race; men and Whites tend to consume higher rates of alcohol and drink more
frequently than women and African Americans (Satre & Arean, 2005; Breslow et al., 2003).
Based on these facts it was hypothesized that there would be several unique trajectories of
6

concurrent use. In addition, it was postulated that men and Whites would be more likely to be
members of group trajectories with higher rates of concurrent use.

2. Longitudinal patterns of concurrent use among community-dwelling older adults
Q-1: Are there varying longitudinal patterns of concurrent use among communitydwelling older adults?
H.1: There are a minimum of two distinct trajectories of concurrent use among
community- dwelling older adults.

Q-2: Do patterns of concurrent alcohol and medication use differ by gender and race?
H.2.a: Males are less likely than female community-dwelling older adults to have
patterns of concurrent alcohol and medications characterized by a trajectory of
no use over time.
H.2.b: White older adults are more likely than their African American counterparts to
have longitudinal patterns of concurrent alcohol and medication use
characterized by a trajectory of sustained concomitant use over time.

7

There are a number of serious consequences associated with concurrent alcohol and
medication use among older adults.

For example, concomitant use of medications like

benzodiazepines, muscle relaxants, and opioids can cause ADEs such as increased sedation and
decreased motor skills; these problems can lead to falls or other accidents (Tanaka, 2003;
Weathermon & Crabb, 1999). Concurrent alcohol and medication use can also adversely affects
the illness for which the medications are prescribed. Many of the chronic conditions common
among older adults such as hypertension, diabetes, gastrointestinal conditions, insomnia and
depression are exacerbated by alcohol use (Moore et al., 2007). Thus, it was hypothesized that
individuals with higher levels of concurrent use would report lower overall physical and mental
health.

8

3. The association between patterns of concurrent use and physical and mental health
status
Q-1: Do patterns of concurrent alcohol and medication use affect the physical health status
of community-dwelling older adults?

H.1.a: Older adults who have sustained longitudinal patterns of concurrent use are more
likely to report poor physical health when compared to individuals with no
concurrent use.
H.1.b: Older adults who have sustained longitudinal patterns of concurrent use are more
likely to report difficulties with physical functioning when compared to older
adults who report no longitudinal pattern of concurrent use.

Q-2: Do patterns of concurrent alcohol and medication use affect the mental health status of
community-dwelling older adults?

H.2.a: Rates of depression are more common among community-dwelling older adults
who have longitudinal patterns of concurrent alcohol and medication use when
compared to older adults who report no longitudinal pattern of concurrent use.

9

1.3

STUDY SIGNIFICANCE

In recent years, significant advances have been made in the understanding of both the aging
process with its attendant health problems and in the understanding and consequences of alcohol
misuse. However, our understanding of concomitant alcohol and medication use in older adults
remains limited. The majority of research regarding concurrent alcohol and medication use has
been conducted with young or middle-aged populations and has focused primarily on chronic
heavy drinkers; few studies have examined the alcohol-medication interactions among low to
moderate users in the general population of older adults (Onder et al., 2002). Some studies have
investigated the prevalence of concomitant use in retirement communities (Adams, 1995),
emergency room departments (Adams, 1992), primary care settings (Blow et al., 2000; Adams et
al., 1996) and hospitals (Bristow & Clare, 1992). Yet, community level studies are scarce, and
those focusing on the effects of moderate alcohol use and medication use among older adults are
even more uncommon.
This study makes a number of significant contributions to social work, gerontology, and
public health policy—all of which can help improve the lives of older adults and their families.
Furthermore, the results of this study can aid in developing programs and policies that reduce the
economic and health burdens associated with medication misuse among older adults. First, the
current study expands upon the existing knowledge base by examining concurrent use among the
full spectrum of drinkers. Examining concurrent use in community-dwelling older adults will
aid in developing a more thorough understanding of concomitant usage rates and patterns among
seniors. Studies indicate that suboptimal drug use and medication errors such as concomitant use
have an important impact on health and the national economy; adverse drug events have been
found to be associated with increased costs of care in both the inpatient and outpatient settings
10

(Burton et al., 2007). In a recent study Ernst and Grizzle (2001) found that since 1995, the costs
associated with adverse drug events has more than doubled. In 2000, the costs of drug-related
morbidity and mortality exceeded $177.4 billion with hospital admissions accounting for nearly
70% of total costs (Ernst & Grizzle, 2001). Older adults are disproportionately affected by
adverse drug events and reactions, yet, research has found that identifying problem alcohol
and/or medication misuse is particularly difficult in elderly individuals (Sullivan, 2007).
Identifying at risk individuals is the key to aiding social workers, health care professionals, and
other members of the Aging care network with designing effective education, prevention, and
intervention strategies that can assist in mitigating the high economic as well as medical burdens
associated with adverse drug events and improve the quality of life for older adults; this study
will assist in identifying specific subpopulations that may be at an increased risk for concomitant
use.
Traditionally, studies examining the concurrent use of alcohol and medication have
focused on heavy or chronic drinkers; thus, we know very little about the prevalence rates,
patterns of usage and the adverse effects of concurrent use among low or moderate drinkers.
Research paradigms that focus on persons who are abusing or who are dependent on alcohol are
not as useful when applied to older drinkers whose alcohol use, despite a lower alcohol
consumption level, can be problematic due to age-related physiological changes, medication use,
and functional mobility (Moore et al., 1999). Given these factors, it is critical that we explore
concurrent use in all older adults who consume alcohol, not just those who are considered
problem drinkers. The current study explored longitudinal patterns of concomitant use in older
adults with a range of alcohol consumption patterns. The identification of various patterns of
concurrent use, as well as the sociodemographic factors associated with unique trajectories of
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concomitant use, is crucial knowledge that can assist social workers, health professionals, and
other members of the aging care network with designing prevention as well as intervention
strategies that target at-risk population such as older adults who consume the majority of
medications taken in the United States.
In addition to issues associated with the conceptualization of concurrent use, the small
body of research that has examined the concomitant use of alcohol and medication in older
adults has largely drawn from acute or primary care settings and tends to focus on prevalence
rates rather than examining health outcomes (Aira, 2005). This study is unique in that it
examines concurrent use in a sample of community-dwelling older adults. The growing
population of older adults coupled with increased life expectancies will likely lead to more
seniors living within the community, making the understanding of the correlates and usage
patterns of concurrent use among older adults increasingly important for social workers, health
care professionals, and other individuals in the aging care network who work with older adults
on a daily basis. Data from this study can be used to educate geriatric social workers, case
managers and other health care professionals about the dangers of concomitant alcohol and
medication use. It can also help to inform relevant professionals of specific subpopulations that
are at an increased risk for concurrent use. Further, this study advances our knowledge of
concurrent use among older adults and can be used to assist geriatric social workers, as well as
other health care practitioners, in the development of policies and programs that educate older
adults about the dangers of concurrent alcohol-medication use. Additionally, it appears that
there is a need for health campaigns to focus on the promotion of safer use of alcohol and
medications by older adults. Public awareness campaigns and educational efforts are two key
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tactics that can play a large role in reducing the burden associated with medication misuse
(Sullivan et al., 2007).
Finally, despite the fact that research has shown that the use of alcohol with alcoholinteractive medications can lead to a number of physical and mental health issues, most of the
empirical research on concurrent use among community-dwelling older adults has explored the
prevalence of adverse drug events associated with concomitant use (Aira, 2005; Blow, 2002). In
the majority of these studies, adverse drug reactions have been the primary outcome measure;
therefore, we have very limited knowledge about the broader adverse health consequences
associated with concurrent alcohol and medication use. This study is unique in that it explores a
variety of health outcomes. Concomitant use is a dangerous practice that can be harmful to older
adults, reducing their quality of life, impacting upon their health, and possibly leading to lethal
consequences (Moore et al., 2007). For example, concomitant use of medications like
benzodiazepines, muscle relaxants, and opioids can cause adverse drug events such as increased
sedation and decreased motor skills, which can lead to falls or other accidents in older adults
(Tanaka, 2003; Weathermon & Crabb, 1999). In order to develop effective policies and
programs aimed at reducing medication misuse among older adults we must have an
understanding of the patterns and correlates of medication use among this population.
Understanding what subpopulations of older adults are at an increased risk for concurrent use
and identifying concomitant use patterns is crucial to developing effective prevention and
intervention strategies.
Over the coming decades, the increasing number of aging baby boomers will have a
considerable impact on the need and demand for health care among older adults (Blow et al.,
2002). With the demographic projections and alcohol use trends indicating that newer cohorts of
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older adults are more likely to drink and to have heavier drinking habits than previous
generations, alcohol use among older adults presents one of the most salient health problems
facing this country. Moreover, as the number of older individuals using prescription medications
increases, so too does the absolute number of older adults using alcohol-interactive medications.
Despite these trends, little is known about the prevalence of concurrent alcohol and medication
use in community-dwelling older adults.
The increased service needs of aging alcohol users will also place additional financial
strain on existing resources. In a recent study Ernst and Grizzle (2001) found that the costs
associated with adverse drug events have more than doubled since 1995. In 2000, the costs of
drug-related morbidity and mortality exceeded $177.4 billion, with hospital admissions
accounting for nearly 70% of total costs, followed by long-term-care admissions, which
accounted for 18% (Ernst & Grizzle, 2001). Prevention and intervention strategies are needed in
order help mitigate the high economic as well as medical burdens associated with adverse drug
events.
In spite of these facts, little is known about patterns of concurrent alcohol and medication
use among older Americans, a common form of medication misuse among older adults which
can lead to adverse drug events. The growing population of older adults has led to service
providers making primary disease prevention and the promotion of healthy lifestyles top
priorities in the provision of services to older adults. Gaining a better understanding of the
prevalence, correlates, and consequences of concomitant alcohol and medication use is critical to
developing prevention and intervention strategies that effectively meet the needs of older adults.
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2.0

2.1

REVIEW OF LITERATURE

OVERVIEW OF LITERATURE REVIEW

The literature review is divided into three major sections: alcohol use, medication use, and
concurrent alcohol and medication use among older adults. In the first section there is an
overview of the basic mechanisms for processing alcohol by older adults. The description of
alcohol pharmacokinetics is followed by a discussion of definitions, guidelines and screening,
and diagnostic issues associated with alcohol use among older adults. The next section includes
a summary of past research on the prevalence rates of alcohol use among older adults. The final
alcohol section is a review of the literature on the relationship between alcohol use and health
status among older adults.
The review of the literature on medication use among older adults follows a similar
format to that of the section on alcohol use, beginning with a summary of the pharmacokinetics
of prescription medications. This is followed by a discussion of the literature regarding the
prevalence of medication use and the risks associated with using prescription medications drugs.
The portion of the review on concurrent use ties together the research reviewed regarding alcohol
and medication use among older adults. This section includes a discussion of the prevalence and
potential consequences of concurrent use.
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2.2

2.2.1

ALCOHOL USE AMONG OLDER ADULTS

Alcohol pharmacokinetics

Alcohol pharmacokinetics in humans is a complex process and is dependent upon a number of
factors, including the amount and type of alcohol ingested, the presence of food in the stomach,
body water, age, and gender (Norberg et al., 2003). There are three basic processes associated
with the delivery and removal of alcohol (ethanol) from the body: absorption, distribution and
metabolism.
After entering the body, most alcohol (80%) is absorbed by the duodenum, a portion of
the small intestine; the remaining alcohol is absorbed through the stomach (Swift, 2003). There
are a number of factors that determine the rate at which alcohol is distributed throughout the
body. The most important is the presence of food in the stomach (Paton, 2005; Swift, 2003).
Food slows the rate of alcohol delivery to the intestine by delaying gastric emptying. Reducing
the speed at which alcohol is transported to the intestine serves to lower the resulting blood
alcohol level (Swift, 2003). In addition, food in the stomach lowers the concentration of alcohol
by dilution (Swift, 2003). Other factors that impact the absorption process are time of day, the
concentration of the alcohol ingested, and the pattern of drinking (Norberg et al., 2003).
After the stomach and intestine have absorbed the alcohol, it is distributed in the body via
the bloodstream (Swift, 2003). Most tissues—such as the heart, brain, and muscle—are exposed
to alcohol because it is dispersed throughout the water in the body (Paton, 2005). The majority
of alcohol ingested (95–98%) is metabolized in the liver, while the remainder is excreted through
the breath, urine, and sweat (Norberg et al., 2003).
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The metabolism of alcohol is a two-step process. First, the enzyme gastric alcohol
dehydrogenase (ADH) converts the alcohol to acetaldehyde (Swift, 2003). The acetaldehyde, a
highly reactive and toxic substance, is then converted to harmless acetic acid by the enzyme
aldehyde dehydrogenase (ALDH), metabolizing ethanol in the body (Paton, 2005). In healthy
individuals this oxidation process happens rapidly (Paton, 2005). As stated earlier, there are a
number of physiological and behavioral factors that influence the body’s ability to process
alcohol; of particular importance to this study are age, gender, and medication use.

2.2.1.1 Factors Influencing the Metabolism of Alcohol

Age
Older adults are especially susceptible to the adverse consequences of alcohol use because of
physiological changes associated with aging (Sullivan et al., 2007; Lands, 1998; Atkinson et al.,
1992; Vestal, 1977). Between the ages of 25 and 65, the proportion of total body weight
represented by fat dramatically increases: it doubles in men and grows by almost 50% in women
(Dufour, 1992). The result is a vast decrease in lean body mass and a reduction in total body
water (Friedlander & Norman, 2006). Alcohol is a water-soluble substance; therefore, when
alcohol is distributed in a lower volume of body water it leads to a high blood alcohol
concentration (Friedlander & Norman, 2006). As a result older adults, because of their low
levels of body water, develop higher blood alcohol levels than younger individuals who consume
the same amount of alcohol.
In addition to changes in the body’s composition, other physical conditions associated
with aging also affect the distribution and metabolism of alcohol in older adults. Aging leads to
an impaired ability to metabolize and clear alcohol from one’s system due to compromised
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hepatic and renal functioning, a decreased effectiveness of the blood brain barrier, and an
increased use of medications (Sanjuan & Langenbucher, 1999). Older adults also have lower
levels of the enzyme ADH, which inhibits their ability to metabolize alcohol as rapidly as
younger people. The result is an increased blood alcohol concentration (Beechem, 2002). A
slower metabolic rate also increases the amount of time that alcohol is in the stomach,
intensifying its toxic effects (Beechem, 2002).

Gender
Due to physiological differences between the sexes, women of all ages prove more susceptible to
the effects of alcohol than men. Women reach higher blood alcohol concentrations than their
male counterparts in the same weight-adjusted levels of alcohol consumption (Epstein et al.,
2007). This is due to several factors: women have less body water than men of a similar weight;
less lean muscle mass; and lower levels of the enzyme ADH, which is responsible for breaking
down alcohol in the stomach (Epstein et al., 2007). The unique physiology of women leads to
what has been termed the “telescoping effect”: females develop issues earlier in their drinking
careers; they suffer more severe adverse health consequences from their alcohol consumption;
and the health effects of their alcohol use emerge more rapidly than the rates seen in men
(Redgrave et al., 2003).
An example of the telescoping effect is the development of cirrhosis of the liver:
compared to men, women develop cirrhosis with less alcohol consumption and after a shorter
duration of alcohol use (Nolen-Hoeksema, 2004). Age-related changes in physiology, coupled
with the decrease of lean tissue experienced by older women, serve to intensify the telescoping
effect in females. Thus, even low to moderate levels of alcohol consumption can be particularly
hazardous for older women (Epstein et al., 2007).
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2.2.2

Alcohol Guidelines for Older Adults

The physiological changes associated with aging, high levels of physical and mental health
problems, and increased levels of medication use have led to the creation of alcohol guidelines
for older adults that are lower than those recommended for other age cohorts. The National
Institute of Alcohol Abuse and Alcoholism (NIAAA) recommends that individuals ages 65 and
older consume no more than one standard drink a day or seven standard drinks a week (NIAAA,
1995). A standard drink contains approximatly14 grams or 0.6 fluid ounces (NIAAA, 1995).
Although different brands and types of beverages vary in their actual alcohol content, a standard
drink is roughly the equivalent of one 12-ounce beer, a 5-ounce glass of wine, or 1.5-ounces of
80 proof distilled liquor (Blow et al., 2002). NIAAA guidelines also recommend that older
adults should not consume more than two drinks on any one occasion; more than this is
considered binge drinking (Blow et al., 2002). The NIAAA-recommended guidelines for levels
of alcohol use among older adults are consistent with research regarding alcohol-related
problems, as well as current data on the beneficial health effects of moderate alcohol
consumption (Blow et al., 2002).

2.2.3

Definitions of Alcohol Use among Older Adults

Older adults who consume alcohol can be placed into one of five categories: abstinence, lowrisk, at-risk, problem, and alcohol abuse or dependence (Barry et al., 2001; Blow, 1998). These
categories of alcohol use are designed to form a framework for understanding the spectrum of
alcohol consumption among older adults (Barry et al., 2001; Blow, 1998).
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Older adults who presently consume no alcohol are classified as abstainers (Barry et al.,
2001; Blow, 1998). Individuals are categorized as low-risk drinkers if their alcohol consumption
is below or within the recommended guidelines for older adults—one or less drinks a day or no
more than seven drinks a week (Barry et al., 2001; Blow, 1998). Older adults who drink above
the recommended guideline but who do not meet specific criteria for alcohol abuse or
dependence are classified as at-risk drinkers (Oslin & Holden, 2002; Barry et al., 2001; Blow,
1998).
At-risk drinkers are individuals who may develop alcohol-related problems because they
consume more than one drink a day or seven drinks a week. This is a particularly relevant
classification category for older adults who may be consuming what they believe are safe
amounts of alcohol, but who are putting themselves at risk for alcohol-related problems due to
the physiology of aging and increased levels of medication use.
Problem use is defined as the consumption of alcohol at a level that has already led to a
least one adverse medical, psychological or social consequence (Olsin & Holden, 2002; Barry et
al., 2001; Blow, 1998). For example, an individual’s alcohol use may negatively impact his/her
depression or diabetes. It is not assumed that alcohol is the cause of the problem; however, there
is an inference that the usage has led to or has exasperated the issue (Olsin & Holden, 2002).
The final classification category is alcohol abuse or dependence. According to the most
recent version of the Diagnostic and Statistical Manual Fourth Edition (DSM-IV), alcohol abuse
is characterized by an inability to fulfill responsibilities and continued drinking despite
experiencing negative consequences (American Psychiatric Association (APA), 2000). Alcohol
dependence or alcoholism is distinguished by the following: a loss of control, a preoccupation
with alcohol, and physiological symptoms such as tolerance and withdrawal (APA, 2000). It is
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worth noting that the DSM-IV criteria for diagnosing alcohol abuse and dependence have
undergone minimal validation with older adults; criteria are based on knowledge gathered from
young to middle-aged adults (Olsin & Holden, 2002). Therefore, the DSM-IV criteria may not
be the best way to assess hazardous drinking in older adults (Olsin & Holden, 2002). Recently,
the accuracy of current problem rates among older adults has been called into question (Barrick
& Connors, 2002; Klein & Jess, 2002; Johnson, 2000). It is suggested that the prevalence of
alcohol use among older adults significantly underestimates the problem (Barrick & Connors,
2002).

2.2.4

Screening and Diagnostic Issues

Diagnostic criteria and screening instruments for addictive disorders have tended to ignore age,
lending to a dearth of information on specific diagnostic criteria for older adults (O’Connell et
al., 2004). Thus, traditional screening instruments are not as useful when applied to older
drinkers where substance use, regardless of consumption level, can be problematic because of
age-related physiological changes, medication use, and functional mobility (Moore et al., 1999).
A lack of adequate detection and diagnostic techniques for older adults means that substance
abuse often goes undetected in this population, and those needing treatment do not receive
services. One of the primary issues associated with determining accurate prevalence rates of
alcohol use among older adults is the lack of adequate geriatric screening and diagnostic tools.
This problem is confounded by age-related social and physiological issues. The number and
interrelationship of physical and mental health disorders in older adults can complicate the
diagnosis and treatment of substance abuse disorders. Typically, substance-related problems in
this population are only identified when these individuals are hospitalized for physical illnesses.
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Although screening instruments and diagnostic criteria for alcohol use disorders are
clearly defined for younger populations, there is a lack of information on age-specific criteria for
older adults (O’Connell et al., 2004). In a study of patients entering a general hospital in the
United States, 60% of people under the age of 60 who screened positive for alcoholism were
identified, as compared to only 37% of those persons 60 and older (Lynskey et al., 2003). Many
of the social and legal problems that have served as traditional markers of alcohol-related
problems may not be applicable to older individuals (Lynskey et al., 2003).
Additionally, existing measures of alcohol use, even those developed specifically for
geriatric populations, are based on paradigms of alcohol use that have conceptualized alcoholrelated problems in terms of abuse and dependence. These paradigms are not as useful when
applied to older drinkers whose alcohol use, regardless of consumption level, can be problematic
because of age-related physiological changes, medication use, and issues related to functional
mobility (Moore et al., 1999). Adequately determining alcohol usage among older adults is
further complicated by the natural processes of aging. Self-reports of alcohol consumption by
older adults may be difficult to assess due to poor recall, especially if there are medical or
psychiatric conditions that impair cognitive functioning (Crum et al., 2002). Moreover, service
providers may have problems distinguishing symptoms of excessive alcohol consumption from
health problems that are natural consequences of aging, such as forgetfulness, depression and
unsteady gait (Klein & Jess, 2002).
Thus, screening tools that detect hazardous drinking (consumption above the
recommended guidelines for older adults) as well as alcohol abuse among older adults need to be
designed. Furthermore, diagnostic criteria should be able to classify drinking behaviors among
older adults along a spectrum of use that takes into account the unique risks associated with
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drinking in late life. Finally, screening and diagnostic tools need to be designed in a manner that
takes into account the unique challenges associated with aging such as cognitive decline and
comorbid health conditions.

2.2.5

Prevalence Rates of Alcohol Use among Older Adults

In recent years, there has been an increase in research on the use, misuse and abuse of alcohol by
older adults (Klein & Jess, 2002; Johnson, 2002). Scholars have identified five primary reasons
for the expanded interest in problem drinking among older adults: (1) the growing population of
individuals aged 65 and older; (2) the lower prevalence of abstinence and more problem drinking
among younger age cohorts; (3) the continued under-identification, diagnosis and treatment of
older adults with alcohol use disorders; (4) the likelihood of the increased utilization of mental
health services among older adults; and (5) the high costs associated with treating alcohol and its
related health conditions (Gurnack, 2002; Klein & Jess, 2002; Gurnack & Hoffman, 1992).
Even though there has been an expansion of the literature about alcohol use disorders in
older adults, the findings have often been inconsistent, and there are still large gaps in the
knowledge base, especially in regards to alcohol use among older women and minority
populations. Despite inconsistent findings, it is almost universally accepted that substance
misuse and abuse, particularly of alcohol, among older adults is becoming one of the fastest
growing health problems in the United States (ASA, 2001; Rigler, 2000).
Research indicates that 50% of older adults consume some alcohol, with approximately
34% of respondents reporting regular alcohol consumption (Onder et al., 2002; SAMHSA, 2002;
ASA, 2001). A recent study of Medicare beneficiaries found that one-quarter of respondents
drank within the NIAAA guidelines for older adults (Merrick et al., 2008). These findings are
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similar to those found in a large sample of primary care patients: 21.5% drank within the
guidelines of seven or less drinks a week (Kirchner et al., 2007). Although half of all older
adults abstain from alcohol use and an additional quarter are low-risk drinkers, many older adults
drink above the recommended guidelines, placing themselves at risk for the negative
consequences associated with alcohol use (NIAAA, 2004).
It is estimated that anywhere from 1% to 15% of older adults are at-risk or problem
drinkers; rates vary based on how rates of alcohol use were conceptualized (NIAAA, 2004). In
their cross-sectional study of nearly 50,000 older adults, Kirchner and colleagues (2007) found
that 4.1% of respondents were at-risk drinkers, consuming between 8 to 14 drinks a week, which
is in excess of the recommended alcohol guidelines for older adults. Another recent study of
alcohol usage among seniors found that 9% of the study participants utilized alcohol at levels
that exceeded the guidelines of no more than 30 drinks a month or the single day limit of three
drinks (Merrick et al., 2008). Analysis of the 2005 National Survey on Drug Use and Health
revealed that 8.3% of older adults reported binge use, defined as 5 or more drinks on one
occasion which is the standard for adults but greater than the recommended definition of binge
drinking for older adults which is 2 or more drinks on one occasion (Merrick et al., 2008; Blow
et al., 2002). Other recent research also points to harmful alcohol use among older adults. In a
large study of older primary care patients, 4.5% were heavy drinkers, consuming 14 or more
drinks a week (Kirchner et al., 2007). These findings are consistent with epidemiological
research on alcohol use among older adults which estimate that anywhere from 2% to 15% of
older adults are at-risk or problem drinkers and between 2% to 5% of these seniors meet the
criteria for alcohol abuse or dependence (Grant et al., 2004; NIAAA, 2004; Olsin & Holden,
2002; ASA, 2001).
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It should be noted that recent work has called into question the accuracy of current
statistics regarding the prevalence of alcohol use disorders in elderly populations. Rates vary
based on methodological differences between studies including: the study's location, the
population studied, how alcohol-related problems are defined, and the age limits used. One of
the primary reasons for variations in prevalence rates results from the various definitions of
problem alcohol use employed by the researchers and how studies define levels of drinking
behavior (Blow & Barry, 2002). Some studies use NIAAA guidelines to classify individuals into
categories based on the quantity of alcoholic beverages they consume while others look at the
quantity and frequency of consumption but use general drinking guidelines instead of those
specifically designed for older adults. Moreover, researchers and clinicians have suggested that
problem drinking is underestimated due to a variety of factors, including low rates of alcohol
screening, insufficient diagnostic criteria, and misinterpretation of abuse symptoms.

2.2.5.1 Gender Differences in Prevalence Rates of Alcohol Use by Older Adults
Although limited research has focused on alcohol consumption and older women, the research
that does exist suggests that there are gender differences in prevalence rates and utilization
patterns between men and women. Studies have shown that older women are more likely to
abstain from alcohol use than men, and that women that do drink have lower rates of heavy
drinking than their male counterparts (Breslow & Smothers, 2004; Breslow & Smothers, 2003).
Between 2000 and 2001, approximately 11 million older adults consumed alcohol
however, the prevalence and level of alcohol use differs between men and women (Breslow et
al., 2003). In a recent study, a higher percentage of older women (62.8%) than older men
(48.9%) reported abstaining from alcohol use in the past year; women also had higher levels of
lifetime abstinence compared to men (42% versus 19.3%) (Breslow et al., 2003). Data from the
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National Health Interview Survey also indicate lower levels of alcohol use by older women, with
41% of women compared to 56% of men between the ages of 65 to 74 consuming alcohol in the
past year (Schoenborn & Adams, 2002). Of individuals ages 75 and older, 30% of women
versus 45% of men reported drinking in the last year (Schoenborn & Adams, 2002).
In addition, to variations in the prevalence of alcohol use between the genders, evidence
also points to differences in usage patterns between men and women. Research on the
prevalence of alcohol use in individuals over the age of 65 has found that 37.6% of men and
32.3% of women consumed moderate amounts of alcohol; both men and women consume less
quantities of alcohol at one time as they age (Breslow & Smothers, 2004; Breslow et al., 2003).
Finally, studies indicate that older men have a higher prevalence of hazardous drinking than
women—10% to 16% versus 1% to 8%, respectively (Merrick et al., 2008; Breslow & Smothers,
2004; Breslow et al., 2003; Fleming, 2004).
Despite the fact that men consume more alcohol than women, alcohol use by females is a
growing problem. Decreased disparity in drinking between younger men and women, coupled
with other emerging cohort-related factors impacting women’s consumption patterns, creates an
expectation that the prevalence of older female drinkers will increase in the upcoming decades
(Epstein et al., 2007). For example, in their study of cohort effects on gender differences in
alcohol use, Holdcraft and Iacono (2002) found higher rates of alcohol dependence in individuals
born in later cohorts compared to participants from earlier birth groups. This difference was
particularly high among women: the prevalence of alcohol dependence in later cohorts was
117% greater for women versus only 21% for men (Holdcraft and Iacono, 2002).
In addition to gender differences in consumption rates, a growing body of literature has
provided evidence to support assertions that there are variations in alcohol usage patterns
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between men and women. Research indicates that roughly one-third of older alcoholics are lateonset drinkers who typically experience their first alcohol-related problems after age 40
(Menninger, 2002). Late-onset drinking appears to be more prevalent in females than males and
is often associated with difficulties coping with a wide variety of age-related changes and
stressors (Barrick & Connors, 2002). Variations in drinking patterns between the sexes have also
been found in longitudinal studies of alcohol use among older adults. One examination of
alcohol consumption by the elderly found that moderate drinking in women decreased with age;
however, heavy drinking remained stable (Breslow et al., 2003).

2.2.5.2 Racial Differences in Prevalence Rates of Alcohol Use among Older Adults
Little research has specifically focused on alcohol use among older adult racial and ethnic
minority populations. The majority of the research on alcohol-related issues in the United States
has been conducted with samples of Whites, largely ignoring the potential influence of cultural
factors such as race or ethnicity (Caetano, 1998). Over the past decade, while considerable
advances have been made in alcohol studies among ethnic minorities these groups remain
underrepresented in alcohol research, particularly in studies regarding older adults. The limited
research that does exist on alcohol use in racial and ethnic minority populations has primarily
focused on comparing drinking patterns and problems between African Americans and Whites
(Jones-Webb, 1998). Therefore, this discussion will focus on the prevalence of alcohol
consumption in African Americans and Whites.
Studies have consistently found that older African Americans tend to drink less than
Whites (Satre & Arean, 2005; Breslow et al., 2003). For example, a report using data from
National Survey on Drug Use and Health (NSDUH) found that in 2000, rates of alcohol
consumption among individuals aged 55 and older during a one-month period were twice as high
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among Whites (40%) as compared to African Americans (20%) (SAMHSA, 2001). NSDUH
data from 2002 and 2003 also showed higher rates of alcohol consumption among Whites aged
50 and older (SAMHSA, 2005). Alcohol use in the past month for adults aged 50 and above was
48.3% among Whites versus only 30.2% among African Americans (SAMHSA, 2005).
Older Whites drink higher quantities of alcohol than older African Americans. In their
analysis of data from three nationally representative surveys, Breslow and colleagues (2003)
found that in older White men and women had the highest prevalence of moderate and heavy
alcohol use compared to other racial and ethnic groups. These findings are supported by a recent
study of nearly 50,000 Medicare beneficiaries ages 65 and older, in which African (81%) had
higher rates of abstinence than Whites (63%) (Merrick et al., 2008). In the same study, nearly
10% of Whites versus only 5.6% of African Americans, reported drinking above the
recommended guidelines of one drink a day or seven drinks a week (Merrick et al., 2008).

2.2.6

Alcohol Use and Health Status among Older Adults

Research has shown that many of the acute and chronic medical and psychiatric conditions
experienced by the elderly are influenced by the consumption of alcohol (Blow & Barry, 2002).
Although rates of heavy drinking among older individuals are fairly low, many older Americans
engage in alcohol consumption that exceeds the recommended guidelines for older adults. It is
estimated that nearly 10% of older adults drink alcohol above the NIAAA recommended limits
(Blow & Barry, 2002). Age-related changes in physiology cause levels of alcohol tolerance to
decline while sensitivity increases, potentially putting older persons who consume alcohol,
especially those that exceed recommended guidelines, at risk for adverse health consequences
(Kennedy et al., 1999). Alcohol use among older adults can lead to the development of new
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physical and mental health conditions, can interfere with the management and treatment of
existing conditions, and can decrease overall quality of life in old age (Zanjani et al., 2008;
Onder et al., 2002; Weintraub et al., 2002).
Alcohol-related health problems account for a significant proportion of hospital
admissions among older adults, with considerable economic and social costs as well as high
morbidity and mortality rates (Onder et al., 2002). Furthermore, serious medical conditions are
more common among older adults who misuse alcohol than among the overall population of a
similar age (O’Connell, 2003). Individuals who have had a history of heavy drinking have also
been shown to be affected by more major illnesses, self perceived health status, more visits to the
doctor, and more depressive symptoms than non-heavy drinkers and alcohol abstainers
(O’Connell, 2003). For example, in a recent study of male veterans aged 65 and above,
individuals classified as problem drinkers were significantly more likely than non-problematic
alcohol users to report having a chronic disease, a diagnosis of depression or a functional
impairment (Zanjani et al., 2008).
In addition to impacting the overall health burden experienced by older adults, alcohol
use is a primary correlate of disease. Alcohol has been linked to over 60 diseases: including,
cancer, gastrointestinal disturbances, depression and cognitive impairment (Taylor et al., 2005;
Corrao et al., 2004; Moore et al., 2003). The relationship between alcohol and disease etiology
is based on a variety of factors including the average amount of alcohol consumed as well as the
pattern of consumption (Taylor et al., 2005).
Epidemiological evidence has made a strong link between the use of alcohol and an
increased risk for certain cancers. For example, in a recent meta-analysis of studies on alcohol
consumption and disease, the use of alcohol was strongly associated with an increased risk for

29

cancers of the oral cavity, esophagus, and larynx (Corrao et al., 2004). There is also an
association between alcohol consumption and cancers of the liver, bowel and breast (Zhang et
al., 2007; Corrao et al., 2004). Furthermore, heavy use of alcohol has been linked to a number of
gastrointestinal disorders, including gastritis, stomach ulcers, cirrhosis and pancreatitis (FalckYtter et al., 2000). For example, prolonged alcohol use over the lifespan can lead to cirrhosis
and pancreatitis in approximately 20% of people (Perreira & Sloan, 2002). In their metaanalysis, Taylor and Rehm (2005) found that even a moderate intake of alcohol was related to a
number of gastrointestinal conditions. Finally, chronic alcohol use is associated with a decrease
in the effectiveness of the immune system, which results in a heightened susceptibility to
infections such as pneumonia and tuberculosis (Chang et al., 2002).
Alcohol not only impacts the physical health of older adults, it can also contribute to the
development of mental health disorders such as depression and anxiety. Serotonin and other
neurotransmitters in the brain that play an integral role in preventing depression are affected by
alcohol use (Devanand, 2002; Thomas et al., 2002; Swift, 1999). Comorbid alcohol use
disorders and depression are common among older adults; it is estimated that anywhere from
15% to 30% of individuals with late-life depression also have alcohol-related problems
(Devanand, 2002). Problem alcohol use has also been associated with cognitive decline
(Thomas et al., 2001). Neurotoxic effects associated with problem alcohol use can lead to the
development of alcohol-related dementia or other illnesses, such as Alzheimer’s or WernickeKorsakoff syndrome (Thomas et al., 2002; SAMHSA, 1998). These illnesses are associated with
memory loss, cognitive problems and motor impairment (Friedlander & Norman, 2006).
Despite the solid body of research correlating alcohol use with health and disease, the
relationship between health and drinking in late-life has become complicated in light of a
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growing body of literature touting the benefits associated with moderate levels of drinking
(Hendriks & van Tol, 2005). This emerging research increasingly points to the benefits of lowrisk alcohol use among older adults. In general, findings suggest that the consumption of
moderate amounts of alcohol are not necessarily harmful and may have some beneficial impacts
upon health (Hendriks & van Tol, 2005). For instance, the relationship between cardiovascular
health and alcohol use among older adults has been widely explored, and has often been used as
an example of the protective effects of alcohol use among older adults (Turvey et al., 2006; Thun
et al., 1997; Scherr et al., 1992). One illustration of this protective relationship between alcohol
and disease can be seen in a study of individuals ages 70 and older: persons who consume
approximately one drink per day had a lower relative risk of coronary disease compared to
abstainers or heavy drinkers (Turvey et al., 2006). It should be noted that moderate alcohol
consumption has only been shown to reduce the risk of specific conditions, including some
forms of dementia, cardiovascular disease, and certain cancers (Blow, 2002).
The benefits of moderate drinking need to be weighed in light of the risks they pose to
other key geriatric syndromes, such as cognitive impairment, depression and falls. Furthermore,
good health among older adults who use moderate amounts of alcohol may be a function of
positive health behaviors, such as proper diet and exercise, rather than a direct benefit from
alcohol use (Tivis & Tivis, 2008). Finally, variations in the conceptualization and measurement
of moderate drinking between studies inhibit the ability draw any concrete conclusions about the
benefits of alcohol use among older adults (Tivis & Tivis, 2008). Further research is needed to
fully explore the effects of various levels of alcohol consumption on a broad range of health
outcomes with diverse populations, including women and people of color.
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2.2.6.1 Gender Effects of Alcohol Consumption on Health among Older Adults
The effect of alcohol consumption on health continues to be debated. Increasingly, studies have
focused on investigating both the harmful, as well as beneficial, effects of alcohol use among
older adults. Recently, a number of studies examining the health consequences of moderate
drinking in individuals aged 65 and older have found sex-dependent effects (Beulens et al., 2007;
Flannery et al., 2007; Mann et al., 2005; Burger et al., 2004). These studies have primarily
focused on cardiovascular disease, cancer, neuro-cognitive functioning, bone disease and liver
problems (Epstein et al., 2007).
For example, a recent review of the literature regarding how gender affects the onset of
liver disease reported that studies have consistently found that it takes less time and lower doses
of alcohol exposure to cause liver damage in females than in males (Kovacs & Messingham,
2002). The consumption of moderate amounts of alcohol by women is associated with an
increase risk of breast cancer (Zhang et al., 2007). Studies on cognitive functioning have been
mixed: some research indicates that female alcoholics perform as poorly as men, even with fewer
years of drinking and smaller quantities of alcohol consumed at each drinking occasion
(Flannery et al., 2007; Mann et al., 2005). Sohrobji (2002) found increased risk of dementia and
memory deficiencies among women. In contrast, while there may be a positive relationship
between moderate alcohol consumption and cognition in both men and women, the association is
strongest in women (McGuire et al., 2007; Britton et al., 2004).
Although some studies have documented significant gender differences in health
outcomes related to alcohol consumption, many have found comparable effects for both men and
women. Moderate drinking has been found to have similar effects on cardiovascular
functioning, cognition, diabetes risk, and bone density in both men and women (Djousse et al.,
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2007; Lang et al., 2007; Mukamal et al., 2007; Sierksma et al., 2007). Contradictory findings
regarding gender differences in the effects of alcohol on health status point to a continued need
for research that investigates the relationship between alcohol use and health in older adults.
Understanding the relationship between health and alcohol use is especially salient for older
women who, even in the absence of alcohol use, face a number of unique health challenges
associated with aging (Blow et al., 2000). Additionally, although findings indicate some benefits
associated with alcohol consumption by older women, studies have continued to document that
on average, despite drinking for the same length of time and consuming about the same amount
of alcohol, women exhibited more severe health consequences from their alcohol use than their
male counterparts (Redgrave et al., 2003; Hill, 1995).
In summary, women are particularly vulnerable to the adverse consequences associated
with alcohol consumption, including physical injury, cognitive impairment, cirrhosis, heart
disease and negative drug interaction (Blow, 2000). Despite this fact, alcohol use in older
women often goes undetected and treated (Sedlak et al., 2000). Further investigation of the
epidemiology of alcohol use in subpopulations of older adults, especially with women, is key to
identifying at-risk populations and developing effective intervention strategies.

2.2.6.2 The Impacts of Minority Status on the Effects of Alcohol Use on Health Status of
Older Adults
Since African Americans are often underrepresented in longitudinal studies of alcohol use, the
literature regarding the role that race plays in the relationship between alcohol and health among
older adults is scarce. However, research on the general population indicates that the negative
consequences of alcohol use have disproportionally impacted racial and ethnic minorities
(McDonald et al., 2004; Boyd et al., 2003; Jones-Webb, 1998). For example, alcohol mortality
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rates are highest for African-American men in all age cohorts, even though alcohol use tends to
be more moderate for African Americans than for Whites or Hispanics (Caetano, 1998). African
Americans are also more likely than Whites to die from cirrhosis of the liver or from an alcohol
related injury (Jones-Webb, 1998). It has been postulated that older African Americans are more
severely impacted by alcohol consumption because their health is typically worse than the health
status of older Whites (Satre and Arean, 2005). Further research is needed to examine the
relationship between race, alcohol use and health status.

2.3

2.3.1

MEDICATION USE AMONG OLDER ADULTS

Medication Pharmacokinetics

The pharmacokinetics of medications or how drugs are handled by the body is related to
absorption, distribution and elimination, which consists of metabolism and excretion (Wright &
Warpula, 2007). In order to produce their pharmacological effects, medications must be
absorbed into the body and distributed to the site of action (Sharif, 2003). Absorption is the
process by which a drug passes from the site of administration into circulation via the
bloodstream. The rate, ease and degree of absorption are related to the route of administration
(Sharif, 2003). Once the medication has been administered and absorbed into the bloodstream, it
is then distributed to various organs in the body (Sharif, 2003). The distribution of medications
is influenced by a number of factors, including: how well each organ is supplied with blood,
organ size, binding of the drug to various components of blood and tissue, and the permeability
of tissue membranes (Lococo & Staplin, 2006).
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The majority of medications are metabolized in the liver. The cytochrome P-450
(CYP450) enzyme system is the most important known system for drug metabolism (Wright &
Warpula, 2004; Sharif, 2003). As they pass through the liver, drugs undergo either phase I
(oxidation, reduction, and hydrolysis) or phase II (glucuronidation, sulfation, and acetylation)
metabolism (Wright & Warpula, 2004). Phase I reactions use the CYP450 system; the reaction
can produce biologically active metabolites. More than half of all drugs are metabolized via the
CP450 enzyme pathway (Wright & Warpula, 2004; Williams, 2002). Phase II metabolism
produces inactive metabolites, which are more readily excreted by the kidneys (through urine)
and the liver (through bile) than those formed in phase I non-synthetic reactions (Wright &
Warpula, 2004). Some drugs undergo only phase I or phase II reactions; thus, phase numbers
reflect functional rather than sequential classification (Williams, 2002). After drugs are
metabolized they are removed from the body, with the kidney primarily responsible for drug
elimination (Wright & Warpula, 2004).

2.3.1.1 The Influence of Age and Alcohol on the Metabolism of Medications
Two of the key factors that impact upon the body’s ability to metabolize medications are age and
alcohol consumption. Advancing age is accompanied by pharmacokinetic and pharmodynamic
changes that, in conjunction with comorbid health conditions and the use of multiple
medications, influence the metabolism of drugs in older adults (Herrlinger & Kolz, 2001). Some
of the primary physiological changes that influence medication pharmacokinetics include:

1. As individuals age, there is a decrease in lean body mass and an increase in fat.
Therefore, fat soluble drugs, such as valium, will remain in the body longer (Wright &
Warpula, 2007; Williams, 2002).
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2. The liver enzymes responsible for metabolizing and detoxifying medications decrease in
efficiency in older individuals (Wright & Warpula, 2007; Williams, 2002).
3. Kidney extraction may not function as well, so drugs may remain in the body longer than
anticipated (Wright & Warpula, 2007; Williams, 2002).
4. Absorption of drugs in the gastrointestinal tract is slowed (Wright & Warpula, 2007;
Williams, 2002).

In addition to age, alcohol consumption also has a marked effect on the body’s ability to process
medications. There are four primary alcohol-drug interactions. First, alcohol may inhibit the
metabolism of a drug by competing with the medication for the same set of metabolizing
enzymes in the liver (Blow, 2002). This type of interaction prolongs and enhances the
medication’s availability, which can result in an increased risk for experiencing harmful side
effects from the drugs (AADAC, 2003). Second, long term alcohol use may activate drugmetabolizing enzymes, thus decreasing the drug’s availability and diminish its effects (Blow,
2002). In a third type of reaction, enzymes activated by chronic alcohol consumption transform
some medications into toxic chemicals that can damage the liver and other organs (Palmer,
2004). Finally, alcohol can interact with sedative and narcotic medications, magnifying the
inhibitory effects of these drugs (Lococo & Staplin, 2006). To add to the complexity of alcoholdrug interactions, some drugs affect the metabolism of alcohol, which alters its potential for
intoxication and the adverse affects associated with alcohol consumption (AADAC, 2003).
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2.3.2

Definitions Related to Medication Use

There are a variety of terms used to describe patterns of medication use and their associated
consequences among older adults. Of particular importance to this study are the terms
potentially inappropriate medications, alcohol-interactive medications, and concurrent use. All
refer to various patterns of medication use.
A potentially inappropriate medication (PIM) is defined as any drug that poses more risks
than benefits when used by older adults; many PIM interact with alcohol (Fick et al., 2003). In
other words, if the potential risks outweigh the possible clinical benefits, the therapeutic use of
the medication is considered to be inappropriate (Egger at al., 2006). The Beers criterion is the
most widely used approach to assess the appropriateness of the use of specific medications with
the elderly (Fu et al., 2007). The Beers criterion, first compiled in 1991 by an expert consensus
panel, consists of a list of medications that may be unsuitable for use among older adults
(Budnitz et al., 2007). Table 1 provides some examples of medications or therapeutic classes
considered potentially inappropriate for use among older adults. Many of the medications
identified as inappropriate under the Beers criteria could potentially interact with other drugs
and/or alcohol.
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Table 1 Inappropriate Medications and Therapeutic Classes to Avoid in Older Adults

Classification

Medication

Never appropriate

Barbiturates
Dicyclomine, propantheline, phenobarbital
Flurazepam
Meperidine
Meprobamate
Pentazocine
Trimethobenzamide

Rarely appropriate

Chlordiazepoxide, diazepam
Muscle relaxants (chlorzoxazone, metaxalone, methocarbamol)
Propoxyphene

Sometimes appropriate Amitriptyline
Diphenhydramine, cyproheptadine, hydroxyzine, promethazine
Indomethacin
Alprazolam
Lorazepam
Zolpidem
Source: Wright & Warpula, 2004; Frick et al., 2003; Zhan et al., 2001

A prescription medication or over-the-counter drug is considered to be alcohol-interactive if the
concurrent use of alcohol and the medication influences the metabolism of the drug, impacts the
enzymes involved in drug pharmacokinetics or magnifies the effects of the medication (Jalbert et
al., 2007; AADAC, 2003). Some examples of classes of alcohol-interactive medications
commonly used by older adults and the effects of these interactions are:

1. Nonsteroidal anti-inflammatories/Aspirin: interactions between alcohol and antiinflammatory drugs can lead to gastritis and gastrointestinal hemorrhage;
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2. Antidepressants/Antipsychotics: interaction between alcohol and these psychotropic
medications and cause leads to decreased drug metabolism, causing toxicity and central
nervous system depression; and
3. Narcotic analgesics: narcotic analgesics such as Codeine or Vicodin interact with
alcohol and can cause CNS depression (Lynskey et al., 2003; SAMHSA, 1999). 2
Often medications are used in concert with a variety of other substances, such as alcohol,
illicit drugs, over-the-counter medications and/or prescription drugs. Studies typically refer to
this behavior as simultaneous or concurrent polydrug use (McCabe et al., 2006). Simultaneous
drug use is defined as the co-ingestion of different drugs at the same time; for instance, the
simultaneous use of alcohol and marijuana (Schensul et al., 2005). Concurrent polydrug use also
refers to the use of more than one substance within the same time period (e.g., 1 day, 30 days, or
12 months), but not necessarily at the same time (Schensul et al., 2005). For example, an
individual may take an antidepressant each morning to treat anxiety; however, it is also this
individual’s pattern to have a glass of wine with dinner. Although the two substances are not
ingested together, they are taken within the same time period—in this case the same day.
Therefore, this usage pattern would be considered concurrent use. The specific focus of this
discussion is the concurrent use of medications with alcohol. 3

A more extensive list of specific alcohol-interactive medications and the associated reactions is
presented later in this review (see Table 2.)
3
The terms concurrent and concomitant will be used interchangeably throughout this document.
2
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2.3.3

Prevalence Rates of Medication Use among Older Adults

2.3.3.1 Rates of Medication Use Among Older Adults

Older adults consume more prescription and over-the-counter medications than any other age
group (Perhats et al., 2008). Though older adults comprise only 14% of the total U.S.
population, they use more than 30% of all prescription drugs and approximately 40% of all overthe-counter medications [Department of Health and Human Services (DHHS), 2004]. Seniors
use prescription drugs approximately three times as frequently as the general population, and
their use of over-the-counter medications is even more extensive (Patterson & Jeste, 1999).
On average, seniors take 5.3 prescription drugs and 5.7 over-the-counter drugs per day
(ASA, 2001). A survey of the noninstitutionalized U.S. population found that more than 90% of
individuals aged 65 and older used at least one medication per week (Gurwitz et al., 2004;
Kaufman et al., 2002). Moreover, 40% reported using 5 or more different medications a week,
and 12% utilized 10 or more different drugs (Gurwitz et al., 2004). These findings are consistent
with other research on patterns of medication use among community-dwelling older adults. For
example, in a recent national study of Medicare beneficiaries, only 11% of seniors reported not
taking any prescription medications; however, 22.8% of participants reported taking 1–2
medications, just over 25% were taking 3–4 medications, and 41% reported using 5 or more
prescription medications (Wilson et al., 2007).
Not only do older adults consume high numbers of medications, they also use
medications from different therapeutic categories, this substantially increases their risk of
experiencing an adverse drug event or reaction. For instance, a recent study of nearly 28,000
Medicare+Choice enrollees found that 49% of participants were prescribed drugs from four or
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more classes (Gurwitz et al., 2003). Similarly, in a study of homebound elders, Sharkey and
colleagues (2005) found that, typically seniors used drugs from 3 to 4 different medication
classes. Research indicates that the most common medications taken by seniors are
cardiovascular drugs, antibiotics/anti-infectives, diuretics, opiods, antihyperlipidemics, NSAIDs,
and medications for the gastrointestinal tract (Gurwitz et al., 2003). Older adults are also
substantial users of psychotropic medications. A retrospective analysis of the 1996 Medical
Expenditures Survey (MEPS) found that nearly 1 in 5 community dwelling older adults (19%)
used a psychotropic medication (Aparasu et al., 2003). The most commonly used psychotropic
medications were antidepressants and antianxiety drugs. Gurwitz and colleagues (2003) found
similar rates of use among community-dwelling older adults: just over 13% of participants
reported using an antidepressant and 12.9% were taking a sedative or hypnotic drug (Gurwitz et
al., 2003).

2.3.3.2 The Relationship of Demographic Characteristics to Medication Use Patterns

Although the majority of seniors report taking one or more medications, demographic
characteristics also predict rates of medication use. Variations in both rates of use as well as the
types of drugs taken have been found by age group, gender and race. Studies have continually
reported that among older persons, women and Whites are more likely to use medications.

Gender
Most studies indicate that gender predicts medication use; older women have higher rates of
medication use and consume a larger number of medications than older men (Ballantyne et al.,
2005; Xu et al., 2003; Linjakumpu et al, 2002). For instance, a study of adults in the ambulatory
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care setting aged 18 and above, found that women aged 65 and older had higher rates of
prescription medication use than all other adults (Kaufman et al., 2002). In the same study, 81%
of the women surveyed reported taking at least one medication and 23% used five or more
different drugs per week (Kaufman et al., 2002). Not only do females use medications at higher
rates than men, but women take larger quantities of medications that are potentially
inappropriate. In an analysis of rates of potentially inappropriate medication use among older
adults enrolled in managed care plans, women, when compared to men, had greater rates of use
of medications that were classified as “should always be avoided,” 6.1% versus 3.8% (Simon et
al., 2004). The same study found that women also used medications classified as “rarely
appropriate” at higher rates than their male counterparts, 15.7% versus 10.5% (Simon et al.,
2004). Older women also use more psychotropic medications than older men; females are more
likely to use higher rates of antidepressants and antianxiety agent (Aparasu et al, 2003). Many
psychotropic medications are alcohol-interactive or considered inappropriate for use among older
adults. This places women at an increased risk for adverse drug events (ADE) and adverse drug
reactions (ADR).

Race
Continued disparities in health outcomes among African Americans and Whites have fueled
recent research efforts to document disparities in health service utilization and to identify their
causes (Wang et al., 2007). Unfortunately, studies have not addressed the use of prescription
drugs in a comprehensive manner, especially among older adults. The existing body of literature
suggests that, in general, African Americans have lower rates of mediation use and take fewer
medications than Whites (Sirey et al., 1999; Brown et al., 1995; Fillenbaum et al., 1993; Hanlon
et al., 1992). In a more recent study of new prescription drug utilization by individuals age 18
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and older, racial disparities were found: Whites were more likely than African Americans to
obtain and use a new prescription (Wang et al., 2007).
Racial differences in medication use have also been found in several studies specifically
focused on use among older adults. For instance, in a study of Medicare beneficiaries, Gaskin
and colleagues (2006) reported that Whites used 2.3 more prescriptions on average than African
Americans. The same study also found that much of the disparity in prescription drug spending
was attributed to race: total spending for Whites was nearly 9% more than for African Americans
(Gaskin et al., 2006). In addition, racial differences in medication use among older adults are
greatest for psychotropic medications. For example, Blazer and colleagues (2000) found that
among community-dwelling older adults, only 5% of African Americans were taking an
antidepressant compared to 14% of Whites. In another study of the use of psychotropic
medications by the elderly, African Americans were less likely than Whites to report sedative
and hypnotic usage (Aparasu et al., 2003).

Summary
The large volume of medications taken by older adults coupled with the higher likelihood that
they will be prescribed an alcohol-interactive medication puts them at increased risk for adverse
drug interactions. Also, drug-drug or alcohol-medication interactions in older adults can be
especially problematic because of slowed metabolic and clearance mechanisms, which can result
in the delayed resolution of adverse reactions (SAMHSA, 2004). Finally, differences in rates
and types of medications used by gender as well as race place certain groups—women and
Whites—at an increased risk for experiencing an ADE or ADR.
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2.3.3.3 Prevalence of Adverse Drug Events and Adverse Drug Reactions Among Older
Adults
The unintentional or intended misuse of prescription drugs can have a number of negative
consequences; two widely investigated outcomes are ADEs and ADRs. Both ADEs and ADRs
are caused by one of three primary types of interactions: drug-drug, drug-disease, or drugnutritional interactions. Drug-drug interactions are defined as the effects that one drug has on
another; these interactions are pharmacokinetic or pharmacodynamic in nature (Lococo &
Staplin, 2006). If a medication exacerbates an underlying disease or medical condition, it is
referred to as a drug-disease interaction (Mallet et al., 2007). Of particular relevance to this
study are drug-nutritional interactions; this includes interactions between medications and
alcohol, food or herbal products (Mallet et al., 2007). All of these interactions have the potential
to cause medication-related problems, ADEs, or ADRs in older adults.
Typically, an ADE is defined as any injury resulting from the use of a prescription or
over-the-counter medication (Gurwitz et al., 2003). ADEs included both expected drug side
effects as well as events due to error (Lococo & Staplin, 2006). Problems that occur when
treatment goes beyond the desired effect or when the medication causes additional problems are
termed side effects. Some fairly common medication side effects include symptoms such as
dizziness, fatigue, nausea and vomiting (Agency for Healthcare Research and Quality, US
Department of Health & Human Services (AHRQ), 2001).
Although some ADEs are the unintended consequence of side effects resulting from the
use of a particular drug, other ADEs the product of errors made by the patient or by medical
professionals, which by definition are considered preventable (Lococo & Staplin, 2006).
Examples of common errors that can lead to ADEs include: poor medication adherence,
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inappropriate prescribing, and incorrect drug dosing (Perhats et al., 2008; Lococo & Staplin,
2006). It should be noted that identifying something as an adverse event does not imply
negligence or poor quality of care; it simply denotes an undesirable clinical outcome which is not
the result of an underlying disease process, has resulted from some aspect of the chosen
pharmacological therapy (AHRQ, 2001.).
In contrast to ADEs, ADRs are harmful unintended reactions resulting from the use of a
certain medication. These reactions are produced by the use of a drug in the recommended
manner (Lococo & Staplin, 2006; AHRQ, 2001). The World Health Organization (1975) defines
ADRs as any response to a drug which is noxious and unintended, and which occurs at doses
normally used in humans for diagnosis, therapy of disease, or for the modification of
physiological function. These effects can range from minor irritants to severe reactions. Some
examples of common ADRs include a rash or diarrhea caused by an antibiotic or a major
hemorrhage from taking a blood-thinning agent (Lococo & Staplin, 2006).
Advances in drug therapy have provided older adults with effective treatments that have
made it possible to improve outcomes for conditions that were previously untreatable (Simonson
& Feinberg, 2005). However, if used inappropriately, pharmacological therapies can cause more
harm than good. If adverse drug effects were classified as a disease, they would rank as the fifth
leading cause of death for among adults in the United States (ASA, 2001; Lazarou et al, 1998).
In 2004 and 2005, over 700,000 individuals were treated for ADEs in U.S. emergency
departments; one out of every six of these patients required hospital admission (Budnitz et al.,
2006). Furthermore, older adults have a markedly greater risk for medication-related problems
as a result of physiological changes associated with aging, the presence of multiple health
problems, and the type and number of medications they consume (Chrischilles et al., 2007;
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Simonson & Feinberg, 2005). Therefore, medication safety among seniors is a major safety
concern.
The latest research indicated that rates of ADEs and ADRs among older adults are
relatively high: among Medicare enrollees more than 1.9 million ADEs occur each year and
approximately 200,000 of these events are life-threatening or fatal (Simonson & Feinberg, 2005;
Gurwitz et al., 2003). A recent study of injury-related visits to the emergency room among
individuals aged 65 and older found that ADEs were the second most frequent mechanism of
injury and were associated with a three-fold increase in hospitalization risk (Carter & Gupta,
2007). Factors related to the type and amounts of medications used, as well as individual
characteristics, have been linked with an increased risk for experiencing an ADE (Evans et al.,
2005). For example, a study of community-dwelling residents aged 72 and older found that total
number of medications was associated with an increased risk of adverse drug outcomes (Agostini
et al., 2004). Other studies have shown that increased age, being female, and a greater number of
comorbidities increase an individual’s great risk of suffering an ADE (Evans et al., 2005).
Despite the high rates and severe costs associated with ADEs and ADRs, it is estimated that
approximately half of the illnesses, disabilities and deaths caused by these events may have been
preventable (Gurwitz et al., 2003).
Many ADEs and ADRs result from medication adherence errors and are therefore
preventable. Common patient errors include: administering medications incorrectly; modifying
the medication regime; and not following clinical advice regarding medication use, such as
ignoring directives to avoid using certain foods, over-the-counter-medications, or alcohol with a
particular drug (Field et al., 2007). In a large sample of Medicare enrollees, Field and colleagues
(2007) found that nearly 42% of ADEs resulted from a modification to the medication regimen;
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31.8% occurred due to incorrect medication administration; and 21.7% happened because the
patient did not follow clinical advice (Field et al., 2007).
These findings are consistent with other studies on ADEs (Gurwitz et al., 2003).
Investigations of adverse drug effects indicate that the most frequent types of preventable ADEs
are related to electrolyte/renal, gastrointestinal, hemorrhagic and central nervous system issues
(Chrischilles et al., 2007; Gurwitz et al., 2003). Some of the most common medications
associated with avoidable ADEs included: cardiovascular medications, diuretics, nonopioid
analgesics, hypoglycemic and anticoagulants (Gurwitz et al., 2003). Many of the medications
associated with preventable adverse drug effects are alcohol-interactive. Consequently, one of
the major causes of preventable ADEs and ADRs is the concurrent use of alcohol and
medications (Field et al., 2007; Onder et al., 2002).
One of the major risk factors for experiencing an adverse drug event or reaction is
medication nonadherence. The concurrent use of alcohol and medication is a common and
dangerous form of nonadherence that can have serious consequences for older adults. Most
people who consume alcohol also take medications; this is particularly true for older adults who
consume more medications than any other age cohort (Perhats et al., 2008; Weathermon et al.,
1999). As a result, many older adults ingest alcohol while a medication is in their body or vice
versa. A large number of prescription and over-the-counter medications can interact with
alcohol, resulting in potentially serious medical consequences (Lococo & Staplin, 2006). In fact,
it is estimated that alcohol-drug interactions play a role in 25% of all emergency room
admissions for all age groups (Holder, 1992). Significant problems can result from the
concurrent use of medications and alcohol, making alcohol-related adverse drug interactions an
important health concern for older adults.
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2.4

2.4.1

CONCURRENT ALCOHOL AND MEDICATION USE

Prevalence of Concurrent Use among Older Adults

While there is a large body of knowledge on the prevalence, usage patterns and epidemiology of
alcohol use among older adults, few studies have focused on the concurrent use of alcohol and
medications. Consequently, estimates on the prevalence of concurrent use are limited.
However, the research that does exist suggests that concomitant use is a common problem
among older adults (Swift et al., 2007; Aira et al., 2005; Pringle et al., 2005; Fink et al., 2002;
Onder et al., 2002; Adams, 1995). Yet, most of these studies are cross-sectional in nature and
were conducted in acute or primary care settings.
A recent population-based study in Australia found that 35.4% of the individuals
surveyed aged 65 years and older had recent (last 24 hours) concomitant use; 21.8% reported
using both prescription and over-the-counter medications with alcohol in the last 24 hours (Swift
et al., 2007). Higher prevalence rates were also found in a study of community-dwelling elders
75 years and older living in Finland: nearly 87% of respondents who used alcohol also reported
using medications on a regular basis (Aira et al., 2005). In the same study, widespread rates of
concurrent use of alcohol with alcohol-interactive drugs such as sedatives, pain killers and
Warfarin were reported (Aira et al., 2005). Although these studies are important and add to the
knowledge base regarding the prevalence rates of concurrent use among older adults, cultural
differences in alcohol and medication use as well as variations in prescribing practices between
these countries make the results less generalizable to the United States.
In the United States, estimates of concurrent use among community-dwelling older adults
range from 19% to 38% (Pringle et al., 2005; Memmott, 2003; Fink et al., 2002; Adams, 1995).
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Some of the first studies of concurrent use among older adults in the United States found fairly
high rates of concomitant use. One study reported that 25% of community-dwelling older adults
were at risk for alcohol-drug interactions due to concurrent use (Forster et al., 1993). In a study
of older adults residing in retirement communities, Adams (1995) found that nearly 38% of the
residents concurrently used alcohol with alcohol-interactive medications. Adams’ work in
retirement communities represents an important contribution to the literature regarding
concurrent use among older adults yet, the sample is comprised of a unique subset of older adults
who reside in retirement communities. Therefore, it is possible that the concomitant use
behaviors of individuals in this particular study may not be reflective of all community-dwelling
older adults.
More recent analyses of concomitant use among older adults have found lower
prevalence rates than that in Adams’ (1995) study. For example, an analysis of concurrent
alcohol and prescription drug use among older adults living in the US and enrolled in the
Pennsylvania Pharmaceutical Assistance Contract for the Elderly (PA-PACE) found that 77% of
all prescription drug users were exposed to one or more alcohol-interactive medications.
Moreover, nearly one-fifth (19%) of older adults who used alcohol-interactive drugs reported
concurrent alcohol and medication use (Pringle et al., 2005). However, this study utilized a
cross-sectional design; therefore, we do not know if these prevalence rates hold true overtime
and we are unable to ascertain various patterns of concurrent use. Additionally, in the PA-PACE
study, data on alcohol use was based on self-report data obtained from a mail survey; self-report
data can be problematic with older adults for a number of reasons such as cognitive impairment
or decline and underreported behavior. Finally, the sample was comprised of PA-PACE
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members who tend to be older, female, White and have more chronic conditions than the general
population of older adults in the United States.
Emerging research also suggests that concurrent use is associated with the number of
drugs taken and the therapeutic class of those medications, as well as individual level
characteristics. For instance, in a study of current drinkers aged 65 and older, Fink and
colleagues (2002) report that 88% of participants used alcohol-interactive medications; 46% used
1 to 3 medications; 32% used 4 to 6 medications; and 9% used 7 or more medications. The most
common concurrent use pattern was one or more drinks per day with the following classes of
medications: arthritis and pain medications, H2-receptor antagonist, antidepressants,
anticoagulant (Warfarin), nitrates, antihistamines, or antiseizure drugs (Fink et al., 2002).
Similar results were found in a large sample of older adults enrolled in the PA-PACE program;
the most common medications concomitantly used with alcohol were NSAID pain relievers
(20.2%), antihistamines (20.1%), antihypertensive (19.9%), and angiotensin-receptor blockers
(19.6%) (Pringle et al., 2005). Limited information exists on the influence of individual level
characteristics on concurrent use; however, recent work suggests that such individuals are
younger, White, better educated and in better health tend to have higher rates of concurrent use
(Jalbert et al., 2008; Pringle et al., 2005).
Although few studies have explored the concurrent use of alcohol and medications
among older adults, the research that does exist suggests that concomitant use is common
amongst this group. Although rates of alcohol consumption typically decline with age, many
older adults engage in patterns of use that exceed recommended guidelines. This coupled with
the high rate of alcohol-interactive medications taken by seniors places them at an increased risk
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of experiencing ADRs or ADEs related to concurrent use. The significant problems associated
with concomitant use make it a salient public health concern for older adults.

2.4.2

Consequences of Concurrent Use

The use of alcohol not only has the potential to impact many of the health conditions for which
medications are used, but it can also interact with the medicines themselves (Swift et al., 2007).
Age-related physiological and metabolic changes can increase the likelihood of adverse
interactions at lower alcohol and medication doses (Swift et al., 2007). As a result, there are a
number of serious consequences associated with concurrent alcohol and medication use among
older adults. For example, concomitant use of medications like benzodiazepines, muscle
relaxants, and opioids can cause ADEs such as increased sedation and decreased motor skills;
these problems can lead to falls or other accidents (Tanaka, 2003; Weathermon & Crabb, 1999).
Another common type of interaction that can result from concurrent alcohol and medication use
occurs when alcohol adversely affects the illness for which the medication was prescribed.
Many of the chronic conditions common among older adults such as hypertension, diabetes,
gastrointestinal conditions, insomnia and depression are exacerbated by alcohol use (Moore et
al., 2007).
An extensive discussion of all the negative health outcomes resulting from concurrent
alcohol and medication use is beyond the scope of this review; however, information on the two
types of alcohol-drug interactions and some of the common reactions associated with
concomitant use in older adults will be presented.
Alcohol-medication interactions fall into two primary categories: pharmacokinetic and
pharmacodynamic. When the presence of alcohol directly interferes with the normal metabolism
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of a medication, the interaction is pharmacokinetic in nature (Weathermon & Crabb, 1999).
Pharmacokinetic interactions either decrease the breakdown and excretion of the medication
because the drug must compete with alcohol for metabolism or alcohol enhances the activity of
medication-metabolizing enzymes, thereby accelerating the metabolism of the affected drug
(Adams, 2002; ASA, 2001). When alcohol alters the effects of a medication without changing
the medication’s concentration in the blood, it is referred to as a pharmacodynamic reaction. For
example, the use of alcohol and antidepressants enhances the sedative effects of the medication
(Adams, 2002; Weathermon & Crabb, 1999). The type of ADE or ADR experienced is based on
a number of factors, including the type of alcohol-drug interaction (pharmacokinetic or
pharmacodynamic), the amount and type of alcohol consumed, physiological difference, and
individual characteristics (Lococo & Staplin, 2006)
There are a number of alcohol-interactive medications widely used by seniors that, when
concurrently used with alcohol, can cause negative reactions. Table 2 presents an overview of
some of the alcohol-interactive medications commonly used by older adults and the potential
reactions associated with concomitant use (A more extensive table is presented in Appendix A.).

52

Table 2 Examples of Common Alcohol-Interactive Medications Used by Older Adults

Drug Class
(Symptoms / Conditions)

Medication
(Brand Name)

Potential Reactions
with Alcohol

Antibiotics
(infections)

Acrodantin
Flagyl
Grisactin
Nizoral

Rapid heartbeat
Sudden changes in blood pressure
Stomach pain & upset; vomiting
Headache
Liver damage

Anticoagulants
(prevention of blood clots)

Warfarin
Coumadin

Internal bleeding
Blood clots, strokes, or heart attack

Antihypertension
(high blood pressure)

Accupril
Capozide
Hytrin

Drowsiness & Dizziness
Fainting
Heart problems such as arrhythmia

Benzodiazepines
(sedative agent)

Ativan
Valium
Xanax

Drowsiness
Increased sedation
Decreased motor skills

Histamine antagonists
(ulcers, heartburn)

Axid
Zantac

Increased alcohol effects
Sudden changes in blood pressure

NSAIDs
(pain relief, inflammation)

Naprosyn
Orudis
Voltaren

Gastrointestinal bleeding

Opioids
(pain relief)

Oxycodone
Percocet
Vicodin

Drowsiness
Increased sedation
Decreased motor skills

Statins
(high cholesterol)

Advicor
Crestor
Lipitor
Vytorin
Zocor

Liver damage
Nausea & vomiting
Rapid heartbeat
Sudden change in blood pressure
Risk stomach bleeding

Tricyclic antidepressants
(depression)

Celexa
Dizziness
Prozac
Increased risk of sedation
Zoloft
Increased risk overdose
Sources: NIAAA, 2007; Lococo & Staplin, 2006; Weathermon & Crabb, 1999
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Although reactions to concurrent use are specific to the medication involved, some of the
most frequent consequences of interactions experienced by older adults fall into three broad
categories: central nervous system depression, gastrointestinal issues, and liver toxicity (Adams,
2002).

2.4.2.1 Central Nervous System (CNS) Depression
Older adults have substantial rates of CNS medication use, which places them at an increased
risk for the negative reactions associated with concurrent use of alcohol and CNS depressants. In
addition, physiological changes make older adults more susceptible to the effects of medications
that suppress central nervous system activity. Table 3 gives an overview of therapeutic classes
of drugs that are CNS depressants (Adams, 2002).

Table 3 Classes of CNS Medications

• Antihistamines
• Antidepressants
• Barbiturates

• Benzodiazepines
• Narcotic analgesic
• Opioids

These medications often cause sedation and decrease motor skills in older adults (NIAAA, 2007;
Lococo & Staplin, 2006). Alcohol, which is also a CNS depressant, has an added sedative effect
when combined with these drugs (Weathermon & Crabb, 1999). The concomitant use of alcohol
and medications suppress central nervous system functioning, causing impaired balance and
predisposing seniors to falls; slowing reaction times, which may lead to negative outcomes such
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as automobile accidents; and excessive drowsiness (Lococo & Staplin, 2006; Adams, 2002). The
concomitant use of psychotropic drugs and alcohol is most likely to produce these impairments.
Benzodiazepines, commonly used by older adults, have a strong potential for this type of
alcohol-drug reaction (Lococo & Staplin, 2006; Adams, 2002). Research has also shown that
some tricyclic antidepressants also interact with alcohol, impairing alertness and motor
functioning (Adams, 2002; Weathermon & Crabb, 1999).

2.4.2.2 Gastrointestinal Issues
Arthritis and other musculoskeletal problems are among the most common health problems faced
by older adults (Adams, 2002). Nonsteroidal anti-inflammatory drugs (NSAIDs) and over-thecounter pain relievers (e.g., aspirin or ibuprofen) are often used to treat these disorders in seniors
(Adams, 2002). The use of NSAIDs has been associated with an increased risk for developing
ulcers and gastrointestinal bleeding in older adults (Weathermon & Crabb, 1999). The
concurrent use of alcohol and NSAIDs or other anti-inflammatory drugs can have several
detrimental effects. Concomitant use may:
1. increase risk for gastrointestinal bleeding;
2. increase gastric inflammation; and
3. cause longer bleeding times (Kaufman, 1999).
In addition to pain relievers, some statins used to treat high cholesterol have been associated with
gastrointestinal bleeding (NIAAA, 2007). Further, the concurrent use of alcohol and aspirin has
been shown to increase blood alcohol levels after small alcohol doses, possibly by inhibiting
first-pass metabolism (Weathermon & Crabb, 1999). All of these potential reactions are serious,
especially in light of research that indicates that older adults are more likely to die from
gastrointestinal bleeding than younger adults (Adams, 2002).
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Concurrent use of alcohol and the anticoagulant Warfarin can also cause internal
bleeding. Warfarin is used to prevent blood clots in patients with irregular heartbeats or artificial
hearts; it is also used to treat clots that form in the body’s extremities (Weathermon & Crabb,
1999). The anticoagulant effects of Warfarin are appreciably altered by even small amounts of
alcohol (Weathermon & Crabb, 1999). The interaction of alcohol and Warfarin results in the
decreased metabolism of the drug; this increases the anticlotting effects of the medication,
leading to an increased risk for bleeding (Adams, 2002). On the other hand, the chronic use of
alcohol results in increased enzyme activity in the liver, resulting in higher rates of drug
metabolism (Weathermon & Crabb, 1999). As a result, Warfarin breaks down faster than
normal; therefore, higher doses of the drug are needed to achieve the desired effect (Adams,
2002). Anticoagulant medications are commonly used by older adults and Warfarin is one of the
most common medications implicated in ADEs and ADRs. The concurrent use of alcohol and
Warfarin is, therefore, highly discouraged among older adults.

2.4.2.3 Liver Toxicity
Drugs can sometimes cause serious injury to the liver. These injuries can cause loss of hepatic
function leading to illness, disability, hospitalization, and even life threatening liver failure and
death (Food & Drug Administration, 2009). Medications can cause liver damage for a number
of reasons, and many drugs are intrinsically toxic to the liver (Palmer, 2004). Some drugs have
the potential to cause liver injury when the medication is taken in a dosage that exceeds the
recommended amount; drugs in this category are usually broken down by the cytochrome P450
enzyme system (Palmer, 2004).
In situations of chemical-driven liver damage (hepatotoxicity), medications are broken
down into toxic byproducts instead of benign ones; the byproducts cause liver damage as they
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begin to accumulate (Palmer, 2004). The drugs in this category may cause liver injury if taken in
combined excess with another hepatotoxic substance, such as alcohol (Palmer, 2004; Adams,
2002). Some of the most notable examples of this effect are the hepatotoxicity of antibiotics
such as isoniazid, acetaminophen, and the pain reliever phenylbutazone (Palmer, 2004; Adams,
2002).
It is worth noting that certain opioids commonly used by older adults to treat pain also
contain acetaminophen (Weathermon & Crabb, 1999). Using these pain medications with
alcohol can be especially harmful because of these “hidden” doses of acetaminophen, a known
hepatotoxic drug (Weathermon & Crabb, 1999). Liver toxicity is a particularly salient issue for
older adults since they commonly use many of the medications that, if taken incorrectly and
combined with alcohol, can lead to liver damage.

2.4.3

Summary

As stated earlier, research indicates that approximately 50% of older adults consume some
alcohol and the vast majority of older adults take one or more medications a day (Onder et al.,
2002; ASA, 2001). However, little is known about the sociodemographic and health factors
associated with concurrent use of alcohol and medications in older Americans. The majority of
research regarding alcohol-medication interactions has been conducted with young or middleaged populations and has focused primarily on chronic heavy drinkers; few studies have
examined the adverse drug effects among low to moderate users in the general population of
older adults (Onder et al., 2002). Some studies have investigated the prevalence of concomitant
use of alcohol and medication in retirement communities (Adams, 1995), emergency room
departments (Adams, 1992), primary care settings (Blow et al., 2000; Adams et al., 1996), and
57

hospitals (Bristow & Clare, 1992). Yet, community-level studies are scarce, and those focusing
on the effects of moderate alcohol and medication use among older adults are even more
uncommon.
The limited research that does exist suggests that older adults are at risk for adverse
health effects due to concomitant use of alcohol and medications. As reported earlier, studies
indicate that approximately 1 out of every 5 older adults concurrently use alcohol with alcoholinteractive medications, placing themselves at risk for alcohol-related ADEs or ADRs (Pringle et
al., 2005; Fink et al., 2002). Even more alarming is the recent finding that 5.5% of all
medication users were exposed to five or more alcohol-interactive drugs in combination with
some amount of alcohol (Pringle et al., 2005).
An additional concern is the fact that many concurrent users drink above the
recommended guidelines. The risk for interactions is greater at higher levels of use. Research
indicates that anywhere between 1% to 15% are considered problem drinkers and in one recent
analysis 6% of concomitant users meet the criteria for heaving drinking (Pringle et al., 2005;
NIAAA, 2004). Despite the fairly common concurrent use of alcohol and medications and the
severe negative consequences associated with the interaction of the two, most studies of adverse
drug effects in older adults have focused on concomitant use of interactive prescription drugs
(i.e., drug-drug interactions); little attention has been give to alcohol-drug interactions.

2.5

CURRENT STUDY

With the demographic projections and alcohol use trends indicating that newer cohorts of older
adults are more likely to drink and have heavier drinking habits than previous generations,
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alcohol use among older adults presents one of the most salient health problems facing this
country. Moreover, as the number of older individuals using prescription medications increases,
so will the absolute number of older individuals using alcohol-interactive medications. Despite
these trends, little is known about the prevalence of concurrent alcohol and medication use
among community-dwelling among older adults
In recent years, significant advances have been made in the understanding of both the
aging process (with its attendant health problems) and in the understanding and consequences of
alcohol misuse. However, our understanding of concomitant alcohol and medication use in older
adults remains limited. Traditionally, studies examining the concurrent use of alcohol and
medication have focused on heavy or chronic drinkers. Thus, we know very little about the
prevalence rates and adverse effects of concurrent use among low or moderate drinkers.
Research paradigms that focus on persons who abuse or are dependent on alcohol are
not as useful when applied to older drinkers whose alcohol use, regardless of consumption level,
can be problematic due to age-related physiological changes, medication use, and functional
mobility (Moore et al., 1999). In addition to issues associated with the conceptualization of
concurrent use in past studies, the small body of research that does examine concomitant alcohol
and medication use in older adults has largely drawn from acute or primary care settings and
tends to focus on prevalence rates rather than examining health outcomes (Aira et al., 2005). In
the majority of these studies, adverse drug reactions have been the primary outcome measure.
Therefore, we have very limited knowledge about the broader adverse health consequences
associated with concurrent alcohol and drug use in older adults.
Gaining a better understanding of the prevalence, correlates and consequences of
concomitant alcohol and medication use is critical to developing prevention and intervention

59

strategies that effectively meet the needs of older adults. The current study expands upon the
existing knowledge base by examining concurrent alcohol and medication use outside of the
acute and primary care settings. Rates and correlates of concomitant use are reported for a large
sample of community-dwelling older adults. Examining concurrent use in community-dwelling
older adults will aid in the development of a more thorough understanding of concomitant usage
rates and patterns among seniors. Past research has found that identifying problem alcohol
and/or medication misuse is particularly difficult in elderly individuals; this analysis will assist in
identifying specific subpopulations that may be at an increase risk for concomitant use. Finally,
given their heightened susceptibility to the effects of alcohol and medications due to various
physiological factors, it is critical that we explore concurrent use in all older adults who consume
alcohol, not just those who are considered problem drinkers. Subsequently, the current study
explores longitudinal patterns of concomitant use in older adults with various alcohol
consumption patterns.
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3.0

3.1

3.1.1

METHODOLOGY

METHODS AND PROCEDURES

Design, Sampling and Selection Criteria

Funded by the National Heart, Lung, and Blood Institute (NHLBI), the Cardiovascular Health
Study (CHS) is a population-based, longitudinal study of risk factors for the development and
progression of coronary heart disease and stroke in adults 65 years or older. Starting in 1989 and
continuing through 1999, participants underwent annual clinical examinations and were
contacted by phone at six-month intervals. Since 1999, participants have been contacted every
six months by phone, primarily to ascertain health status. The CHS is one of the richest
available data sets characterizing the health status of the elderly. Only a few other longitudinal
studies have followed cohorts of older individuals for as long as the CHS. The CHS data set is
extensive and includes information from interviews as well as from physical and laboratory
examinations. It has excellent measures of alcohol use, physical and mental health status, and—
one particularly unique aspect—a vast amount of longitudinal data available on medication use.
Finally, unlike many other existing data sets, the CHS sample is comprised of a sufficient
number of both women and African Americans.
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The CHS cohort consists of men and women ages 65 and older drawn from four U.S.
communities: Forsyth County, North Carolina; Sacramento County, California; Washington
County, Maryland; and Allegheny County, Pennsylvania (Fried et al., 1991; Tell et al., 1993).
Potential participants were identified using Medicare eligibility lists of the Health Care Finance
Administration (HCFA) from these four counties. To be eligible to participate in the study
individuals needed to meet the following criteria: (a) they were 65 years or older at the time of
examination, (b) were non-institutionalized, (c) were expected to remain in the area for the next
three years, and (d) were able to give informed consent and did not require a proxy respondent at
baseline (Fried et al., 1991; Tell et al., 1993). Individuals were ineligible to participate in the
study if they were wheelchair-bound in the home at baseline or were receiving hospice treatment,
radiation therapy or chemotherapy for cancer (Fried et al., 1991 & Tell et al., 1993).
Recruitment began in June of 1989 and ended one year later. Stratified random samples
were selected from the four site and were designed to produce a cohort with a 60:40 female to
male ratio in each of four age groups with the following age strata: 65 – 69 (35%), 70 -74 (20%),
75 – 79 (20%), and 80+ (20%) (Fried et al., 1991; Tell et al., 1993). The population from the
Allegheny County site was entirely urban; the remaining three sites recruited a mixture of urban
and rural populations. A total of 3,695 individuals were recruited from the HCFA sample; an
additional 1,547 eligible persons who lived in households with sampled individuals were
enrolled into the study (Tell et al., 1993). The initial study sample was primarily Caucasian
(95%); therefore, in an effort to achieve better representation of the African American
community, three of the study sites were asked to recruit an additional 200 African American
participants between 1992 and 1993 (Tell et al., 1993).
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All of the recruitment procedures initially employed were also followed in the second
recruitment period. An additional 687 African Americans were recruited to participate in the
study during this second recruitment phase (Tell et al., 1993). Data collected during the baseline
exam on the original 244 African American participants were compared to data collected during
1992-93 on the additional 687 African American participants to look for differences related to
protocol changes or technician drift (Tell et al., 1993). All of the continuous variables were
comparable for the two groups; therefore, baseline data for the new cohort of African Americans
was combined with baseline data collected on the original sample. The final sample consisted of
5,888 individuals. These individuals were examined yearly from 1989 through 1999 (Tell et al.,
1993).

3.1.2

Procedures

The baseline examinations consisted of two stages: a home interview and a clinic examination.
First, interviewers went to the participants’ homes to collect a variety of personal and medical
information. If the person was eligible and agreed to participate in CHS, an appointment was
made for a clinical evaluation. The second phase of the baseline consisted of a clinical visit
where a variety of procedures, including a physical exam, were completed. In addition,
participants completed several interviews assessing their cognitive functioning, nutrition habits,
and neurological history.
Prior to 1999, semi-annual contacts alternated between clinic examinations and telephone
contacts, during which information about hospitalizations and health status was collected. Major
exam components were repeated during annual follow-up examinations through 1999.
Participants have been contacted by telephone twice a year since 1999. During these telephone
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interviews, participants were asked to provide information about their general health, major
illnesses, hospitalizations, and medication use. Although primary data collection ended in 1999,
follow-up information on key health outcomes has been continually collected through telephone
interviews.

3.1.3

Sample

The basic demographic characteristics of study participants at baseline are presented in Table 4.
The respondents mean age at baseline was 72.8 (5.61), with a range 65 to 100 years of age. Of
the 5,888 study participants, 57.6% were female and 42.4% were male. The majority of study
participants are White (83.6%), the remaining 16.7% of the sample are African American or
classified as “other.”
At baseline, most of the respondents reported being married (66.1%) and nearly 25%
reported being widowed. The remaining respondents were divorced (4.1%), separated (1.1%), or
never married (4.0%). The mean educational attainment was 13.7 years (SD=4.76). The range
of years of education spanned from no schooling to 21 years. Nearly 30% of participants
reported having 11 years of education or less. Just over 27% of respondents reported having a
high school degree or GED, and 20.4% graduated from college or held a graduate or professional
degree. The majority of the sample reported an income of less than $25,000 a year (61.8%), with
nearly 27% of respondents reporting an income of $12,000 or less.
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Table 4. Overview of Study Participants at baseline

Variable

Sample (n= 5,888)

Gender
Female
Male

57.6%
42.4%

Race
White
African American

83.6%
16.4%

Education
Less than high school
High school diploma
Some college
1-3 Years Vocational Training
College Degree
Graduate or Professional Degree

29.5%
27.5%
14.0%
8.6%
10.4%
10.0%

Marital Status
Married
Widowed
Divorced
Separated
Never Married

66.2%
24.6%
4.1%
1.1%
4.0%

Income
Under $12,000
$12,000 to $15,999
$16,000 to $24,999
$25,000 to $34,999
$35,000 to $49,999
Greater than $50,000

25.0%
14.5%
18.3%
14.4%
9.3%
12.1%

3.2

HUMAN SUBJECTS

The Institutional Review Board at each participating study site approved the Cardiovascular
Health Study and all participants gave informed consent. Allegheny County was one of the four
communities that participated in the CHS study, and the University Center for Social and Urban
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Research (UCSUR) at the University of Pittsburgh has access to the CHS data. The CHS data
used in this study were provided by UCSUR; they have permission as one of the primary data
collections sites to utilize these data and are in compliance with NHLBI requirements. In
addition, the Institutional Review Board at the University of Pittsburgh, which adheres to all
federal regulations involving studies with human subjects, approved this study. This secondary
data analysis was conducted using a de-identified version of the CHS dataset; no additional
human subject involvement was needed with respect to the present investigation.

3.3

STUDY VARIABLES AND MEASUREMENT

Below is an overview of the key variables used in the present study. Many of the variables
utilized in the analysis were transformed from their original state in the CHS datasets.

3.3.1

Alcohol Use

During the baseline and follow-up interviews, participants were asked to report their usual
consumption of alcoholic beverages (daily, weekly, monthly, yearly, or rarely/never).
Respondents were then asked to report the usual number of 12-ounce cans or bottles of beer, 6ounce glasses of wine, and liquor drinks or shots (approximately 1.5 oz) that they drank on each
occasion (Mukamal et al., 2001). This information was used to calculate a continuous variable
representing each individual’s weekly alcohol consumption (Mukamal et al., 2001; CHS, 1999)
Calculated weekly alcohol use was then used to create a categorical variable representing
various levels of alcohol consumption. Participants were placed into one of five categories
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according to weekly ethanol consumption: abstainers, below recommended guidelines (< 1 drink
weekly), within recommended guidelines (1 to 7 drinks weekly), above recommended guidelines
(8 to 14 drinks weekly), and problem users (15 or more drinks a week). These categories were
based on the recommended guidelines for alcohol consumption by older adults (NIAAA, 2004;
Oslin & Holden, 2002; Barry et al., 2002; Blow, 1999). Additionally, a dichotomous alcohol
variable was computed for hazardous alcohol consumption (0= no problem use, 1= problem use)
with individuals who drank 14 or more drinks a week (two times the amount of drinks
recommended for weekly consumption by older adults) classified as hazardous users.

3.3.2

Medication Use

To assess the prevalence of prescription medication use, the medication inventory method of
assessment was used. Study participants were asked to bring the medications they had used in
the past 14 days to their annual clinical visits. Interviewers then transcribed information directly
from the medication containers, including the name of the drug, the dose in milligrams, and the
total number of doses prescribed daily, weekly, or monthly. In addition, study participants were
asked how often they had actually used each medication in the past 14 days (self-reported
dosing). Questions were also asked about the use of certain non-prescription medications
including aspirin, sleeping pills and antihistamines. This method of collecting prescription drug
information from older adults has been shown to be more reliable than recall methods of
medication ascertainment (Psaty et al., 1992). A computer program developed by CHS was used
to match the medication names collected by interviewers with the corresponding National Drug
Code Directory numbers and then used to group medications into analytical categories (i.e.,
antidepressants or beta blockers).
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In order to assess each medication’s risk for interaction with alcohol, a pharmaceutical
consultant was employed to code the CHS medication data on a three point scale based on the
severity of the drugs interaction with alcohol. Thomson Micromedex, a comprehensive drug
database, was used to look up the class and clinical teaching for each medication. Medications
were recoded into a three-point scale based on the severity of the drug’s interaction with alcohol,
where 0= no interaction, 1= minor to moderate interaction and 2= severe interaction. Interaction
ratings were determined by the following criteria:
a) Medication with an ethanol interaction rated contraindicated or major by Micromedex
Interactions received a rating of two, severe interaction.
b) Drugs classified as having a moderate or minor interaction in Thomson Micromedex
were given a rating of one, minor to moderate interaction.
c) If the drug summary document in Thomson Micromedex did not discuss any potential
interactions with alcohol, the medication received a rating of zero, no interaction.
d) In certain cases Thomson Micromedex did not specify an alcohol interaction or the
drug received an unknown rating for ethanol interaction. In these situations ratings
were based on a combination of the pharmacist’s clinical knowledge and the
information listed in the drug monograph of Thomson Micromedex.
After each medication was coded for its level of interaction with alcohol, the information
was used to create several new scale variables: the total number of alcohol-interactive
medications, the total number of medications with a mild to moderate interaction, and the total
number of medications with a severe interaction taken in the past 14 days. Also, a dichotomous
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variable was created with zero being no alcohol-interactive medication use and one representing
any alcohol-interactive medication use in the past 14 days.

3.3.3

Concurrent Use

Information from the alcohol use and medication use measures was used to derive the variable
“concurrent use.” For the purposes of this analysis, concomitant use was defined as those
individuals who consumed alcohol on a weekly basis and were taking one or more alcoholinteractive medications. A dichotomous variable was created where 0= no concomitant use and
1= concomitant use. A variable representing the level of concurrent use was derived by
multiplying the total number of alcohol-interactive medications by weekly alcohol consumption;
this scale was then recoded into a categorical variable representing low to high levels of
concurrent use. Individuals were placed into one of four categories: no concurrent use, low level
of use (.02 – 10), moderate level of use (11 – 29.99), and high level of use (30 or more). Finally,
a continuous variable was created indicating the total number of years an individual concurrently
used alcohol with alcohol-interactive medications over the course of the study (range 1 – 6).

3.3.4

Health Status

Past research indicates that a broad range of measures are necessary to accurately assess physical
and mental health functioning (Newsom & Schulz, 1996). The CHS questionnaire on physical
health was designed to assess the spectrum of physical functioning in study participants. The
questionnaire was modified from the National Center for Health Statistic Supplement on Aging
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and the NIA EPESE Study. A combination of the array of measures collected by the CHS will
be used to obtain the most comprehensive measure of health status possible.

3.3.4.1 Physical Health
The National Health Interview Survey Supplement on Aging questionnaire, which assesses
activities of daily living (ADL) and instrumental ADL (IADL), was used to measure physical
functioning (Fulton et al., 1989). The ADL is designed to assess respondents’ difficulty with
basic self-care activities. It includes questions on essential activities, such as walking around the
home, getting out of bed, bathing, dressing, and eating. The IADL scale measures participants’
difficulty with activities considered essential for living in the community. Respondents are
asked about six tasks: heavy housework, light housework, shopping, preparing meals, managing
money, and using the telephone. For both the ADL and IADL scales, response alternatives are
dichotomous: 0 = no difficulty and 1= difficulty. The number of “yes” responses are summed to
yield a total score; scores can range from 0 – 6 for each scale. Higher scores reflect greater
difficulties with ADL and IADL. The scale ADL and IADL variables were also converted into
categorical variables; the categories were based on the frequency distributions of the raw number
of ADL and IADLs. The vast majority of respondents reported zero (91.8% and 75.1%) or one
(4.8% and 18.1%) for total number of ADLs and IADLs, respectively. The percentiles were so
low in the other categories (less than 5%), that the scale variables were collapsed into categorical
variables. The total number of ADL and IADL scale contained the following categories: 0=Zero,
1=One, 2=Two and 3= Three or more.
Perceived health was assessed using single-item measures of perception of one’s health.
Participants were asked to rate their general health on a 5-point Likert scale from “excellent” to
“poor.” The second self-report health questionnaire asked respondents to compare their health to
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that of others with three options: worse than, the same as, or better than others. On these two
measures, higher scores indicate better perceived health.

3.3.4.2 Mental Health Status
Depression status was measured using the 10-item Center for Epidemiological Studies
Depression Scale (CES-D) (Radloff, 1977). Participants were asked to describe how they had
felt during the previous week. Responses to statements such as “I am depressed” or “I felt
lonely” – were rated on a 4-point scale ranging from 0 to 3 (“rarely to none of the time” to “most
of the time”) and focuses on five areas: mood (5 items), level of irritability (1 item), energy level
(2 items), concentration (1 item), and sleep (1 item). The 10-items were summed to create a
depression score with a range from 0 to 30; higher scores indicated greater experience of
depressive symptoms in the past week.
The 10-item CES-D was derived from the 20-item CES-D, which is one of the most
widely used self-report instruments for assessing depression status (Schroevers et al., 2009). The
psychometric properties of the CES-D scale have been tested in several populations of varying
sociodemographic factors and health status. In general these studies have supported the
reliability and validity of the CES-D (Lee & Chokkanathan, 2008; Turvey et al., 1999; Pasacreta,
1997; Andersen et al., 1994; Callahan & Wolinsky, 1994; Radloff, 1977). Reliability statistics
have found the 10-item CES-D to be comparable to those reported for the original CES-D (Irwin
et al., 1999).
The 10-item CES-D has been found to be a valid measure for use as a screening
instrument for identification of depression in older adults (Irwin et al., 1999; Turvey et al., 1999).
For example, Andersen and colleagues tested the reliability and validity of the CES-D 10 in a
sample of healthy older adults (1994). The CES-D showed good predictive accuracy when
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compared to the full-length 20-item version of the CES-D (kappa = .97, P < .001) (Andersen et
al., 1994). In addition, the CESD-10 showed a negative correlation with positive affect (r = -.63)
and was also positively correlated with showed with poorer health status (r = .37) (Andersen et
al., 1994). Validation of the CESD-10 against the 20-item CES-D using a cut-offs points of
eight, nine and ten 10 have been conducted. A cut-off score of ten or more, which is used in the
current study, has been shown to minimize false positives with little loss of sensitivity (Andersen
et al., 1994).

3.3.5

Demographic Information

A number of demographic characteristics were measured during the baseline interviews and at
each follow-up assessment. The measures included gender, age, race, marital status, educational
attainment, income, and employment status.

3.4

3.4.1

DATA ANALYSIS PLAN

Descriptive and Univariate Analyses

The first part of the analysis consisted of cross-sectional analyses of baseline data using the
statistical software SPSS 15.0. As mentioned earlier, there were no statistically significant
differences in baseline data between participants in the first wave of data collection and those in
the additional recruitment period between 1992 and 1993. Therefore, baseline data from the
second wave of recruitment was combined and analyzed with that of the original cohort.
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This preliminary analysis was employed to determine baseline rates of concurrent alcohol
and medication use, as well as physical and mental health status among community-dwelling
older adults. The two goals of this descriptive data analysis were to derive a general description
of the data and to establish baseline prevalence rates for crucial study variables. These
preliminary analyses were conducted on all key study variables at wave 1, time point 1 (face-toface interview), and serve as the primary source of comparison throughout the analysis.
Analysis of sociodemographic variables (e.g., gender, race, age) related to alcohol,
medication, and concurrent use was conducted. Frequency counts and percentages were utilized
to summarize the various categorical variables. Additionally, descriptive statistics—including
measures of central tendency (means, medians, modes) and dispersion (standard deviations and
ranges)—were obtained for key study variables such as alcohol consumption, medication use,
and health status. Cross tabulations were run to examine bivariate relationships between
sociodemographic variables and alcohol consumption, medication use, and concurrent use at
baseline. Finally, bivariate relationships between concurrent use and health status at baseline
were also explored using cross tabulations.

3.4.2

Multivariate Analysis

The multivariate portion of the analysis focused on examining various patterns and consequences
of concurrent alcohol and medication use over time. The two primary goals of the multivariate
analyses were to identify trajectories of concurrent use among older adults and to examine how
various trajectories impacted health status over time. The follow-up point, not the interview
year, was essential to conducting the group-based trajectory modeling analyses, appropriately
using both the original and the new cohort of study participants. Because of the introduction of a
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second cohort of individuals into the CHS study in year 5, the data needed to be reorganized so
that each wave was representative of the equivalent follow-up time point for each of the two
groups. For example, year 3 is the second follow-up for the original cohort; however, the second
follow-up time point for the new cohort actually took place in year 7. These two datasets were
combined to create wave 2 (follow-up 2). Table 5 summarizes how the datasets used in this
analysis were formulated.

Table 5. Overview of CHS Data sets

Baseline
Original

Year 1 & 2

Second
Follow-up
Year 4

New

Year 5

Year 7

Third
Follow-up
Year 5

Fourth
Follow-up
Year 6

Fifth
Follow-up
Year 7

Sixth
Follow-up
Year 8

Year 8

Year 9

Year 10

Year 11

Note: Data from the first follow-up was not included in this analysis because several key study variables were not
collected for the original cohort at this measurement point (Year 3).

3.4.2.1 Group-Based Trajectory Analysis
Group-based trajectory modeling is a specialized application of finite mixture modeling that can
be used to simplify longitudinal data by identifying clusters of individual developmental
trajectories on a likelihood basis. The technique creates groups by clustering individuals whose
trajectories most closely resemble one another using a probability function. The methodology
assumes the existence of latent subpopulations. Although these groups do not necessarily exist,
their identification has applications in both the interpretation and further analysis of longitudinal
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data (Broadbent et al., 2008). Handling a small number of groups of trajectories is less
complicated than analyzing hundreds of individual trajectories (Nagin, 2005). Group-based
trajectory analysis was used to: 1) identify the number of unique trajectories of concurrent use
among older adults over the six-year study period; 2) examine the trends of concurrent use
among this population, and; 3) assess whether group membership varied based on
sociodemographic factors, including gender, race, and age. To meet these objectives, trajectories
based on concurrent use were generated using the SAS-based procedure known as Proc Traj.
Group-based trajectory models are designed to identify clusters of individuals following
similar progressions of behavior or outcomes over age or time. Mixture models are useful for
modeling unobserved heterogeneity in a population. They also allow for the inclusion of timestable and time-dependent covariates (Jones & Nagin, 2007). Time-stable covariates are
incorporated into group-based trajectory models by assuming the influence the probability of
belonging to a particular group. On the other hand, time-dependent covariates can directly affect
the observed behavior (Jones et al., 2001). Proc Traj is a specialized application of finite mixture
modeling intended to identify distinctive groups of individual trajectories within the study
population and for profiling the characteristics of between-group differences (Nagin, 2005,
1999). The group-based logit modeling yields two results: the optimal number of groups and the
proportion of the sample belonging in each of the trajectory groups.
The group-based modeling is an elaboration of the conventional maximum likelihood
model that forms the basis for many statistical methods, such as logit and Tobit regression (Xie
et al., 2006). The statistical method provides the basis for determining the number of groups that
best fits the data. Determining the optimal number of groups and the shape of the trajectory for
each group is a dynamic modeling fitting process. To determine the optimal number of
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trajectory groups that best fit the data, models with various numbers of groups are estimated
(Nagin, 2005). After defining the models, the optimal number of groups and the appropriate
degree of the polynomial (constant, linear, quadratic, or cubic), which is used to define the shape
of the trajectory for each group, is determined (Xie, et al., 2006).
Group-based trajectory modeling is a fairly new technique that is continuing to evolve.
As a result, no true consensus on determining the best fitting model currently exists (Xie et al.,
2006). However, the Bayesian Information Criterion (BIC) is widely recommended as the
preferred goodness-of-fit statistic; the larger the BIC the better the fit of the model (Nagin,
2005). P-values for the specified order of each trajectory were also considered as a model-fit
indicator. Thus, the model with the highest BIC value and significant trajectories was considered
the best fit for the data.
Proc Traj not only allows for the determination of the optimal number of trajectories, it
also determines the probability of belonging to each of the group trajectories. The probability
scores generated by Proc Traj show the percentage of individuals assigned to each group as well
as the likelihood of correct group assignment. It produces an explicit metric for every study
participant (i.e., the probability of group membership to each trajectory) for evaluating the
accuracy of group assignment (Nagin, 2005, 1999). The term probability score refers to the
probability of membership in each of the trajectory groups. Proc Traj also assigns a categorical
score based on each individual’s highest probability score, referred to as the categorical score.
For example, if four groups were identified for a specified model, each participant would receive
four probability scores based on that individual’s probability of being in each of the four groups.
In addition to the probability score, each participant would be assigned a categorical score based
on the respondent’s highest probability score (e.g., group 2). Continuing on with the four group
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solution, “Participant A” might have probability scores of .10, .05, .60 and .25 for groups 1, 2, 3
and 4, respectively. Because the probability score was highest for the third group, “Participant
A” would be assigned to group 3. Cote and colleagues (2002) assert that mean trajectory group
assignment probabilities around or greater than .70 – .80 implies a good fit. Group assignment
probabilities were also considered when determining model fit.
Group-based trajectory modeling assumes data is missing completely at random (MCR)
or missing at random (MR). Conceptually it was not appropriate to assume that data missing for
concurrent use was MCR or MR because the majority of attrition in the CHS data is due to death.
Therefore, in order to accurately classify an individual developmental trajectory and correctly
assign them to a trajectory group it was necessary to be able to establish their concurrent use
behavior at each of the study measurement points. In order to accurately classify an individual
into the correct trajectory group it was necessary to be able to establish their concurrent use
behavior at each of the study measurement points. Therefore, only individuals with data on
concurrent use at all of the six data points were included in the longitudinal portion of the
analysis. Of the 5,888 study participants nearly 60% (58.9%) had no missing information on
alcohol and medication use for all six waves of the study. As a result, it was possible to
determine whether or not these participants reported concomitant use at each measurement point
making it possible to chart their longitudinal patterns of use and they were included in the
trajectory analysis (N=3,470). Of the 2,478 participants that were dropped from this section of
the analysis, 15.5% were missing one wave of data, 8.2% were missing two waves of data and
the remaining 17.3% were missing three or more waves of data. As stated earlier, the entire
sample was included in the cross-sectional analysis of baseline data. In addition, post-hoc
analyses were conducted to examine differences between participants who completed the study
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and those who dropped out due to attrition or death. As a result, it was possible to determine
whether or not these participants reported concomitant use at each measurement point making it
possible to chart their longitudinal patterns of use and they were included in the trajectory
analysis (N=3,470). Of the 2,418 participants that were dropped from this section of the
analysis, 15% reported only one wave of data, 26.1% were had two or three waves of data and
the remaining 57.9% four or five waves of data. As stated earlier, the entire sample was included
in the cross-sectional analysis of baseline data. In addition, post-hoc analyses were conducted to
examine differences between participants who completed the study and those who dropped out
due to attrition or death.
Post hoc analysis of sociodemographic factors and key study variables at baseline
revealed that the participants who were excluded from the trajectory analysis were fairly
comparable to those respondents who were included. At baseline the majority of participants in
each group were women and White. The mean age at baseline for the excluded group was 74.5
which is slightly higher than the mean age for individuals included in the multivariate analysis
(71.7). Just over 46% of those persons excluded from the analysis reported weekly alcohol
consumption versus 52.6% of those individuals who were included. Medication use was fairly
comparable between the two groups although rates were slightly higher for individuals who were
not included in the trajectory analysis. The mean number of medications taken for the excluded
group was 2.7 compared to 2.09 for the analysis group and the total number of alcoholinteractive medications used by persons not included was 1.48 versus 1.09 for individuals
included in the trajectory analysis. Last, in both groups 28% of participants reported concurrent
use at baseline.
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Although the two groups have similar sociodemographic profiles, rates of medication
use, and drinking behaviors, those participants who were excluded from the study reported
poorer overall health. Individuals in the excluded group were nearly two times more likely to
report fair or poor (35.7%) than those participants who were included in the group-based
trajectory analysis (18.3%). In addition, analysis revealed that those persons excluded from the
multivariate analyses had more difficulties with activities of daily living (ADL) as well as
instrumental activities of daily living (IADL). Only 5.8% of individuals who were included in
the trajectory analysis reported difficulties with ADLs compared to 11.7% of those who were not
included. Also, 32.6% of individuals dropped from the analysis reported difficulties with IADLs
where as only 21.1% of respondents who were included in the analysis reported problems with
IADLs. Finally, when compared to those participants who were included in the trajectory
analysis, respondents in the excluded group reported higher rates of depression, 13.7% versus
17.4%. These differences in physical as well as mental health status at baseline are not
unexpected given that the majority of attrition in the CHS data is due to mortality. Therefore, it
would be anticipated that individuals who did not complete the study due to death would report
poorer over health status at baseline than those participants who completed the study.
In the current study, it was hypothesized that there would be a minimum of two unique
trajectories of concurrent use among older adults. In addition, it was theorized that longitudinal
patterns of concurrent use would vary by sociodemographic characteristics, including gender,
race, and age. In order to assess these hypotheses, group based trajectory analyses were run to
determine the most appropriate number of groups. For the current study the assessment points
served as the independent variable and concurrent use (0=No, 1=Yes) served as the dependent
variable. To determine the optimal number of trajectory groups that fit the data, 1, 2, 3, 4, and 5
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group models were estimated. The model that best fit the data was determined by the use of the
BIC P-values for the specified order of each trajectory and group assignment probabilities. After
determining the best fitting model, analysis was run on the model, including the time-dependent
factors of gender and race.

3.4.2.2 Multinomial Logistic Regression
Multinomial logistic regression was used to examine how various trajectories of concurrent use
affect the health status of older adult. Respondent patterns of concurrent use along with
demographic characteristics such as age, gender, and race were regressed on physical and mental
health variables to examine which characteristics predicted health outcomes using SPSS 15.0.
Multinomial logistic regression is designed to handle dependent variables that have more
than two classes, although it is sometimes used for binary dependents (Garson, 2009). Logistic
regression can be used to predict the percentage of variance in the dependent variable explained
by the independent variable, to rank the relative importance of independent, to assess the
interaction effects, and to understand the impact of covariate control variables (Pampel, 2000).
Logistic regression applies maximum likelihood estimates after transforming the dependent
variable into a logit variable—the natural odds of the dependent variable occurring or not
occurring (Pampel, 2000). Thus, logistic regression estimates the odds of a certain event
occurring.
Logistic regression is popular because it lacks many of the restrictive assumptions of
OLS regression. Specifically, logistic regression does not assume a linear relationship between
the dependent and the independent variable, does not require normally distributed variables, does
not assume homoscedasticity, and has overall less stringent requirements (Garson, 2009).
Multinomial logistic regression is the best regression procedure for this particular study because
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it can handle dependent variables with multiple classes and allows for between-group
comparisons. Therefore, I am able to assess the results in relation to how members of a
particular group compared to those classified in all the other trajectories. For example, members
of the no to low use trajectory may be significantly more likely than individuals in the increasing
use group to report excellent health rather than good health. Multinomial regression allows these
types of comparisons to be made.
In the current study, it was hypothesized that individuals with higher levels of concurrent
use would report poorer overall health than those individuals who had no-to-low levels of
concurrent use. Main-effects multinomial logistic regression was used to test this hypothesis;
models were run using data from the final follow-up point (Wave 6) 4. Several logistic regression
models were run. In all of the models, group membership (that is, belonging to the no to low use,
decreasing use, increasing use or high use trajectory) served as the independent variable. SPSS
automatically generated three dummy variables for the group membership variable; no to low use
served as the comparison group. In order to assess the impact of concurrent use on physical
health status, group membership was regressed on self-reported health status, the number of
IADLs and the number of ADLs at wave six. Assessing the impact of concurrent use on mental
health status was determined by running a multinomial logistic regression with group
membership predicting depression status at wave six. The covariates of gender, race and age
were included in all of the models. Models were evaluated using the Person and Deviance
goodness-of-fit statistics, the likelihood ratio tests and the parameter estimates.

4

Multinomial logistic regressions were only run on the follow-up time point because the independent variable,
group membership, was formulated based on the group-based logit modeling and includes the time component.
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3.4.2.3 Logistic Regression
Four additional logistic regression models were run to investigate the extent to which
participants physical and mental health status at baseline helped explain reported health status at
Wave 6. In each of the models, health status (self-reported health status, number of IADLs and
ADLs and depression status) at baseline and group membership (belonging to either the low to
no use, decreasing use, increasing use, or high use cohort) were included as independent
variables. The dependent variables from Wave 6 serving as proxies for physical health status
included self-reported physical health status (1=Excellent, 2=Very Good, 3=Good,
4=Fair,5=Poor), total number of IADLs (0=none,1= one to three, 2= four to six) and total
number of ADLs (0= none, 1=one to two, 2= three to six). The demographic covariates of
gender (0=Female, 1=Male), race (0=African American, 1=White) and age (continuous) were
included in all four of the logistic regression models. Since no a priori hypotheses had been
made to determine the order of entry of the predictor variables, a direct method was used for
these multiple linear regression analyses.

3.4.2.4 Cox Regression
Cox regression analysis was employed to examine the relationship between concurrent use and
mortality status; the entire sample was included in this regression analyses (N=5,888). The time
variable in this model, or duration to the event, was study wave and the binary variable of
mortality was used as the status or outcome variable. Two measures of concurrent use were used
to predict the event (time until death): having ever concurrently used during the study (0=No and
1=Yes) and the interaction of weekly alcohol consumption and total number of alcoholinteractive medications (concurrent use) at baseline. The additional covariates of gender
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(0=Female, 1=Male), race (0=African American, 1= White) and age (continuous) were included
in the model.
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4.0

4.1

RESULTS

OVERVIEW OF RESULTS

The results are presented in three sections. The first section includes baseline information on key
study variables as well as information from cross-sectional analyses on concurrent use. This
preliminary analysis provides descriptive statistics about the prevalence of concurrent alcohol
and medication use among community-dwelling older adults. The second section focuses on
longitudinal patterns and correlates of concurrent alcohol and medication use among older
adults. I tested the hypothesis that there would be several different trajectories of concurrent use
among older adults. Furthermore, I evaluate the relationship of various socio-demographic
characteristics with different patterns of concurrent use. To tests these hypotheses I use groupbased trajectory modeling. The final section discusses the impact of concurrent use on physical
and mental health status. I hypothesized that individuals with higher levels of concurrent use
would have poorer physical and mental health outcomes than those individuals who reported no
or low levels of concomitant use. I use Multinomial logistic regression to assess these
hypotheses.
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4.2

DESCRIPTIVE ANALYSIS

The following analysis provides a general description of the data and establishes the baseline
status of the sample (wave 1) for key study variables. Further, I review the relationship between
concurrent use and socio-demographic as well as other key factors such as health status.

4.2.1

Alcohol Use

Table 6 provides an overview of alcohol consumption at baseline. Most respondents either
abstained from alcohol use (50.1%) or drank below (36.3%) or within (3.7%) NIAAA guidelines
for older adults (1 drink a day). However, 6.7% of participants drank above recommended
guidelines (more than 1 drink a day) and 3.3% of respondents reported drinking twenty or more
drinks a week, nearly three times the recommended consumption for older adults. Moreover,
7.7% of respondents were classified as hazardous users, drinking 14 or more drinks a week
which is double the recommended alcohol consumption for older adults. These statistics are
consistent with past research on alcohol consumption patterns among older adults that suggests
that approximately 50% of seniors consume alcohol and 10% drink above recommended
guidelines (Blow & Barry, 2002).
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Table 6 Overview of Alcohol Consumption at Baseline

Men (58.2%) were statistically more likely than women (43.8%) to report weekly alcohol
consumption. Men also reported higher rates of alcohol consumption; the mean number of
drinks per week for men (3.7) was nearly two and a half times as much as the reported mean for
females (1.5). In addition, 11.2% of men reported hazardous alcohol use, consuming 14 or more
drinks a week or twice the NIAAA recommended guidelines, compared to only 5.1% of women.
There were statistically significant differences in rates of alcohol consumption between Whites
and African Americans. Only 5.5% of African Americans reported drinking above NIAAA
guidelines compared to 10.8% of Whites; Whites were also more likely than African Americans
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to be hazardous alcohol users. Furthermore, rates of alcohol use differed by age with those
individuals age 75 and older having higher rates of abstinence and lower rates of alcohol
consumption than individuals under the age of 75. Additionally, individuals over the age of 75
were less likely than their younger counterparts to report hazardous use, 8.3% versus 6.5%
respectively. These findings are consistent with past research that indicates that although rates
and levels of alcohol consumption decrease with age, nearly half of all older adults continue to
drink alcoholic beverages; consumption of alcohol among older adults is most prevalent among
men, Whites, and younger individuals (Hanson & Gutheil, 2004).
In looking at rates of alcohol use among drinkers only, the average number of alcoholic
beverages consumed weekly by drinkers only was 4.9; 15% of the drinkers were classified as
hazardous users (consuming 14 or more drinks a week) (see Table 7.). Men and Whites had
higher rates of weekly alcohol consumption than women and African Americans. Nearly 16% of
male drinkers reported consuming levels of alcohol above the recommended guidelines and 9.4%
drank 20 or more drinks a week whereas only 11.3% of women drinkers reported rates of
consumption above the recommended guidelines and even fewer (3.6%) consumed 20 or more
drinks a week.
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Table 7 Overview of Alcohol Consumption at Baseline (Drinkers Only)

4.2.2

Medication Use

Table 8 describes the sample baseline of medication use. Seventy-seven percent of participants
took at least one medication in the past 14 days; on average participants took 2.34 medications a
day. Just over 52% of participants reported daily use of 1 to 3 medications, 19.6% were using 4
to 6 medications and 5.1% took seven or more medications a day. Sixty-two percent of the
sample reported taking an alcohol-interactive medication at baseline; the mean number of
alcohol-interactive medications used by respondents was 1.25.
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Table 8 Medication Use at Baseline

Women were statistically significantly more likely than men to be taking any
medications, ( p < .001). Analysis of the total number of alcohol-interactive medications being
take by study participants revealed that usage rates for alcohol-interactive medication also varied
by gender with women taking more alcohol-interactive medications than their male counterparts
(p < .001). The percentage of participants using medications differed by race. African
Americans were less likely than Whites to be taking no medications, 18.5% versus 24.0% (p <
.001). In addition to taking fewer medications than African Americans, Whites used alcoholinteractive medications less than African Americans (p < .001). Finally, age was found to be a
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significant predictor of medication use. At baseline individuals age 75 and older were more
likely to be taking multiple medications, χ2(4, N = 5888) = 30.33, p < .001. However, there were
no statistically significant differences in rates of usage of alcohol-interactive medications
between age categories.

Figure 1 Alcohol-Interactive Medication Use by Age at Baseline
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4.2.3

Health Status

One of the primary goals of this investigation was to examine the impact of various patterns of
concurrent use on the physical as well as mental health status of older adults. Prevalence rates of
key health status indicators were analyzed at baseline in order to gain a general overview of the
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health of the older adults in the sample. The relationships between health status and gender, race
and age were also examined.

4.2.3.1 Physical Health Status
The majority of participants, 61.1%, reported being in good or very good health at baseline (see
Figure 2.). Over 57% of respondents felt their health was better than others their age. African
Americans were significantly more likely than Whites to report fair or poor health, 42.4% versus
22.2% respectively (p < .001). However, no racial difference in how respondents viewed their
health compared to others were found; the majority of both African Americans and Whites felt
their health was better than others their age. There was no statistically significant difference in
self-report health status by gender, the majority of both women (60.7%) and men (61.7%)
reported good to very good health. However, men were significantly more likely than women to
consider their health to be better than others their age, 60.1% versus 55.1% (p < .001).
Individuals 80 and above were significantly more likely than other age groups to report fair or
poor health (31.8%). However, older individuals, eighty and above, were more likely to believe
there health was better than others their age; for example, 61.3% of individual eighty and over
compared to 52.8% of individuals age 65 to 69 (p < .001).
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Figure 2 Self-Reported Health Status at Baseline
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Table 9 describes overall physical functioning for the study sample at baseline;
percentages of total number of ADLs and IADLs are reported for the overall sample as well as
by race and gender.
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Table 9 Physical Functioning at Baseline
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Women reported significantly more difficulties with Activities of Daily Living (ADL)
and Instrumental Activities of Daily Living (IADL) than men (p < .001). African Americans had
significantly higher levels of reported ADL deficiencies than Whites (p < .001); they also had
more difficulty with IADLs than Whites but the difference was not statistically significant. Age
was a significant predictor of both ADLs and IADLs with individuals in the older age categories
reporting higher rates of ADLs and IADLs (p < .001).

4.2.3.2 Mental Health
Using the recommended cut-point for the CES-D of 10, 13.8% of respondents were classified as
depressed at baseline. The mean CES-D score was 4.41 (SD=4.6) with a range from 0 to 29.
Women and African Americans were significantly more likely to be depressed than men and
Whites (p<.001). Nearly 17% of women compared to only 9.8% of men were classified as
depressed at baseline. Twenty-one percent of African Americans had a positive screen for
depression at baseline versus 12% of Whites. Depression status was not significantly related to
age category yet older individuals had higher rates of depression at baseline; for example 12.9%
of individuals between the ages of 65 and 79 were classified as depressed at baseline compared
to 15.7% of individuals in the age range of 80 to 84.

4.2.4

Concurrent Use

Twenty-eight percent of all study respondents reported concurrently using alcohol with one or
more alcohol- interactive medications at baseline. Of those individuals who reported weekly
alcohol use, 56.7% were taking one or more alcohol-interactive medications. The number of
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alcohol-interactive medications used by individuals who reported concurrent use ranged from 1
to 9 with a mean of 1.06 (SD=1.24). Most participants were taking one alcohol-interactive
medication (48%) however; 22.1% of respondents who reported concurrent use were taking three
or more alcohol-interactive medications.
At baseline, concurrent users had higher rates of overall medication use and were taking
more alcohol-interactive medications than individuals who reported no concurrent use. Over
35% of concurrent users reported taking 4 or more medications compared to just 20.4% of nonconcurrent users, p < .001. Study participants who reported concomitant use were also more
likely than non-concurrent users to take multiple alcohol-interactive medications; 22.1% versus
14.1% respectively (p < .001).
Men had greater rates and reported more hazardous levels of concurrent use than women.
At baseline, rates of concurrent use for women and men were 26% and 32% respectively. Men
were statistically more likely to report concurrent alcohol and medication use than women, χ2=
27.91, p < .001. Men were also more likely than women to report high levels of concurrent use
at baseline (see Figure 3.); level of concurrent use was determined by the amount of weekly
alcohol consumption and total number of alcohol-interactive medications being taken. Men
(9.6%) were twice as likely as women (4.6%) to have high levels of concurrent use at baseline (p
< .001).
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Figure 3 Level of Concurrent Use by Gender at Baseline (Drinkers Only)
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Rates of concurrent use varied by race as well; 29% of Whites verses 23% of African
Americans reported concurrent use at baseline. Whites were significantly more likely than
African Americans to report concurrent use, p < .001. Additionally, Whites reported higher
levels of concurrent use than their African American counterparts, p < .04 (see Figure 4).
Nearly 16.2% of Whites reported moderate levels of concurrent use compared to only 9.9% of
African Americans. No significant difference in rates of concurrent use were found for age (p =
.66), concurrent usage rates remained fairly stable regardless of age category.
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Figure 4 Level of Concurrent Use by Race at Baseline (Drinkers Only)
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Although the majority of individuals taking alcohol-interactive medications drink at or
below the NIAAA recommended guidelines for older adults (81.2%), nearly 19% of respondents
reported drinking above the recommended guidelines (>8 drinks a week). Individuals who were
classified as problem users, drinking nearly three times the weekly recommended guidelines for
older adults (>20 drinks a week), were statistically more likely to concurrently use than nonproblem users; 54.4% versus 26.1% respectively (p < .001).
Differences in health status between concurrent users and non concurrent users at
baseline were also examined (these results were used as a comparison point for the later
multivariate analysis that assessed whether or not longitudinal patterns of concurrent use impact
health outcomes). There were no statistically significant differences between concurrent users
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and non concurrent users at baseline, Table 10 shows rates of self-reported health, physical
functioning and depression status for concurrent users versus non concurrent users.

Table 10 Health Status at Baseline: Concurrent User versus Non-Concurrent Users
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4.3

GROUP-BASED TRAJECTORY MODELS

As stated earlier, initial descriptive analyses were conducted as a precursor to more in-depth
multivariate analysis examining concurrent alcohol and medication use among older adults. It
was hypothesized that there would be more than one pattern of concurrent use. Preliminary
explorations of the data revealed that, of the respondents with complete data on concurrent use
for all measurement points (N=3,470) nearly half (48.9%) concurrently used alcohol with
alcohol-interactive medications during at least one of the six waves of the study; 58.7% of
concurrent users reported concomitant alcohol-medication use in 3 or more waves of the study
(see Figure 5).

Figure 5 Total Waves of Concurrent Use by Gender and Race
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The preliminary findings indicated the possible existence of different trajectories of
concurrent use. Additionally, it appeared that longitudinal patterns of concomitant use varied by
gender and race. Group-based logit modeling was used to test these hypotheses. The groupbased logit modeling yielded two results: the optimal number of trajectory groups as well as the
proportion of the sample belonging in to each of the trajectory groups. Determining the optimal
number of groups and the shape of the trajectory for each group is a dynamic modeling fitting
process. In this analysis two, three, four, and five-group models were fitted. The Bayesian
Information Criterion (BIC) was used for model selection. BIC scores for the various models are
listed in Table 11; two BIC scores are presented, one based on the total number of participants
and another based on the total number of observations. Based on the BIC scores, the model with
four groups has the best fit, as this model has the largest BICs (-8448.40 and -8465.43).
After determining the model with four groups was the best-fitting model, the parameter
estimates were refined to create a more parsimonious model. In the initial analyses, all groups
were set to calculate through the cubic order however, only the increasing use group was
significant up to the cubic order. Therefore, the model was refined to create a more
parsimonious model. In the refined four group model only the increasing use group was set to
calculate up to the cubic order, the other three groups only calculated through the quadratic
order. All of the four groups maintained similar trajectory patterns, refining the model simply
served to eliminate the unnecessary parameters to create the most parsimonious model that best
reflects the four unique trajectory patterns.
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Table 11 BIC Scores for Concurrent Use Models

Parameter estimates for the four group model are displayed under Model One in Table 12
and Figure 6. This population includes a mixture of four distinctive groups that are defined by
their trajectories with respect to concurrent use over the six years study period. Group 1, which
was classified as the no to low use trajectory constitutes the majority of the population (61.9%)
and is defined by the intercept linear, and quadratic parameters. The no to low use trajectory is
characterized by a slight U-shaped pattern with concurrent use starting off slightly elevated in
wave one, declining and maintain a fairly stable level in waves two through five and increasing
slightly in the final wave of the study. The trajectory for Group 2 or the decreasing use
trajectory, accounts for 14.2% of the sample and is stable in the initial waves of the study but
overtime it begins to steadily decline. Group 3, the increasing use trajectory, is comprised of
7.2% of the sample and is defined by all four of the parameters (intercept, linear, quadratic and
cubic); this trajectory starts off low but, steadily increases overtime with a slightly decrease near
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the end of the study.

Group 4 is defined by the intercept, linear, and quadratic parameters. Just

over 16.6% of study participants belonged to Group 4, entitled the high use trajectory, which is
characterized by a curve shaped trajectory. In the high use group there is an increase in
concurrent use between waves one and two of the study; rates remain high and stable between
waves two and four and then begin to decrease in wave five.
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Table 12 Parameter Estimates for Group Trajectories and Group Membership 5

Group (N=3470)

1 No to low
2 Decreasing
3 Increasing

4 High

Parameter

Intercept
Linear
Quadratic
Intercept
Linear
Cubic
Intercept
Linear
Quadratic
Cubic
Intercept
Linear
Quadratic

Model 1

Model 2

Estimates SE

Estimates

-2.63
-0.67
0.09
0.41
0.08
-0.06
-1.19
-1.60
0.87
-0.09
1.71
0.76
-0.12

0.11**
0.10**
0.02**
0.17*
0.10
0.02**
0.27**
0.50**
0.22**
0.02**
0.15**
0.13**
0.02**

-2.69
-0.67
0.09
0.40
0.07
-0.06
-1.35
-1.57
0.87
-0.09
1.70
0.78
-0.12

SE
0.11**
0.09**
0.02**
0.16*
0.09
0.02**
0.28**
0.51**
0.22**
0.02**
0.15**
0.13**
0.02**

Group Membership 6
1 No to low
2 Decreasing

3 Increasing

4 High

Constant
Constant
Sex (Male= 1)
Race
(White=1)
Constant
Sex (Male= 1)
Race
(White=1)
Constant
Sex (Male= 1)
Race
(White=1)

0.00
-1.22
0.08
-0.28

0.16**
0.16
0.14

-3.27
0.93
0.69

0.47**
0.20 **
0.40

-2.07
0.59
0.56

0.18**
0.10**
0.17**

*Significant at p<.05
**Significant at p<.001

5

Model 1 is an unconditional model that only identifies group membership. Model 2 is a conditional model that
links demographic variables to group membership.
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Posterior probabilities were also determined and used as an indicator of good model fit
(Cote et al., 2002). Table 13 shows the number of individuals assigned to each group along with
the average and range of posterior group assignment probabilities. The percentage of the sample
assigned to each of the four groups (64.4%, 12.2%, 6.1% and 17.4%) based on maximum
posterior probabilities corresponds closely to the estimated group probabilities (61.9%, 14.2%,
7.2% and 16.6%). Table 13 also shows the average trajectory group assignment; these
probabilities are 0.95, 0.80, 0.77 and 0.90 for the four groups, respectively. Therefore, between
77 to 95 percent of individuals were correctly assigned to different trajectory groups. These
probabilities are around or greater than the minimum acceptable threshold defined by Nagin
(2005) as having all group posterior probabilities at or above 0.7. The BIC scores and the
posterior probabilities both indicate that the four trajectory model is the best fit.

Table 13 Trajectory Group Assignment Probabilities
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Each of the four cohorts identified by the best fitting model are characterized by their
own distinct patterns of concurrent use. The no to low use trajectory (Group 1), is comprised of
individuals who did not concurrently use alcohol and medications or those individuals who had
low levels of concomitant use. The trajectory for the no to low use (Group 1) group is fairly flat
and essentially these individuals maintained a stable pattern of no or low levels of use over the
course of the study. The decreasing use trajectory (Group 2) is characterized by a gradual and
steady decrease in concurrent use over time. Rates of concurrent use were moderately high
among members of the decreasing use group (Group 2) in the initial waves of the study but
substantially decreased with time so that by the final study wave concurrent use was fairly low
among this population. The trajectory for Group 3, increasing use, is best characterized as a
group of individuals whose concurrent use fluctuates over time. Initially levels of concurrent use
in the increasing use cohort (Group 3) were fairly low. However, concurrent use increases
among this population over the course of the study; by wave 5 this group was characterized by
moderate to high levels of concomitant use. Finally, the trajectory for the high use cohort
(Group 4) is indicative of high-stable rates of concurrent use over time. Individuals in the high
use cohort (Group 4) tended to concurrently use alcohol and medications throughout the course
of the study.
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Figure 6 Longitudinal Patterns of Concurrent Use among Older Adults
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In addition to identifying the best-fitting model in terms of the optimal number of groups
and their trajectory shapes, analysis was also run to determine whether or not any of the
individual-level covariates predict or distinguish group membership. The model containing time
constant demographic covariates is contained in Table 12; Model 1 identifies group membership
only whereas Model 2 also assesses whether individual-level covariates are associated with
group membership. In Model 2, using the no to low use group as the comparison group, both
gender and race were a significant predictors of group membership. Males had a higher
probability of group membership in the high use group and the increasing use. There were no
106

significant differences by gender for membership in the decreasing use trajectory. Race also
predicted cohort membership; being White increased the probability of group membership in the
high use group with significant coefficients of 0.56. However, race did not predict membership
in the decreasing use (p=0.08) or increasing use (p=0.08) groups yet, African Americans had a
higher percentage of membership in the decreasing use group and Whites had higher rates of
membership in the increasing use trajectory. Additional cross-tabular analyses displaying rates
of group membership by gender, race, and age are displayed below in Table 14.
Men were nearly twice as likely as women to be in the increasing use group and had
higher rates of membership in the high use cohort, 21.6% of men compared to only 14.7% of
women. Just over 15% of African Americans were in either the increasing use or the high use
trajectories whereas 24.8% of Whites were placed in one of these cohorts. Age was
significantly related to group membership (p=0.015). The majority of individuals in each age
category (65 – 69, 70 – 74, 75 – 79, 80 – 84, and 85+) were in the no to low use group.
Membership in the decreasing use group was highest for individuals ages 80 to 84 (17.9%) and
the 85 and over category (19.6%) which is nearly double the percentage of those ages 65 to 69 in
this group (11%). Membership in the high use trajectory was greatest among the younger age
categories. For example, 17.9% of individuals ages 65 to 69 were members of the high use
trajectory compared to only 5.4% of individuals ages 85 and older.
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Table 14 Demographic Characteristics by Group Membership

Group
No to low Use
Decreasing Use
Increasing Use
High Use

Men

Women

(n=1369)

(n=2101)

58.3%
11.8%
8.3%
21.6%

68.3%
12.5%
4.6%
14.7%

4.4

𝒙𝒙𝟐𝟐

.000**

African
American /
Other

White

(n=489)

(n=2981)

68.5%
16.2%
4.5%
10.8%

63.7%
11.5%
6.3%
18.5%

𝒙𝒙𝟐𝟐

.000**

MULTINOMIAL LOGISTIC REGRESSION

After identifying the four major patterns of concurrent use (no to low use, increasing use,
decreasing use, and high use) multinomial logistic regression was used to analyze the
relationship between patterns of concurrent use and the physical as well as mental health status
of community-dwelling older adults. In the baseline analysis of the relationship between
physical health status and concurrent use, no significant differences were found between
concurrent users and non-concurrent users on measures of self-reported health and physical
functioning (IADLs and ADLs) as well as depression status. To examine how various
trajectories of concurrent use impact upon the physical health of older adult’s four multinomial
logistic models were run. In each of the models, group membership served as the independent
variable (belonging to either the low to no use, decreasing use, increasing use, or high use
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cohort); dependent variables from Wave 6 serving as proxies for physical health status included
self-reported physical health status, total number of IADLs, and total number of ADLs.
Additionally, a model to assess the effects of patterns of concurrent use on mental health status
was run with group membership as the predictor variable and depression status as the outcome
variable. The demographic covariates of gender (0=Female, 1=Male), race (0=African
American, 1=White) and age (continuous) also included in the model were included in all four of
the logistic regression models. Frequency distributions were run to determine the appropriate
reference category for each of the dependent variables. For the independent variable of group
membership, consisting of three dummy variable, the no to low use trajectory was used as the
default comparison group in all analyses.

4.4.1

Physical Health

4.4.1.1 Self-Reported Health Status
In the first model, group membership was regressed upon physical health status with the
covariates of gender, race, and age also included in the model. Model fitting information
indicated the existence of a relationship between the independent variables and self-reported
health status; the probability of the model chi-square (159.40) was significant at p<.001.
Furthermore, the likelihood ratio test indicated a significant relationship between concurrent use
and self-reported health status; ratio tests also confirmed a statistically significant relationship
between health status and gender, race and age (see Table 15). Finally, both the Persons
(p=.637) and Deviance (p=.997) goodness-of-fit statistics were not statistically significant
indicating adequate model fit.
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Table 15 Likelihood Ratio Tests for Physical Health Regression Models (N=3470)
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Using good health as the reference category, being male increased the odds of reporting
excellent to very good health rather than good health by 1.7 and 1.2, respectively. There were no
significant differences between Whites and African Americans in reporting excellent rather than
good health. However, Whites were significantly more likely than African Americans to report
very good health; African Americans had significantly higher rates of self-reported fair or poor
(p<.001). Being White was associated with a 46.5% decrease in fair and a 70.8% decrease in
poor rather than good self-reported health status. Additionally, compared to younger individuals,
older respondents were significantly more likely to report fair or poor health than good health
(p<.001). Looking at trajectories of concurrent use, members of the high use trajectory are
significantly less likely than those in the no to low use group members to report excellent health
rather than good health; no other group membership contrasts were significant (see Table 16. for
parameter estimates). This finding is a departure from the initial baseline analysis which found
no significant differences between non-concurrent users and concurrent users possibly indicating
that it is the pattern of concurrent use, not necessarily concurrent use in itself that affects health
status.
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Table 16 Parameter Estimates for Self-Reported Health Status Regression Model (N=3,470)
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4.4.1.2 Physical Functioning
Two models were run to assess the relationship between patterns of concurrent use and physical
functioning. In the first model, group membership was regressed upon the categorical variable
number of IADLs with the covariates of gender, race and age also included in the model. In the
second model, group membership was the independent variable and the categorical variable
number of ADLs was the dependent variable. In both models, the reference category for the
independent variable of group membership was the low to no use trajectory and for the
dependent variables the comparison group was having no IADLs or ADLs. Model fitting
information indicated the existence of a relationship between the independent variables and
physical functioning; the probability of the model chi-square (295.59) was significant at p<.001
for the IADLs model and the model chi-square for the ADLs model was also significant, χ2 =
152.21, p<.001. Goodness-of-fit statistics for both models were non-significant indicating
satisfactory model fit for both physical functioning models (see Table 17). The likelihood ratio
tests indicated a significant relationship between concurrent use and physical functioning (see
Table 13). Additionally, statistically significant relationships between total number of IADLs as
well as ADLs and gender, race and age were found (see Table 15).
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Table 17 Goodness-of-Fit Statistics For Physical Functioning Regression Model

Parameter estimates showing significant relationships between total number of IADLs
and gender, race, and age can be found in Table 18. An inverse relationship was found between
total number of IADLs and gender and race. However, the likelihood ratio test did not show race
to be significantly related to the independent variable, number of IADLs, therefore it is not
appropriate to assess its role in distinguishing between pairs of groups. Women were
significantly more likely than men to report having any IADLs rather than no IADLs. Being
male was associated with a 34% decrease in reporting one IADL, a 62.2% decrease in reporting
two IADLs and a 58.6% decrease in having four to nine IADLs. Age was positively correlated
with total number of IADLs with older individuals reporting higher rates of IADLs compared to
no IADLs. As with race, comparisons of group membership were not assessed because the
likelihood ratio test found no significant relationship between cohort membership and number of
IADLs.
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Table 18 Parameter Estimates Physical Functioning (IADL) Regression Model (N=3,470)
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Similar to the IADL model, gender, race and age were all significantly related to the total
number of ADLs reported by an individual (See Table 15 for likelihood ratio tests and Table 19
for parameter estimates). Men were more likely than women to report having no ADLs versus
having one or more ADLs. Being female increases the odds of reporting one, two, and three or
more ADLs rather than no ADLs by 0.61, 0.58 and 0.44, respectively. Whites were more likely
than African Americans to report having no ADLs versus one or more ADLs. Being African
American increases the odds of reporting one (0.65), two (0.56) or three or more (0.51) ADLs
rather than no ADLs. Increasing age was significantly related to the number of ADLs reported.
Each one year increase in age corresponds to a 0.05 unit increase in reporting one ADL versus
none, a 0.08 unit increase in reporting two ADLs rather than none and a 0.12 unit increase in
reporting three or more ADLs rather than no ADLs. Finally, among this set of predictors, group
membership was helpful in distinguishing among the groups defined by total number of ADLs;
this is a significant relationship that was not found when using a dichotomous comparison at
baseline. Respondents in the decreasing use group were more likely than individuals in the no to
low use group to report having one ADL or two ADLs rather than no ADLs; there was no
significant difference between reporting three or more ADLs for individuals in the decreasing
use group compared to the no to low use group.
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Table 19 Parameter Estimates for Physical Functioning (ADL) Regression Model (N=3,470)
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4.4.2

Mental Health

In order to assess the relationship between patterns of concurrent use and mental health status
group membership was regressed on depression status; the covariates of gender, race, and age
were also included in the model. Goodness-of-fit statistics suggested an adequate model fit with
both the Persons (p=.578) and Deviance (p=.1214) being non significant. Model fitting
information also indicated the existence of a relationship between the independent variables and
depression status, χ2 = 49.26, p<.001. Likelihood ratio test were significant indicating a
relationship between group membership and depression status (See Table 20). Finally, ratio tests
confirmed statistically significant relationship between depression status and gender, race and
age.

Table 20 Likelihood Ratio Tests for Mental Health Regression Model
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Table 21 shows the parameter estimates for the mental health regression model. There
was a significant inverse relationship between gender and depression status with females being
more likely to have a diagnosis of depression than males. The odds of being clinically depressed
decreased by 0.64 for men compared to women. There was also a significant relationship
between race and depression status with African Americans having a higher rates of depression
compared to Whites. The odds of having a depression diagnosis rather than no depression
diagnosis were 23% less for Whites versus African Americans. Age is positively associated with
depression status; older individuals have higher rates of depression than their younger
counterparts. Considering patterns of concurrent use, a significant relationship between
depression status and membership in the increasing use and the decreasing use trajectories was
found; no other contrasts for group membership were significant. The odds of being depressed
rather than not depressed increased by a factor of 1.35 for individuals in the decreasing use
group rather than those in the no to low use trajectory. On the other hand, when compared to
individuals in the no to low use group, being a member of the increasing use trajectory is
associated with lower levels of depression; the odds of being depressed decrease by 0.64 for
members of the increasing use group. Given that rates of depression were comparable for nonconcurrent users and concurrent users, the results indicate that, as with physical functioning, it is
the pattern of concurrent use that explains the relationship between concomitant use and
depression status.
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Table 21 Parameter Estimates for Mental Health Regression Model (N=3,470)

4.4.3

Medication Use and Alcohol Consumption

Follow-up analyses using multinomial logistic regression models were run to assess the
relationship between medication and alcohol use and physical as well as mental health status in
wave 6 of the study. Alcohol use (number of drinks a week), total number of medications, the
total number of alcohol-interactive and the interaction effect of alcohol with the medication
variables was regressed on self-reported health status, total number of IADLs, and total number
of ADLs; the covariates of gender, race, and age were also included in the model. In the selfreported health model, good health was used as the reference category in the analysis and in the
physical functioning models reporting no IADLs or ADLs served as the reference point for the
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models. In the fourth model run alcohol use (number of drinks a week), total number of
medications, the total number of alcohol-interactive, and the interaction of alcohol use with the
medication variables was regressed on depression status. Sociodemographic characteristics were
also included as covariates in the model and lack of a depression diagnosis was used as the
reference category for this analyses.
Men, African Americans, and older adults were significantly more likely to report poor
health than good health. Women, African Americans, and older individuals were more
significantly more likely to report difficulties with IADLs and ADLs than men, Whites, and
younger individuals. Medication use was significantly related to self-reported health status.
Individuals taking more medications were less likely to report excellent or very good health and
significantly more likely to report poor or fair health rather than good health. Additionally,
medication use was significantly related to total number of ADLs and IADLs. There was a
positive correlation between number of medications and difficulties with ADLs and IADLs;
individuals with more ADLs and IADLs were more likely to be taking one or more medications
rather than none. Alcohol use was significantly related to self-reported health status yet there
was no significant relationship between alcohol use and total number of ADLs or IADLs. A 1
unit increase in weekly alcohol consumption increased the odds of reporting very good rather
than good health by 1.3%. Conversely, a 1 unit increase in alcohol consumption decreased the
odds of reporting poor rather than good health by 23.5%. The interaction effect of alcohol and
medications was not significantly related to self-reported health status or physical functioning
models.
Multinomial logistic regression models were also run to examine the effect of alcohol and
medications use on depression status. Females and older individuals were more likely to report
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depression when compared to men and younger respondents. Medication use was significantly
related to depression status. A one unit increase in the total number of medications being used
increased the chance of being depressed rather than not depressed by 11.9%. Alcohol use was
not significantly related to depression status nor was the interaction between weekly alcohol use
and total number of medications.

4.4.4

The Relationship between Baseline Health Status and Overall Health in Wave 6

Four additional logistic regression models were run to investigate the extent to which
participants physical and mental health status at baseline helped explain reported health status at
Wave 6. In each of the models, health status (self-reported health status, number of IADLs and
ADLs and depression status) at baseline and group membership (belonging to either the low to
no use, decreasing use, increasing use, or high use cohort) were included as independent
variables. The dependent variables from Wave 6 serving as proxies for physical health status
included self-reported physical health status (1=Excellent, 2=Very Good, 3=Good,
4=Fair,5=Poor), total number of IADLs (0=none,1= one to three, 2= four to six) and total
number of ADLs (0= none, 1=one to two, 2= three to six). The demographic covariates of
gender (0=Female, 1=Male), race (0=African American, 1=White) and age (continuous) were
included in all four of the logistic regression models. Since no a priori hypotheses had been
made to determine the order of entry of the predictor variables, a direct method was used for
these multiple linear regression analyses.
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4.4.4.1 Physical Health Status
In the first model, logistic regression was employed to help determine the influence of group
membership and self-reported health status at baseline on reported health status in the final wave
of the study. Together group membership, health status at baseline, gender, race and age explain
27.5% of the variance in self-reported health status in Wave 6 (F (5, 3453)= 262.98, p=.000).
Regression coefficients are presented in Table 22. The strongest predictor was self-reported
health status at baseline (β=.43). The independent variable of group membership also predicted
health status (β=.26). The covariates of race and age significantly predicted self-reported health
status; gender was not a statistically significant. African Americans and older respondents were
more likely to report lower levels of self-reported health than Whites and younger study
participants.

Table 22 Regression Coefficients for Self-Reported Physical Health Regression Model (N=3,470)

Unstandardized
Coefficients
B
SE
Constant
1.09
Group Membership
.026
Health Status (Wave 1)
.431
Gender
-.040
Race
-.160
Age
.010
*Statistically Significant at p<.05
**Statistically Significant at p<.001

.206
.010
.013
.026
.036
.003
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Standardized
Coefficients
Β

t

Significance

.036
.502
-.022
-.064
.057

5.28
2.44
34.16
-1.54
-4.39
3.94

.000**
.015*
.000**
.124
.000**
.000**

4.4.4.2 Physical Functioning
Two logistic regression models were run to determine the impact of physical functioning at
baseline and cohort membership on reported functional status in Wave 6. Group membership
was not a significant predictor of number of reported difficulties with IADLs or ADLs in Wave
6. The covariates of gender, race and age significantly predicted physical functioning in both
models. The greatest predictor of total number of IADLs in the final wave of the study was total
number of IADLs at baseline (β=.47). Number of IADLs at baseline, gender, race and age
explain 19.9% of the variance in rates of IADLs in Wave 6 (F (5, 3434)= 172.07, p=.000).
Approximately 12% of the variance in the number of ADLs in the final wave of the study was
explained by the independent variable of ADLs at Wave 1 and the covariates of gender, race and
age (F (5, 3406)= 92.48, p=.000). The predictor of total number of reported ADLs (β=.51) in
the final wave of the study. Regression coefficients for both models are presented in Table 23.
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Table 23 Regression Coefficients for Physical Functioning Regression Models (N=3,470)

Unstandardized
Coefficients
B
SE
IADLs
Constant
Group Membership
Total IADLs (Wave 1)
Gender
Race
Age

-1.37
.005
.468
-.068
-.047
.022

Standardized
Coefficients
Β

t

Significance

.134
.007
.020
.017
.024
.002

.012
.367
-.063
-.030
.198

-10.27
.777
23.55
-4.02
-1.97
12.88

.000**
.437
.000**
.000**
.050*
.000**

.129
.007
.029
.016
.023
.002

.023
.284
-0.81
-.055
.132

-5.90
1.43
17.52
-4.96
-3.38
8.20

.000**
.152
.000**
.000**
.001**
.000**

ADLs
Constant
-.761
Group Membership
.009
Total ADLs (Wave 1)
.514
Gender
-.080
Race
-.077
Age
.013
*Statistically Significant at p<.05
**Statistically Significant at p<.001

4.4.4.3 Mental Health
Multiple regression analyses was used to investigate the extent to which participants depression
status at baseline and group membership explained reported depression status in the final wave
of the study. As was the case in the physical health models, the strongest predictor of depression
status in Wave 6 was baseline depressive diagnosis (β=.26). Depression status at baseline,
gender and age explain 7.7% of the variance in mental health status in Wave 6 (F (5, 2596)=
44.39, p=.000). Regression coefficients are presented in Table 24. Group membership and race
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did not predict depression status. The covariates of gender and age significantly predicted mental
health status; women and older individuals were more likely to report depression.

Table 24 Regression Coefficients for Mental Health Regression Model (N=3,470)

Unstandardized
Coefficients
B
SE
Constant
1.09
Group Membership
.026
Health Status (Wave 1)
.431
Gender
-.040
Race
-.160
Age
.010
*Statistically Significant at p<.05
**Statistically Significant at p<.001

4.4.5

.206
.010
.013
.026
.036
.003

Standardized
Coefficients
Β

t

Significance

.036
.502
-.022
-.064
.057

5.28
2.44
34.16
-1.54
-4.39
3.94

.000**
.015*
.000**
.124
.000**
.000**

Concurrent Use and Mortality

Cox regression analysis was employed to examine the relationship between concurrent use and
mortality status; the entire sample was included in this regression analyses (N=5,888). The time,
variable in this model was study wave and the binary variable of mortality was used as the status
or outcome variable. Two measures of concurrent use were used to predict the event (time until
death): having ever concurrently used (0=No and 1=Yes) and the interaction of weekly alcohol
consumption and total number of alcohol-interactive medications (concurrent use) at baseline.
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The additional covariates of gender (0=Female, 1=Male), race (0=African American, 1= White)
and age (continuous) were included in the model.
The likelihood ratio test for the model was significant indicating that one or more of the
covariates contributes significantly to the explanation of duration to death. The null model had a
-2 Log Likelihood of 16,667.58 and the full model had a -2 Log Likelihood of 16188.07. The
model chi-square difference was 540.32 (p<.001). The two measures of concurrent use and the
covariates of gender, race and age were all significantly related to time until death (see Table
25.)

Table 25 Test Statistics for Cox Regression: Concurrent Use and Mortality

B

SE

Wald

df

p

β

Ever Concurrent Use

-.338

.069

23.98

1

.000**

.713

Concurrent Use (Wave 1)

.007

.003

5.36

1

.021*

1.01

Gender

.699

.067

112.85

1

.000**

2.01

Race

-.187

.081

5.15

1

.023*

.830

Age

.090

.005

347.22

1

.000**

1.09

*Significant at p<.05
**Significant at p<.001

For every one unit increase in concurrent use (the interaction of weekly alcohol use and total
number of alcohol-interactive medications) the hazard ratio for mortality increased by a factor of
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1.01. The binary variable of having ever concurrently used over the course of the study was
inversely related to mortality (β=.71). Gender and age were both positively correlated with
mortality with men and older individuals being more likely to experience an event than women
and younger individuals. Finally, being White was significantly associated with a lower risk of
mortality.

4.4.6

Summary of Results

Concurrent use is fairly common among community-dwelling older adults; the majority of study
participants (55.4%) concurrently used alcohol with alcohol-interactive medications during at
least one of the six waves of the study; one-third of concurrent users reported concomitant
alcohol-medication use in 3 or more waves of the study. The majority of individuals who
reported alcohol consumption also reported concurrent use; over the course of the study rates
ranged between 57% to 64%. The most common form of concurrent use was drinking below or
within recommended guidelines and taking one alcohol-interactive medication. Concomitant
alcohol and medication use vary between the subgroups: men, Whites and problem drinkers were
significantly more likely to concurrently use than women, African Americans and low to
moderate alcohol users; there were no significant differences by age.
Group-based logit analysis revealed four distinct patterns of concurrent use. Concurrent
use among the first group of individuals increased over the course of the study. The second
trajectory is fairly flat and is comprised of individuals who maintain a stable pattern of no to low
use over the course of the study. The third group, the decreasing use group, is characterized by
moderately high levels of use in the initial waves of the study however there is a gradual steady
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decrease in concurrent use over time. The final group is indicative of high-stable rates of
concurrent use over time. Using the no to low use group as the comparison group, gender was a
significant predictor of group membership. Males had a higher probability of group membership
in the increasing use and high use groups. Race did not significantly predict membership in the
increasing use group however the relationship was positive indicating a greater number of
Whites in this cohort. Yet, being White significantly increased the probability of group
membership in the high use group.
Regression analysis revealed that specific patterns of concurrent use are significantly
related to both physical and mental health status among community-dwelling older adults. Using
good health as the reference category, being male increased the odds of reporting excellent to
very good health rather than good health. There were no significant differences between Whites
and African Americans in reporting excellent rather than good health. However, Whites were
significantly more likely than African Americans to report very good health; African Americans
had significantly higher rates of self-reported fair or poor. Additionally, compared to younger
individuals, older respondents were significantly more likely to report fair or poor health than
good health. Looking at trajectories of concurrent use, members of the high use trajectory were
significantly less likely than those in the no to low use group members to report excellent health
rather than good health; no other group membership contrasts were significant. Regression
analysis also revealed a significant relationship between medication use and self-reported health
status. Individuals taking more medications were less likely to report excellent or very good
health and significantly more likely to report poor or fair health rather than good health. Alcohol
use was significantly related to self-reported health status yet the interaction effect of alcohol use
and medications was not significant.
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In addition to assessing the relationship between self-reported health status and concurrent
use, models were run to examine the relationship between concomitant use and physical
functioning. Women were significantly more likely than men to report having any IADLs or
ADLs rather than no IADLs or ADLs. Age was positively correlated with total number of
IADLs and ADLs with older individuals reporting higher rates of IADLs and ADLs compared to
no IADLs or ADLs. Group membership was not found to be significantly related to total
number of IADLs however, it was related to total number of ADLs. Respondents in the
decreasing use group were more likely than individuals in the no to low use group to report
having one ADL or two ADLs rather than no ADLs; there was no significant difference between
reporting three or more ADLs for individuals in the decreasing use group compared to the no to
low use group. A positive correlation between number of medications and difficulties with
ADLs and IADLs was found; individuals with more ADLs and IADLs were more likely to be
taking one or more medications rather than none.
Depression status was found to be related to sociodemographic characteristics as well as
group membership. There was a significant inverse relationship between gender and depression
status with females being more likely to have a diagnosis of depression than males. The odds of
being clinically depressed decreased for men compared to women. There was also a significant
relationship between race and depression status with African Americans having a higher rates of
depression compared to Whites. Age was found to be positively associated with depression
status; older individuals have higher rates of depression than their younger. Significant
relationships were also found between depression status and membership in the increasing use
and the decreasing use trajectories. The odds of being depressed rather than not depressed
increased for individuals in the decreasing use group rather than those in the no to low use
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trajectory. Conversely being a member of the increasing use trajectory was found to be
associated with lower levels of depression. Multinomial logistic regression models were also run
to examine the effect of alcohol and medications use on depression status. Medication use was
significantly related to depression status. A one unit increase in the total number of medications
being used increased the chance of being depressed rather than not depressed by 11.9%. Alcohol
use was not significantly related to depression status nor was the interaction between weekly
alcohol use and total number of medications.
Multiple logistic regression models were run to investigate the extent to which
participants physical and mental health status at baseline helped explain reported health status at
Wave 6. Logistic regression revealed that physical and mental health statuses at baseline were
the best predictors of health status in the final wave of the study. Group membership was a
significant predictor of self-reported health status but it did not predict physical functioning or
depression at Wave 6.
A significant relationship was found between concurrent use and duration to death. For
every one unit increase in concurrent use (the interaction of weekly alcohol use and total number
of alcohol-interactive medications) the hazard ratio for mortality increased by a factor of 1.01.
Gender and age were both positively correlated with mortality with men and older individuals
being more likely to experience an event than women and younger individuals. Finally, being
White was significantly associated with a lower risk of mortality.
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5.0

DISCUSSION AND IMPLICATION

5.1

OVERVIEW

The interaction of alcohol and prescription drugs is an important health concern for individuals
of all ages, it is a particularly salient issue for older adults, who take more medication than any
other age cohort and are more susceptible to the effects of alcohol and/or medications due to
physiological changes associated with aging (Moore et al., 2007; Swift et al., 2007; Pringle et al.,
2005; SAMHSA, 2004). Despite older adults’ increased risk of alcohol-medication interaction
there has been limited research focused on the prevalence, patterns and correlates of
simultaneous alcohol and medication use in community-dwelling older adults. To date, the
majority of research regarding concurrent alcohol and medication use has been conducted with
young or middle-aged populations and has focused primarily on chronic heavy drinkers; few
studies have examined the alcohol-medication interactions among low to moderate users in the
general population of older adults (Onder, et al., 2002). Additionally, the body of literature that
has examined concurrent use among community-dwelling older adults has largely been
conducted in primary and acute care settings and has focused on adverse drug reactions.
The current study presents data on the prevalence, usage patterns and health outcomes
associated with concurrent among community-dwelling older adults. Many of the hypotheses
examined in this investigation were at least partially substantiated by the results; however other
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hypotheses were not supported by the data. The following chapter discusses the results of this
study and offers possible justifications for the study’s findings. In addition, implications for
social work practice and policy are presented. Suggestions regarding future research are offered
followed by a discussion of the study's strengths and limitations.

5.1.1

The Prevalence of Concurrent Use among Older Adults

Alcohol Consumption
The first aim of this investigation was to examine rates and correlates of concurrent use among
community-dwelling older adults. In order to assess concurrent use it was first necessary to look
at baseline rates of alcohol consumption and medication use in this sample. Analysis revealed
that half of the respondents reported weekly alcohol consumption; the majority of older adults
who reported weekly alcohol usage drank below or within NIAAA recommended guidelines
(39.8%). However, 6.7% of respondents reported drinking above the recommended guidelines
(8 – 19 drinks a week) and 3.3% consumed 20 or more drinks a week, nearly three times the
recommended guidelines for weekly alcohol consumption for older adults. These statistics are
consistent with past research on alcohol consumption among older adults; research indicates that
between 40% and 50% of seniors consume alcohol and 10% drank above recommended
guidelines (Breslow, Faden & Smothers, 2003; Blow & Barry, 2002). Therefore, rates of alcohol
use in the study sample are comparable to past knowledge regarding drinking behavior among
older adults.
Reduced alcohol consumption in late life is associated with a number of factors including
the onset of chronic condition, increased medication use, age, and gender. However, recent
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studies indicate that gender, not cohort effects, may be a better predictor of both rates and level
of alcohol consumption. Studies indicate that the rates of alcohol consumption among the newer
cohort of aging baby bombers are decreasing slower than previous cohorts indicating that the
“age effect” is not the only factor influencing level of alcohol consumption among older adults
(Karlamangla et al., 2005; Moore et al., 2005) . In addition, research indicates prevalence rates
and the likelihood of heavy drinking declined more slowly with increasing age in men versus
women (Karlamangla et al., 2005). Given that women are more likely to abstain from alcohol
use, have lower levels of consumption and tend to live longer than their male counterparts, it is
likely that gender plays a large role in impacting the prevalence of alcohol use among older
adults.
Men were significantly more likely than women to report weekly alcohol consumption.
Men also reported higher rates of alcohol consumption; the mean number of drinks per week for
men was twice that for females. In addition, males were more likely to be classified as
hazardous alcohol users, consuming 14 or more drinks a week, twice the NIAAA recommended
guidelines. Whites reported higher rates of alcohol consumption than African Americans and
were more likely than African Americans to report drinking above NIAAA guidelines.
Furthermore, rates of alcohol use differed by age, with older individuals having higher rates of
abstinence and lower rates of alcohol consumption. Individuals over the age of 75 were less
likely than their younger counterparts to report hazardous use. The current study supports past
findings regarding drinking behavior among older adults. Although rates and levels of alcohol
consumption decrease with age, nearly half of all older adults continue to drink alcoholic
beverages; consumption of alcohol among older adults is most prevalent among men, Whites,
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and younger individuals (Merrick et al., 2008; SAMHSA, 2005; Breslow et al., 2004;
Schoenborn & Adams, 2002).
By 2040 more than 20% of the US population will be over the age of 65, while alcohol
use generally declines with age the results of this study indicate that at least half of seniors report
weekly alcohol use (Kensella & He, 2009). Moreover, this study further corroborates research
findings that approximately 10% of people over 65 consume alcohol in excess of the NIAAA
guideline for seniors of drinking no more than seven alcoholic beverages in a week (Kirchner et
al., 2007; Blow & Barry, 2002). Research has shown that birth cohorts that experience high rates
of alcohol use in youth or young adulthood have subsequently shown higher rates of use as they
age, relative to other cohorts (SAMHSA, 2000). Significantly higher rates of alcohol and illicit
drug use have been found in the birth cohorts of the “baby boom” generation (SAMHSA, 2001).
The higher prevalence of alcohol and drug use among this generation coupled with the overall
large population size of this cohort, suggests that the number of alcohol and illicit drug users
among older adults will increase in the coming years as this group enters older adulthood.
(SAMHSA, 2001). Therefore, it is expected that the increasing number of aging baby boomers
will probably have an enormous impact on the need and demand for health care among older
adults (Blow, et al., 2002). Of particular concern is the increasing rate of concurrent alcohol and
medication use among older adults.

Medication Use
The hypothesis that concomitant use was fairly common among older adults was supported in the
current study. Seventy-seven percent of participants reported took at least one medication in the
past 14 days; on average participants were taking 2.34 (SD=2.2) medications a day. The rate of
135

medication use among the study sample was somewhat lower than national averages found in the
past. For example, in 2006 more than 93% of adults ages 65 and older reported taking at least
one medication in the last week, over half (58%) reported taking five or more medications, and
18% reported taking ten or more (Slone Epidemiology Center, 2006). The lower percentage of
medication use in the study sample is most likely due to the fact that a number of individuals
such as those in institutional settings were excluded from participating in the study.
Sixty-two percent of respondents were taking an alcohol-interactive medication at
baseline; the mean number of alcohol-interactive medications used by respondents was 1.25
(SD=1.35). The majority of participants reported taking alcohol-interactive medications that had
a low to moderate interaction with alcohol. Women were significantly more likely than men to
be using one or more medications and were also significantly more likely to be taking more
alcohol-interactive medications than their male counterparts. As one might expect, age was
found to be a significant predictor of medication use; older individuals were more likely to be
taking multiple medications and had higher usage rates of alcohol-interactive medication than
study participants younger study participants.
The percentage of participants using medications differed by race as well. African
Americans were less likely than Whites to be taking no medications, 18.5% versus 24.0%.
Interestingly African Americans had significantly higher rates of overall medication use and
reported greater use of alcohol-interactive medications than Whites. There are a number of
possible explanations for this finding. Racial and ethnic disparities in health care have been
described across a wide spectrum of health services, research indicates that being a member of
ethnic or racial minority group appears to be a risk factor for receiving less comprehensive care.
There are three factors that most likely are responsible for racial differences in the rate of use of
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alcohol-interactive medications. First, older African Americans exhibit higher rates of many
common chronic conditions, such as hypertension, diabetes, stroke, circulatory disease, arthritis
and other musculoskeletal impairments, as well as mental health and nervous disorders
(Fillenbaum et al., 2000; Martin & Soldo, 1997). Many of these chronic conditions are
traditionally treated with medications that are alcohol-interactive such as antidiabetic agents,
antihypertention drugs, and NSAIDs which contributes to differences in rates of use of alcoholinteractive drug use between Whites and African Americans.
In addition to differences in health conditions, recent research indicates disparities in
prescribing practices (specifically regarding medication class) between Whites and African
Americans (Hanlon et al., 2009; Blazer, et al., 2000). Using the example of antidepressants,
several recent studies have found that when African Americans are prescribed antidepressants
they are more likely to receive tricyclic antidepressants than SSRIs despite the fact that there is a
significant reduction in side effects with SSRIs than with tricyclic antidepressants (Blazer, et al.,
2000). This is just one example of a difference in prescribing practices that is partially
determined by the race of the patient that may partially explain differences in the use of alcoholinteractive medications between Whites and African Americans.
Finally, as stated earlier, there are differences in the quality of care received by African
Americans. White older adults are more likely than African Americans to receive regular
ambulatory care from private physicians, whereas African Americans tend to use community
health centers, hospital outpatient departments, or emergency rooms (Martin & Soldo, 1997).
These practice settings are characterized by less satisfactory patient-physician relationships and
less continuity of care than private physicians' offices (Martin & Soldo, 1997). Whites may be
less likely to be prescribed alcohol-interactive medications because of the higher quality of care
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they receive; there physicians may be more likely to screen for and / or know about their alcohol
consumption and write prescriptions accordingly.

Concurrent Use
At baseline, just over a quarter of study participants (28%) reported concurrently using alcohol
with one or more alcohol-interactive medications. Although national estimates of the combined
prevalence of alcohol and medication use among individuals aged 65 and older are still
unknown, the rates of concomitant use found in the current study are fairly consistent with the
limited literature that does exist on concurrent use among older adults in the United States
(Moore et al., 2007). One investigation of 667 community-dwelling older adults in northeast
New York estimated that 25% of study participants drank alcohol with alcohol-interactive
medications (Foster et al., 1993). In a more recent study using data from the Pennsylvania
PACE program (a state-funded program providing prescription benefits to older person with low
to moderate incomes), Pringle and colleagues (2005) found that 19% of those individuals who
reported consuming alcohol (20.3% of the sample) took medications that could have negative
interactions with alcohol. The increased service needs of aging alcohol users will most likely
place a financial strain on existing resources, particularly given the high rates of medication use
among this group. Older adults are the heaviest users of prescription medicines and over-thecounter drugs of all population sectors, and mixing these substances with alcohol can cause
harmful interactions as well as exaggerate or reduce the effects of many medications. In addition,
concomitant use increases the risks for falls and accidents, which can be very serious for people
in this age group. Finally, concurrent use can exacerbate many medical conditions common in
older people, such as high blood pressure and ulcers.
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Although medications are central to managing the health of older patients, medication
nonadherence such as concurrent use can lead to a number of adverse outcomes. As the U.S.
population ages, new drugs are developed, and new therapeutic and preventive uses for
medications are discovered, medication use by older adults will most likely continue to grow
(Budnitz & Layde, 2007). Older patients, especially those who are chronically frail or acutely
ill, may require special consideration when making prescribing decisions because of age-related
changes in the metabolism and clearance of medications and enhanced pharmacodynamic
sensitivities (Spinewine et al., 2007). The growing population of older adults has made primary
disease prevention and efforts to promote healthy lifestyles a top priority of those providing
services to older adults. Finding ways to prevent and reduce rates of concurrent use can play a
key role in reducing the health care burden associated with alcohol use among older adults. This
study confirms previous findings that approximately one-quarter of community-dwelling older
adults concurrently use alcohol and medications. Given this statistic it is clear that concurrent
use is a common public health issue among older adults that can lead to significant economic and
social costs as the number of older adult’s increases in this country.

5.1.1.1 Correlates of Concurrent Use among Older Adults
Analyses at baseline reveled concurrent users had higher rates of overall medication use and
were taking more alcohol-interactive medications than individuals who reported no concurrent
use. Study participants who reported concomitant use also were more likely than non-concurrent
users to take multiple alcohol-interactive medications; 22.1% versus 14.1% respectively. These
findings are to be expected, one would hypothesize that individuals who consume more
medications would have a higher likelihood of being prescribed an alcohol-interactive
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medication placing them at an increased risk for concurrent use. Thus, prevention efforts and
education campaigns should target individuals who report taking multiple medications. Men had
greater rates and reported more hazardous levels of concurrent use than women. At baseline,
men had higher rates of concurrent use than women despite the fact the women were more likely
than men to be taking one or more alcohol interactive medications. Rates of concurrent use for
women and men were 26% and 32% respectively. Men (8.4%) were twice as likely as women
(4.8%) to have moderate to high levels of concurrent use at baseline. Additionally, Whites
reported higher levels of concurrent use than their African American counterparts. Nearly 7% of
Whites reported moderate to high levels of concurrent use compared to only 3.8% of African
Americans. Given that men and Whites have a higher frequency of alcohol use and consume
greater quantities of alcohol when compared to women or African Americans it is not surprising
that analysis revealed they were the group with the highest rates and levels of concurrent use.
This finding points to the need for increased monitoring of alcohol consumption and medication
adherence among White males. Interestingly, there were no significant difference in rates of
concurrent use found for age; concurrent usage rates remained fairly stable regardless of age
category. This pattern may be indicative of the fact that alcohol consumption is a behavior that
is carried on throughout the course of life and although rates of consumption may decrease with
age, individuals who have a history of alcohol use continue to drink regardless of the
introduction of medications that can potentially interact with alcohol.
Although many of the interactions between alcohol and medications occur primarily
among individuals who drink heavily (> 3 drinks/occasion), interactions may also occur in
individuals who consume light to moderate amounts of alcohol (1 – 2 drinks/occasion) (Moore et
al., 2007). Older adults are at increased risk for a variety of adverse consequences depending on
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the amount of alcohol and the type of medications consumed. In this investigation it was found
that of those individuals who reported weekly alcohol use at baseline, 56.7% were concurrently
using alcohol with alcohol-interactive medications. Most participants were taking one alcoholinteractive medication (48%) however; 22.1% of respondents who reported concurrent use were
taking three or more alcohol-interactive medications. Individuals who were classified as
problem users, drinking nearly three times the weekly recommended guidelines for older adults
(>20 drinks a week), were statistically more likely to concurrent use than non-problem users. It
is likely that these individuals have a history of misuse or abuse of alcohol that has continued on
into late life. Therefore, they continue to consume alcohol irrespective of the fact that they are
also using one or more alcohol-interactive medications.

5.1.1.2 Prevalence and Correlates of Concurrent use among Older Adults: Implications for
Practice
Social workers and geriatric social workers in particular, try to improve the quality of life for
older adults by alleviating some of the negative aspects of aging. As such, social workers play
an integral role in improving the quality of life of older adults and their caregivers. Geriatric
social workers are employed in a variety of settings and have a range of duties, making them
uniquely situated to deal with issues associated with concurrent alcohol and medication use
among older adults. The results of this study offer data on the prevalence rates and correlates of
concurrent use among community-dwelling older adults and can be used to inform both practice
and policy.
The two most important aspects of promoting medication adherence and preventing
hazardous behavior such as concurrent alcohol and medication use are identifying problem
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behaviors (screening and diagnosis) and providing a system of coordinated care. Although the
current investigation found that a quarter of seniors concomitantly use alcohol and medication
rates more seniors could be at risk due to the increased number of older adults and higher rates of
medication use. Therefore, medication and alcohol use need to be part of the regular screenings
received by older adults in both medical and Aging care network settings. Because social
workers frequently have contact with older adults and they are familiar with the types of
information collected by various agencies in the Aging care network, social work professionals
are in the position to assist in creating brief screening tools to assess medication adherence. In
addition, they can help in implementing screening tools for concurrent use among older adults.
Social workers can also play a key role in creating linkages between primary care, other health
care professionals and agencies in the Aging care network allowing for a continuum of care;
linking these various providers can make it easier to ensure medication adherence. If an
individual not only concurrently uses alcohol and medications but also presents with an alcohol
problem, social workers can assist in helping these individuals get the substance abuse treatment
they need and in some cases actually provide the treatment itself.
Educating older adults, their families, and caregivers about the dangers of concurrent use
is a critical element in reducing concomitant use and improving the overall quality of life and
health outcomes of older adults. Social workers who have a rapport with clients and frequently
meet with seniors, their families, and caregivers can make sure that these individuals are aware
of the problems associated with concurrent use. The findings from this study indicate a
significant need for social work and health care professionals to educate older adults about the
dangers of concurrent alcohol-medication use. Additionally, it appears that there is a need for
health campaigns that focus on the promotion of safer use of alcohol and medications and
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increase public awareness about concurrent use among older adults. Education initiatives should
be senior-specific rather than targeting the larger adult population. Because of their frequent and
ongoing contacts with older adults, social workers are ideal candidates for designing and
implementing educational initiatives aimed at educating the public about concurrent alcohol and
medication use. Social work professionals also have the skills necessary to assist in creating
educational curriculums designed to prevent alcohol and medications by older adults as well as
educational modules aimed at reducing or eliminating harmful medication practices such as
concurrent use. In addition to social workers, health care professionals and pharmacists can
assist in identifying individuals at risk for concurrent use.
The results of this study indicate that the use of medication in concert with alcohol is
fairly common among Americans ages 65 and older it is imperative that health care professionals
regularly ask seniors about their consumption of alcohol even if it is something as simple as
asking “Do you drink any alcohol?” or “How do you use alcohol”. Because even low to
moderate alcohol consumption can lead to harmful adverse drug reaction, simply knowing that
an older adult uses alcohol is useful in determining if they are at risk for or are currently
concomitantly using alcohol and medications. Health care professionals or caretakers who are
with individuals in their homes and therefore are able to observe behaviors regarding alcohol and
medication use are in a unique position to assess harmful behavior. For example, home health
care workers are ideally situated to engage in ongoing monitoring of medication adherence and
to assess whether or not a particular client is at risk for or are engaging in concurrent alcohol and
medication use.
In addition, encouraging medication adherence and appropriate prescribing practices are
critical components necessary to reduce concomitant use among older adults. Health care
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professionals can play a key role in reducing concurrent use by making certain older adults
understand the medications they are taking and the possible side effects. Health care
professionals need to encourage older adults to keep an up to date list of all the medications they
are taking and the dosing to provide at medical appointments; if an individual is seeing multiple
doctors such a list will ensure safe prescribing practices. The use of more than one pharmacy is
a leading cause of adverse drug reactions because there is no running record of all the
prescriptions an individual may be taking which makes it difficult for a pharmacist to assess any
potential interactions. Therefore, nurses and doctors should encourage patients to use only one
pharmacy to fill prescriptions.
Finally, nurses and doctors should encourage older adults to communicate with their
pharmacist about any medications they are taking so that they understand any possible side
effects or interactions. Providers of services to seniors need to make sure that instructions for
taking medications are explicit and understood. Potential declines in hearing and vision may
make it hard for seniors to understand how to properly use their medications; small fonts on
labels and scientific terminology can often lead to the misuse of medications among older adults.
Pharmacists are in a powerful position to assist in preventing concurrent use and can also
aid in identifying problems with medication and alcohol interactions, misuse, or abuse (Sullivan
et al., 2007). Since they are uniquely situated to recognize and prevent concurrent use,
pharmacists need to be aware of the various factors that place older adults at an increased risk for
concurrent use.
Communicating with older adults about their medication use is key; patience and
persistence are crucial factors to effective communication with seniors. Perceptions about
medications used are a significant indicator of how well older adults will adhere to regimes;
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older adults who see medications as necessary, useful, and less harmful are more likely to take as
prescribed (Sullivan et al., 2007; Horne & Weinman, 1999). Pharmacists can assist in
medication adherence and reduce rates of concurrent use by properly explaining the reason for
and the effects of any medications prescribed and dispersed; the dangers associated with
concurrent use should also be reviewed with the patient and / or caregiver. Pharmacists should
get in the habit of asking older adults if they drink when they are filling a prescription for a
medication that is considered alcohol-interactive. Pharmacists should recommend than an
individual not drink when they have been prescribed certain types of drugs such as
benzodiazepines, sedatives and narcotic analgesics; medications commonly used by older adults.
Lastly, when prescriptions for alcohol-interactive medications are refilled, pharmacists should
remind the individual or the caretaker that alcohol should not be consumed when taking that
medication.

5.1.2

Patterns of Concurrent Use among Older Adults

Preliminary explorations of the data revealed that nearly half of all study participants (46%)
concurrently used alcohol with alcohol-interactive medications during at least one of the six
waves of the study; one-third of concurrent users reported concomitant alcohol-medication use in
4 or more waves of the study. Based on these preliminary findings, it was hypothesized that
there would be a minimum of two unique longitudinal trajectories of concurrent use. Groupbased trajectory modeling was used to test the hypothesis that various trajectories of concurrent
use exist among community-dwelling older adults. Group-based modeling was particularly
useful in helping to identify multiple trajectories of concurrent use among community-dwelling
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older adults; often overall percentages obscure important trends and fail to take into account
unique patterns of behavior. The hypothesis regarding multiple patterns of concomitant use was
substantiated by the data; four distinct trajectories of concurrent use were identified.
Each of the four cohorts identified by the best fitting model were characterized by their
own distinct patterns of concurrent use. The majority of respondents were grouped into the no to
low use trajectory which is comprised of individuals who did not concurrently use alcohol and
medications or those respondents who had low levels of concomitant use. The trajectory for the
no to low use group is fairly flat and essentially these individuals maintained a stable pattern of
no or low levels of use over the course of the study. Given that half of seniors do not consume
alcohol and drinking tends to decrease in age we would expect that the majority of older adults
would fall into a developmental trajectory that includes no or low rates of concurrent use. This
cohort is most likely comprised of lifetime abstainers and occasional drinkers and individuals in
this group are at low risk for concurrent use.
The decreasing use trajectory is characterized by a gradual and steady decrease in
concurrent use over time. Rates of concurrent use were moderately high among members of the
decreasing use group in the initial waves of the study but substantially decreased with time so
that by the final study wave concurrent use was fairly low among this population. It is possible
that this group is characterized by individuals with declining health and / or the addition of new
alcohol-interactive medications which lead them to make the decision to not drink alcohol. An
additional possibility is that members of this trajectory have declining rates of concurrent use
because new or existing chronic conditions limit their ability to consume alcohol. Social
workers and other health care providers should encourage individuals in this cohort to continue
to curtail their concurrent use and offer support in assisting them in altering their behavior.
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The increasing use trajectory is best characterized as a group of individuals whose
concurrent use fluctuates over time. Initially levels of concurrent use in the increasing use
cohort were fairly low. However, concurrent use increases among this population over the course
of the study. The most logical explanation for this pattern of concurrent use is this group is
comprised of individuals who developed new chronic conditions over the course of time and
these conditions are treated with alcohol-interactive medications. Yet, despite the introduction
of a new medication into their regime these individuals continue to consume alcohol; this may be
due to the fact that patients are under informed about the potential for alcohol-drug interactions.
Therefore, it is essential that geriatric social workers and health care providers monitor older
adult’s medication regimes and counsel them about the potential interactions of a medication
with alcohol each time the regime is altered.
Finally, the trajectory for the high use cohort is indicative of high-stable rates of
concurrent use over time. Individuals in the high use group, approximately 15% of the sample,
maintained a consistent pattern of concurrently using alcohol and alcohol-interactive medications
throughout the course of the study. As stated earlier it is most likely that this group is
characterized by individuals who have a history of alcohol use and therefore, irrespective of their
medication regime, they continue to drink. This group which is disproportionately comprised of
White males is at an elevated risk for the adverse consequences of concurrent use. Thus,
individuals in the aging care network should use consistently screen individuals who meet this
profile for concurrent use behavior. In addition, education and prevention strategies should
target this at risk group.
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5.1.2.1 Impact of Concurrent Use on the Health Status of Older Adults
Regression analysis was used to examine the relationship between patterns of concurrent use and
health status. Specifically, it was hypothesized that individuals with developmental trajectories
of ongoing concurrent use would have lower rates of self-reported health, lower levels of
physical functioning as well as higher rates of depression. The hypothesis that there was a
relationship between longitudinal trajectories of concurrent use and health status was partially
substantiated by the data. The analysis revealed that specific patterns of concurrent use are
significantly related to both physical and mental health status among community-dwelling older
adults however, the directionality of some of the originally hypothesized relationships did not
hold up.
The hypothesis that self-reported health status would be lower among concurrent users
was partially substantiated by the data. Using good health as the reference category, being male
increased the odds of reporting excellent to very good health. Also, Whites were significantly
more likely than African Americans to report very good health; African Americans had
significantly higher rates of self-reported fair or poor. This finding is consistent with research
that suggests health disparities between Whites and African Americans. Finally, compared to
younger individuals, older respondents were significantly more likely to report fair or poor health
rather than good health. Members of the high use trajectory were significantly less likely than
those in the no to low use group members to report excellent health rather than good health; no
other group membership contrasts were significant. This finding deviates from the results of the
initial baseline analysis where no difference was found between concurrent users and nonconcurrent users. Individuals in the high use may be less likely to report excellent health for a
number of reasons which may be related to the side effects associated with concurrently using
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alcohol with alcohol-interactive medications. An equally valid explanation for this finding is
that the onset or worsening of existing chronic conditions due to concomitant use has lowered
the perceived health status for members of this group. Interestingly, no differences were found
between the no to low use group and the increasing or decreasing use cohorts. Given the
research on self-medication we might expect that individuals in the increasing use group would
report lower levels of overall health when compared to those in the no to low use group. An
alternative explanation for this finding may be that the increasing use of alcohol and medications
is due to pain management but the addition of additional medications to deal with chronic
conditions.
In addition to assessing the relationship between self-reported health status and concurrent
use, models were run to examine the relationship between concomitant use and physical
functioning. Women and older individuals were significantly more likely than men and younger
respondents to report having any IADLs or ADLs. Group membership was found to be to total
number of ADLs. Respondents in the decreasing use group were more likely than individuals in
the no to low use group to report having one ADL or two ADLs rather than no ADLs. This
finding is of particular interest because it partially substantiates the idea that individuals in the
decreasing use trajectory are discontinuing concurrent use practices because of declining health
and / or the addition of new alcohol-interactive medications.
Depression status was also found to be related to socio-demographic characteristics as
well as group membership. There was a significant relationship between gender and depression
status with females being more likely to have a diagnosis of depression than males. There was
also a significant relationship between race and depression status with African Americans having
a higher rates of depression compared to Whites. Age was found to be positively associated with
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depression status; older individuals have higher rates of depression than their younger
counterparts. Finally, significant relationships were found between depression status and
membership in the increasing use and the decreasing use trajectories. The odds of being
depressed rather than not depressed increased for individuals in the decreasing use group rather
than those in the no to low use trajectory. Increased rates of depression in the decreasing use
group may be related to declining physical health or the introduction of a new chronic condition
which has caused mental distress. It is also possible that members of the decreasing use group
have chosen to stop drinking because they are being treated for depression. Conversely being a
member of the increasing use trajectory was found to be associated with lower levels of
depression. Individuals in this group may be in better physical condition and more social
therefore, they are less likely to be isolated which decreases rates of depression but can effect
rates of alcohol consumption which can lead to concurrent use.
Logistic regression revealed that, although group membership was related to specific
health outcomes, physical and mental health statuses at baseline were the best predictors of
health status in the final wave of the study. Although it is not surprising that health status at
baseline was found to be the greatest predictor of physical and mental health outcomes, it is
interesting that trajectories of concurrent use were not related to health status in Wave 6. Group
membership was expected to predict health status and, although the relationships were in the
predicted directions, with the exception of self-reported health, they were not significant. It is
possible that group membership was not a significant predictor of physical and mental health
status because the majority of the people fall into the no to low use group. Thus it is suggested
that future research further investigate the relationship between overall health and concurrent use
among older adults with a wide range of health outcomes.
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Finally, survival analyses of the entire sample (No=5,888) showed a significant
relationship between concurrent use and mortality. The interaction of weekly alcohol
consumption and the total number of alcohol-interactive medications taken at baseline was
significantly related to duration until death; a one unit increase in time increased the risk of
mortality by 1. This finding points to the potentially hazardous consequences of concurrent use
among older adults. More research is needed to fully understand how concomitant use impacts
upon mortality overtime. Interestingly, having ever concurrently used was inversely related to
mortality status. This finding is most likely due to the fact that individuals who live longer are
more likely to be exposed to alcohol-interactive medications and as a result have a higher
likelihood of reporting concomitant use.

5.1.2.2 The Patterns and Consequences of Concurrent Use among Older Adults:
Implications for Practice
The risk posed by concurrent alcohol and medication use among older adults is not minimal,
therefore, from a prevention standpoint it is essential for clinicians to screen for concomitant use
and to provide warnings to older adults to prevent adverse outcomes. Although research has
found that alcohol consumption declines with age, studies have shown that the average amount
of alcohol consumed by older adults who continue to drink does not change overtime (Adams et
al., 1990). The current study reinforces past research, data show that for the majority of study
participants patterns of concurrent use remained fairly stable over the course of the investigation
with fluctuation in usage patterns reported by only 18% of concurrent users. The identification
of four major patterns of concurrent use has further delineated what we know about concomitant
behavior among older adults. This information is particularly useful given demographic
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projections and alcohol use trends indicate that newer cohorts of older adults are more likely to
drink and have heavier drinking habits (Patterson, 1999).
The current investigation substantiates past work which has shown that alcohol use is a
habitual behavior that tends to carry into late adulthood although consumption levels may be
reduced. Given what we know about trends in alcohol consumption it stands to reason that a
subset of older adults are more likely to engage in concomitant use. Individuals in the high use
and increasing use cohorts are at an increased risk for poor health outcomes and lower quality of
life; these individuals include males, Whites, problem users and individuals taking multiple
alcohol-interactive medications. Brief interventions such as harm reduction models can be
useful in preventing and reducing concurrent use among these at risk groups. Moreover, policies
need to be put into place to aid in training of individuals in the Aging care network about
concurrent use and to assist in establishing a more coordinated system of care.
Harm reduction strategies may be useful in preventing and lowering concurrent use
among older adults. Brief interventions such as harm reduction approaches are useful in that
they tolerate a continuum of behavior and do not just target individuals at the highest level of
risk. Such interventions are designed to increase motivation to change a behavior and are well
suited for older adults. In addition, harm reduction strategies are particularly useful for working
with older adults because they can be carried out in numerous settings by a variety of
professionals. Harm reduction strategies are non-confrontational and non-judgmental; they are
used to encourage learning and self awareness about risky behaviors (Royer et al., 2000).
Although this type of intervention may not be useful in reducing concurrent use among
individuals with severe alcohol problems, the current study found that the majority of individuals
exhibited low to moderate patterns of concurrent use. High risk concurrent users, typically
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individuals with alcohol use disorders, will most likely need to be referred to geriatric specific
substance abuse treatment programs to deal with both their medication use and problem drinking
behaviors. However, harm reduction models designed to address concurrent use in low to
moderate users may be an effective strategy to reducing hazardous medication behavior among
the majority of older adults who concurrently used. Harm reduction strategies coupled with
educational and prevention efforts implemented by social workers and other professionals in the
Aging care network appears to be a cost effective strategy to addressing concurrent use among
older adults.
In addition to brief intervention strategies, policies need to be established to support
educational initiatives to raise awareness among older adults, families, and caretakers about the
risks associated with mixing alcohol and medications. In addition, training programs need to be
established for social workers, health care providers, and other individuals in the aging care
network to assist them in understanding the issue of concurrent use among older adults and to
provide them with the skills necessary to assess and intervene with older adults.
Collaboration and communication among professionals and agencies are critical
components of delivering effective services to older adults. Community partnerships can foster
relationships that can increase the coordination of services and assist in the development of a
continuum of care for seniors. Policies that enhance communication between clients, caregivers,
social workers and health care professionals play a vital role in reducing potentially hazardous
behaviors such as concurrent use among older adults.
Older adults are most likely to come into contact with medical professionals in primary
care settings, as well as professionals in the aging services network. It is crucial that these
individuals receive training in identifying potentially hazardous medication usage patterns in
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geriatric populations. In addition, screening tools that are specifically designed for older adults
and are suited for primary care settings are needed to assist healthcare professionals in
identifying individuals who are at risk for or are currently concomitantly using alcohol and
medications. With education, training, and improved tools professionals in primary care settings
and the aging services network can play a vital role in preventing, identifying, and treating the
misuse or abuse of alcohol and medications in older adults. Unfortunately, programs and
assessment tools do not exist to provide geriatric social workers and other health care
professionals who work with older adults with the tools necessary to identify and address
concurrent alcohol and medication use.
In order for social workers and other professionals in the aging care network to
effectively implement strategies aimed at preventing concurrent use as well as programs that deal
with problems associated with the issue, they must first be educated about the issue themselves.
Training programs are needed for service providers to help them gain a better understanding of
alcohol or other drugs in late life and when the use of alcohol and medications may lead to
negative outcomes for seniors (Spencer, 2008). Policies need to be established to develop
programs that provide training to these individuals on how to identify, diagnose, and treat older
adult with hazardous medication use patterns or other substance abuse issues. Medicare is one of
the few federal programs with the ability to implement training initiatives with medical
professionals and other professionals in the aging services network.
Public programs, specifically Medicare and Medicaid, currently serve as the primary
insurers for older adults. Investing in such an initiative would help save the program money in
future healthcare costs associated with adverse drug reactions and health problems exacerbated
or caused by concurrent use. If Medicare is committed to combating the abuse and / or misuse of
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alcohol with medication among older adults, one key strategy would be to establish an outreach
program designed to enhance education, prevention and screening for alcohol and medication
abuse and / or misuse among the elderly. The program would link Medicare to professionals in
primary care settings and those working in the Aging care network who are uniquely situated to
identify and address the needs of older adults who concurrently use alcohol and medications.
Cross-training of healthcare professionals and aging service providers is critical to
preventing, identifying and treating concurrent use among older Americans. Healthcare
professionals along with social workers and mental health service providers need training to
understand how to effectively work with older adults to promote medication adherence and
lower rates of concurrent use among this population (SAMHSA, 2002). Likewise, aging service
providers need to be trained to identify mental and behavioral health problems in older adults
(SAMHSA, 2002). In addition to training, the creation of linkages with community partners,
healthcare professionals, and aging service providers can help identify substance related
problems in an aging patient population by creating a system of coordinated care.
Lastly, funding needs to be made available for research aimed at better understanding the
barriers to prevention and interventions for older adults who concurrently use alcohol and
medications. Future research will be invaluable in assessing the current capacity to deal with
concurrent use among older adults. It will help in identifying gaps in service provision, and can
provide projections regarding future needs of older adults who concomitantly use alcohol and
medications. Funding is of particular importance for the implementation and assessment of
demonstration projects aimed at prevention and intervention with older adult concurrent users.
Pilot projects are essential to identifying best practices for supporting positive decision making
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among older adults, their families, and their caregivers concerning their alcohol and medication
use behavior.
As the number of older adults dramatically increases over the coming decade, service
providers as well as the health care system as a whole will face a number of new challenges.
Current Medicare policies around alcohol and medication use and / or abuse are not
comprehensive, particularly in the areas of prevention, education, and diagnosis. The healthcare
system, especially Medicare, must prepare for the influx of older adults who will need services in
the next twenty years by developing policies and programs designed to meet the unique needs of
older adults; in order to do this the Medicare program and other agencies in the aging care
network will need to being to place more emphasis on prevention.
In summary, harm reduction models and education programs that raise awareness
regarding the dangers of medication non-adherence among providers, patients, caregivers and the
general public will play a key role in reducing adverse health outcomes associated with
concurrent use thus assisting in lowering overall health care costs. Additionally, as budgets
tighten and health care costs increase, federal and state authorities will be increasingly
challenged to emphasize prevention strategies and find new ways to promote healthy lifestyles
among older adults. Education and prevention strategies coupled with an infrastructure of
coordinated care will go a long way in promoting positive health behaviors and preventing
potentially harmful activities such as concurrent alcohol and medication use among older adults.
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5.2

5.2.1

STRENGHTS AND LIMITATIONS OF THE STUDY

Strengths of Current Study

The current study attempted to address gaps in the literature regarding concurrent alcohol and
medication use among community-dwelling older adults. In addition, this investigation sought to
address several important methodological issues present in the existing body of knowledge
regarding concomitant use among older adults; specifically, the present study focused on
measurement and research design.
The Cardiovascular Health Study has the major advantage of including a large population
based community sample of adults 65 years or older. The CHS data set is a large sample
comprised of nearly 6,000 individuals randomly selected from four communities located
throughout the country representing a mix of both urban and rural areas. The large sample size
coupled with the random sampling strategy makes this sample applicable to community-dwelling
older adults in the United States. Unlike many other existing data sets, the CHS sample is
comprised of a sufficient amount of both women and African Americans. Therefore, this study
is unique in that it allowed for the examination of differences in concurrent alcohol and
medication use for various subpopulations within this population of community-dwelling older
adults.
The majority of research on concurrent alcohol and medication use among older adults
comes out of acute or primary care settings and is cross-sectional in nature. The CHS is one of
the richest available data sets characterizing the health status of the elderly; only a few other
longitudinal studies have followed cohorts of older individuals for as long as the CHS. The CHS
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data set is extensive and includes information from interviews as well as from physical and
laboratory examinations. Importantly, the CHS has excellent measures of alcohol use, physical
and mental health status and, one particularly unique aspect, a vast amount of longitudinal data
available on medication use. Therefore, this data set was well suited for examining longitudinal
patterns of concurrent use.
The longitudinal nature of the data allowed for the examination of various trajectories of
concurrent use over the course of the study. Additionally, the use of longitudinal data made it
possible to examine how various patterns of concomitant use affect general physical and mental
health outcomes overtime, something not possible with cross-sectional data. The extensive
physical and mental health indicators available in the CHS data set made it feasible to assess
general health via a number of proxies for physical and mental health status versus “incidents” of
adverse reactions (ADRs) which is the outcome measure typically used in studies examining
concurrent use. The current study was able to move beyond the traditional means of assessing
the effects of concurrent use on health through acute adverse reactions and examine the effect of
concurrent use on health status and quality of life. Finally, because the CHS sample is
comprised only of community-dwelling older adults, information on alcohol use was obtained
from a population of individuals representing the spectrum of drinking behavior among older
adults. Therefore, it was possible to focus the current study on all individuals in sample not just
high risk or heavy alcohol users.
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5.2.2

Limitations of the Current Study

Despite the numerous strengths of the current study design, there are a number of limitations that
should be addressed. First, as with all observational studies, residual confounding factors cannot
be ruled out. Thus, causal inferences about relationships between concurrent use and health
status among community-dwelling older adults should be made with caution.
Second there are several measurement issues that need to be acknowledged as limitation
of the current study design. The reliance on self-report measures for several of the central study
variables including alcohol use and self-reported health status is a cause for concern. The use of
self-reported data can be problematic because of a number of issues including possible response
distortions such as over or under reporting, recall error, and social desirability; this is a
particularly salient measurement issue in research involving older adults. Another measurement
issue concerns the use of the CES-D to assess depression status. There is the potential for
misclassification of depression status, a key outcome measure, because the abbreviated version
of the full CES-D questionnaire was used for this study. However, since several studies have
found that reducing the screening scale to as little as the five-item CES-D scale resulted in a
similar sensitivity and specificity compared with the full 20-item CES-D scale, misclassification
should have been minimal (Irwin et al., 1999 & Turvey et al., 1999; Shrout & Yager, 1989). One
last shortfall associated with measurement concerns the variables used to assess physical and
mental health; there are other indicators of health status that were not addressed in the current
investigation. The current study does not include more refined measures of health status that
may be helpful in assessing the effects of concurrent use on physical and mental health. Future
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studies should include additional measures of physical health status such as specific chronic
health conditions and additional proxies for mental health (i.e. anxiety, quality of life indicators).
Finally, missing data due to incomplete observations, drop-out, and mortality is an issue
in all longitudinal studies. Missing data can increase the potential for bias in study results. In
the subset of the CHS data used for this study, attrition due to drop out was fairly low, 4.7%; an
additional 17.3% of the sample was lost to mortality by the final wave of the study. In order to
adequately model trajectories of concurrent use, all individuals who had incomplete data on
concomitant use were dropped from the group-based trajectory analysis as well as the regression
portion of the analysis. Although nearly a quarter of the sample was lost to attrition by the final
wave of the study, the large sample size negates any issues of inadequate power. The decision to
only include individuals with information on concurrent use for all six waves of the study
ensures that information missing at various points is due to incomplete observations and is
considered missing at random.

5.3

SUGGESTIONS FOR FUTURE RESEARCH

Although there is an emerging body of literature regarding concurrent use among older adults,
there is still a dearth of knowledge on the subject particularly when it comes to assessing patterns
of concurrent use. The current study has a number of implications for further research in the
field. In order to address gaps in the literature, future research should focus on: 1) empirical
research that continues to explore the prevalence, correlates, and patterns of concurrent use
among older adults, 2) examination of the relationship between concurrent use and health status
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and, 3) development and evaluation of educational campaigns and intervention strategies aimed
at reducing concurrent use among older adults.
Future longitudinal studies are needed in order to gain a more complete picture regarding
concurrent use and its associated covariates among community-dwelling older adults. Rates of
combined prevalence of alcohol and medication use among older adults in the United States are
still unknown however, past studies estimate rates between 40% and 50% which is consistent
with this study’s findings (Moore et al., 2006). Variations in prevalence rates are largely due to
variations in study methodology. Future research should continue to examine rates of concurrent
use among this population; efforts should be made to standardize methodological operations of
concurrent use. Additionally, empirical studies should continue investigating the covariates of
concurrent use. This study found that sociodemographic as well as behavioral variables, such as
level of alcohol consumption, were related to concurrent use among older adults. Future
research should continue to explore the complex relationship between concurrent use and a wide
variety of factors including factors like total number of alcohol-interactive medications or total
number of chronic conditions.
The current study is one of the first investigations looking at various developmental
trajectories of concurrent use. Past research has focused on the relationship between concurrent
use and ADRs. The current investigation explored the relationship between concurrent use and
health status in a new way by charting developmental trajectories of use and examining their
impact on general health outcomes rather than ADRs. In the current study, many of the
hypotheses regarding the relationship between patterns of concurrent use and health status were
not supported indicating that there is still much to be learned regarding the relationship between
unique patterns of concurrent use and health outcomes. Future work should continue to examine
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the impact of various patterns of concurrent use on the overall health status of older adults.
Research in this area should also use various health outcomes not included in this study such as
chronic conditions or quality of life. Furthermore, future research on concurrent use should look
at how specific classes of medications and known alcohol-interactive drugs effect the physical
and mental health status of older adults.
Finally, future research should focus on the implementation and assessment of
educational programs, prevention strategies, and intervention with older adult concurrent users.
Research plays a critical role in defining best practices for social work practitioners and other
professionals in the aging care network. Research should begin to develop and test strategies
aimed at fostering positive decision making among older adults, their families, and their
caregivers concerning their alcohol and medication use behavior. Evaluation of the effectiveness
of public awareness and educational efforts aimed at reducing concurrent use among older adults
is an important area of future research. Moreover, future empirical work should also focus on
assessing the effectiveness of various intervention strategies such as harm reduction models
which can be adapted to use with older adults who concomitantly use alcohol and medications.

5.4

CONCLUSION

The current study examined the prevalence, correlates, patterns and consequences of concurrent
alcohol and medication use among community-dwelling older adults. Results suggest that
concurrent use is fairly common among older adults with over half of the study participants
reporting concomitant use in at least one of the six waves of the study. The most common form
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of concurrent use was drinking below or within recommended guidelines and taking one alcoholinteractive medication. Findings from this study provide a greater understanding of the rates of
concurrent use as well as the socio-demographic characteristics associated with concurrent use
among older adults. Results revealed that men, Whites and problem drinkers were significantly
more likely to concurrently use than women, African Americans and low to moderate alcohol
users; there were no significant differences by age. Furthermore, group-based logic analysis
revealed four distinct patterns of concurrent use: a no to low use group, a decreasing use group,
an increasing use group, and a high use group. Males and Whites had the highest probability of
being in the high use group. Group membership was found to be related to physical as well as
mental health. Furthermore, concurrent use was found to be related to mortality.
The growing number of older adults coupled with an increasing use of medications
makes gaining a better understanding of the prevalence and consequences of concurrent use a
particularly salient issue. Over 50% of older adults report regular alcohol use and the rate of take
at least one medication for physical and/or mental health issues is rising among seniors. Over
the coming decades, the rising number of older adults will probably have an enormous impact on
the need and demand for health care among this population. The increased service needs of
aging alcohol user’s comorbid conditions will most likely place a financial strain on existing
resources. The growing population of older adults has made primary disease prevention and
efforts to promote healthy lifestyles a top priority. Gaining a better understanding of the
prevalence, correlates, and consequences of concomitant alcohol and medication use is critical to
developing prevention and intervention strategies that effectively meet the needs of this unique
population.
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In conclusion, understanding the sociodemographic characteristics associated with
concomitant use will aid social work practitioners and other health care providers who work with
geriatric populations in identifying individuals at risk for medication non-adherence (i.e.
concurrent use). Moreover, understanding various development trajectories of concurrent use
will be useful in helping to develop prevention and intervention strategies. Finally, although
further research is needed to fully understand the relationship, the results of this study suggest
that there is a connection between various patterns of concurrent use and health status.
Practitioners can use information on development trajectories of concomitant use to assess
potential risks for adverse physical and mental health outcomes associated with concurrent use
that may affect the quality of life among older adults.
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APPENDIX A

COMMON ALCOHOL-INTERACTIVE MEDICATIONS USED BY OLDER ADULTS

165

Drug Class
(Symptoms / Conditions)

Medication
(Brand Name)*

Analgesics
(pain relief)

Aspirin
Aleve
Excedrin
Motrin
Tylenol

Antibiotics
(infections)

Isoniazid
Acrodantin
Flagyl
Grisactin
Nizoral

Potential Reactions with Alcohol

Stomach upset, bleeding, ulcers
Liver damage
Rapid heartbeat

Rapid heartbeat
Sudden changes in blood pressure
Stomach pain & upset; vomiting
Headache
Liver damage

Anticoagulants
(prevention of blood clots)

Warfarin
Coumadin

Occasional use: internal bleeding
Heavy use: bleeding or can cause
opposite effect resulting in blood
clots, strokes, or heart attach

Anticonvulsants
(seizure disorders)

Phenobarbital
Dilantin
Klonopin

Drowsiness & Dizziness
Increased seizure risk

Antidiabetic Agents
(blood sugar regulation)

Glucophage
Micronase
Orinase

Abnormally low blood sugar levels
Nausea & vomiting
Rapid heartbeat
Sudden change in blood pressure

Antihistamines
(allergies, colds)

Benadryl
Allegra
Claritin
Sudafed
Zyrtec

Drowsiness & Dizziness
Increased risk of overdose
Decreased motor skills

Antihypertension
(high blood pressure)

Accupril
Capozide
Hytrin
Lotensin
Minipress
Vaseretic

Drowsiness & Dizziness
Fainting
Heart problems such as arrhythmia
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Drug Class
(Symptoms / Conditions)

Medication
(Brand Name)*

Potential Reactions with Alcohol

Barbiturates
(anesthesia, pain relief)

Phenobarbital
Butalbital
Pentobarbital
Secobarbital

Increased sedative & hypnotic effects

Benzodiazepines
(sedative agent)

Ativan
Halcion
Librium
Restoril
Valium
Xanax
Axid
Reglan
Tagamet
Zantac

Drowsiness
Increased sedation
Decreased motor skills

Imidazopyridines
(sleep disorders)

Ambien
Lunesta
Prosom
Unisom

Drowsiness & dizziness
Slowed or difficulty breathing
Impaired motor skills
Memory problems
Increased risk overdose

Muscle relaxants
(muscle pain)

Flexeril
Soma

Drowsiness & dizziness
Slowed or difficulty breathing
Increased seizure risk
Impaired motor skills
Memory problems
Increased risk overdose

Narcotic analgesic
(pain relief)

Darvocet
Percocet
Vicodin

Drowsiness
Increased sedation
Decreased motor skills

NSAIDs
(pain relief, inflammation)

Ibuprofen
Nalfon
Naprosyn
Orudis
Voltaren

Risk gastrointestinal bleeding

Histamine antagonists
(ulcers, heartburn)

Increased alcohol effects
Rapid heartbeat
Sudden changes in blood pressure
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Drug Class
(Symptoms / Conditions)

Medication
(Brand Name)*

Potential Reactions with Alcohol

Opioids
(pain relief)

Codeine
Fentanyl
Morphine
Diaudid
Darvon
Demerol

Drowsiness
Increased sedation
Decreased motor skills

Sedatives & Hypnotics

Noctec
Equanil

Sleepiness
Disorientation & incoherence

Statins
(high cholesterol)

Advicor
Crestor
Lipitor
Vytorin
Zocor

Liver damage
Nausea & vomiting
Rapid heartbeat
Sudden change in blood pressure
Risk stomach bleeding

Tricyclic antidepressants
(depression)

Celexa
Lexapro
Paxil
Prozac
Zoloft

Dizziness
Increased risk of sedation
Sudden drop in blood pressure
Increased risk overdose

* Generic names are italicized

Sources: NIAAA, 2007; Lococo & Staplin, 2006; Weathermon & Crabb, 1999
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